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Elucidating the Role of Endogenous Electric Fields in Regulating the 
Astrocytic Response to Injury in the Mammalian Central Nervous System 
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Doctor of Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2015 
 
Major Director: Raymond J. Colello, D. Phil. 
Associate Professor, Department of Anatomy and Neurobiology 
 
Endogenous bioelectric fields guide morphogenesis during embryonic 
development and regeneration by directly regulating the cellular functions responsible 
for these phenomena. Although this role has been extensively explored in many 
peripheral tissues, the ability of electric fields to regulate wound repair and stimulate 
regeneration in the mammalian central nervous system (CNS) has not been 
convincingly established. This dissertation explores the role of electric fields in 
regulating the injury response and controlling the regenerative potential of the 
mammalian CNS. We place particular emphasis on their influence on astrocytes, as 
specific differences in their injury-induced behaviors have been associated with 
differences in the regenerative potential demonstrated between mammalian and non-
xvi 
 
mammalian vertebrates. For example, astrocytes in both mammalian and non-
mammalian vertebrates begin migrating towards the lesion within hours and begin to 
proliferate after an initial delay of two days; subsequently, astrocytes in non-mammalian 
vertebrates support neurogenesis and assume a bipolar radial glia-like morphology that 
guides regenerating axons, whereas astrocytes in mammals do not demonstrate robust 
neurogenesis and undergo a hypertrophic response that inhibits axon sprouting. To test 
whether injury-induced electric fields drive the astrocytic response to injury, we exposed 
separate populations of purified astrocytes from the rat cortex and cerebellum to electric 
field intensities associated with intact and injured mammalian tissues, as well as to 
those electric field intensities measured in regenerating non-mammalian vertebrate 
tissues. Upon exposure to electric field intensities associated with uninjured tissue, 
astrocytes showed little change in their cellular behavior. However, cortical astrocytes 
responded to electric field intensities associated with injured mammalian tissues by 
demonstrating dramatic increases in migration and proliferation, behaviors that are 
associated with their formation of a glial scar in vivo; in contrast, cerebellar astrocytes, 
which do not organize into a demarcated glial scar, did not respond to these electric 
fields. At electric field intensities associated with regenerating tissues, both cerebellar 
and cortical astrocytes demonstrated robust and sustained responses that included 
morphological changes consistent with a regenerative phenotype. These results support 
the hypothesis that physiologic electric fields drive the astrocytic response to injury, and 
that elevated electric fields may induce a more regenerative response among 
mammalian astrocytes.  
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Chapter 1:  Physiologic electric fields regulate wound repair in the CNS 
Dissertation Synopsis 
This dissertation explores the hypothesis that physiologic electric fields (EF) 
regulate repair and regeneration in the mammal central nervous system, with a 
particular emphasis on their influence over astrocytes. This hypothesis is predicated 
upon three axioms: that the mammalian central nervous system (CNS) has a latent 
potential to regenerate that is largely a function of the astrocytic response to injury, that 
regeneration recapitulates the same physiologic mechanisms underlying 
embryogenesis and thus must be conserved in mammals, and that endogenous 
bioelectric fields regulate embryogenesis and regeneration by directly stimulating the 
underlying cellular behaviors. However, none of these axioms is taken for granted in this 
dissertation, and we thoroughly explore the existing literature underlying each 
supposition in chapter one. Through this discussion, it becomes clear that astrocytes 
determine the regenerative potential in the CNS, that EFs are well established in 
regulating embryogenesis and regeneration in peripheral tissues, and that EFs are also 
found in the CNS where they are similarly associated with embryogenesis. While this 
suggests that injury-induced EFs also regulate wound repair and regeneration in the 
CNS, it becomes equally clear that the role of physiologic EFs in the cellular response 
to CNS injury has not been explored. 
 2 
 
Thus, the discussion in chapter one culminates in the overall hypothesis of this 
thesis: that physiologic EFs regulate tissue repair and the regenerative potential of the 
CNS by their influence on astrocytes. Chapters two and three detail studies 
investigating how electric fields regulate astrocyte behaviors associated with the injury 
response; we compare how EF effects differ between cortical and cerebellar astrocytes, 
and relate these differences to differences in regenerative potential and in phylogenetic 
origins between these two brain regions. In chapter four, we describe efforts to develop 
a protocol by which we can acquire longitudinal measurements of injury-induced EFs 
over the entire duration of wound healing in the mammalian CNS, which is a necessary 
prerequisite to designing an EF-based therapeutic strategy. In chapter five, we discuss 
the implications of our findings in the context of the larger hypothesis that endogenous 
bioelectric fields are a universal stimulus that regulates morphogenesis during both 
embryogenesis and regeneration in all metazoans. We discuss established criteria by 
which such a causal hypothesis is evaluated, and we explore how existing research and 
theory regarding regeneration, bioelectricity, and evolution supports this proposed 
causal relationship. Finally, we conclude by addressing the future experimental 
directions that are necessary to advance the therapeutic implications of these 
hypotheses. 
Historical context, epidemiology, and morbidity of CNS injury 
Injury to the CNS has fascinated human civilizations for millennia. People 
suffering from CNS disorders have often been treated as pariahs or have been 
presumed to suffer from demonic possession. These long-held beliefs often reflect a 
tragic misunderstanding of the brain and mind, and they have spawned countless 
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attempts to cure patients from their various afflictions. Many different cultures have 
embodied these fantasies of regeneration within their myths and folklore, as is 
evidenced by the Grecian myth of the hydra whose head regenerated two more upon 
amputation, by the Anglo-Celtic myth of Wayland the Smith who had the power to 
restore lost limbs that have undergone trauma1, by the Aztec legend of the god Xolotl 
who allegedly imbued the amphibian species Axolotl with the power to regenerate2, by 
Catholic biblical teachings of Jesus curing blindness and leprosy, by Old Norse poems 
about the “Mead of Poetry” that could revive the dead3, by the ancient Aryan drink 
called “Soma” that is described in poetry as a drink of immortality4, by the ancient 
Chinese goddess Woman Gua whose regenerative powers were so profound that her 
guts metamorphosed into ten different deities5, and in Nigerian Yoruba mythology by 
the regenerating serpent Oshunmare6. As early as eight millennia ago, cultures have 
taught that trephination – the practice of removing a portion of skull without damaging 
the underlying dura, meninges, or blood vessels – could treat epileptic seizures, 
migraines, and mental health disorders, with examples documented worldwide including 
among cultures from neolithic Europe (6500 BCE France) 7, ancient China (5000 BCE)8, 
and Central America (900-1400 CE) 9. Interest in disorders of the mind and behavior 
were also evident through a persistent obsession with epilepsy, which was presumed by 
the Babylonians, ancient Greeks, and Catholics to be caused by demonic possession. 
As science advanced through the Renaissance and into the modern era, there has been 
an increasing appreciation for the role of the brain as the seat of the mind and the 
source of behavior. The dualism between mind and body has gradually shifted from the 
realm of philosophy to that of science as our understanding of physiology has 
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progressed; the originally distinct fields of psychology and neurology have gradually 
merged over the past 100 years as the neural circuitry and molecular signaling 
underlying ever more complex behaviors continues to be elucidated. Yet in spite of the 
persistent obsession with the role of the CNS in disorders of the mind and behavior, the 
scientific understanding of how to cure them has been stubbornly intractable. 
Each year, over 2.32 million Americans survive a CNS injury (an estimated 1.7 
million patients suffer a traumatic brain injury (TBI) 10-12, 12,000 patients suffer a spinal 
cord injury (SCI) 13-17, and 610,000 patients suffer a first-time stroke) 18, 19, which results 
in direct costs for initial medical management of $45.0 - $73.4 billion annually (TBI: 
$13.1 billion11, 20, 21; SCI: $10.0 - $27.3 billion11, 22; and stroke: $21.9 - $33.0 billion11, 19). 
Advances in acute management of these disorders have improved survival and initial 
outcomes, but there is still no clear consensus on how to treat the resulting deficits and 
recover lost function. Patients often develop significant deficits that require chronic care 
and rehabilitation because the adult brain does not show a significant capacity to 
regenerate itself after an injury. Consequently, up to 43% of patients discharged 
following TBI hospitalization develop a long-term disability12, and no more than 70% of 
this population recovers sufficiently enough to return to work11, 23; upwards of 81% of 
patients surviving SCI are unemployed 1 year post injury, and 39.5% of patients remain 
unemployed after 25 years’ recovery11; and there is only a 50% 5-year survival rate for 
patients suffering a stroke24. There is a total prevalence of 10.78 million patients living 
with the long-term consequences of these diseases (TBI: 3.2 – 5.3 million patients12; 
SCI: 259,000 patients14; and stroke: 6.27 million patients18, 19, 25), which represents a 
total of 3.38% of the estimated 319 million people living in the of the United States of 
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America in 201426; this enormous population of survivors results in indirect costs to 
American society through rehabilitation, supportive care, and lost productivity that are 
estimated at $84.1 - $94.9 billion annually (TBI: $63.9 billion12; SCI: $3.7 billion14; and 
stroke: $16.5-27.3 billion19) 11. As the total value of the US economy (GDP) is estimated 
at $16.768 trillion in 2013 as reported by the World Bank27, CNS injuries represent 
0.268% - 0.438% of GDP in direct costs, and 0.502% - 0.566% of GDP in indirect costs 
each year. (Note, all dollar values reported in this section are in inflation-adjusted 2013 
values for the US dollar.) Thus, the gravity of this issue is enormous, and has led the 
United States Congress to pass the Traumatic Brain Injury Act in 200828 that specifically 
authorizes research and public health activities related to TBI. As the impact of CNS 
injury is expected to grow substantially over the coming years, developing methods to 
promote functional recovery is imperative to improving the outcomes for these patients. 
Injury and regenerative potential in the CNS 
The CNS has evolved to perform extraordinarily complex functions that are of 
fundamental importance to the survival of the host organism – including regulating 
internal physiology, monitoring external stimuli, and generating complex motor 
programs – which requires the constant integration of diverse information. For instance, 
the visual system extracts information on colors, shapes, and locations to identify faces, 
avoid predators, or track prey; the auditory system extracts words from noise and can 
precisely localize sounds in 3-dimensions; the motor system plans and executes 
complicated behaviors and monitors the body’s position in space as these programs are 
executed. Neural processing for each component of a stimulus occurs in discrete nuclei 
throughout the CNS that are intricately interconnected through complex neural 
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networks. Any injury causing a disruption of these neural circuits, either by destroying 
cells within the nuclei where certain information is processed or by disrupting the axon 
tracts that connect discrete regions (Figure 1.1), can have profound functional 
consequences by interfering with the ability of the CNS to perform these fundamental 
activities. In mammals, plasticity in the remaining tissue often permits limited functional 
recovery, but these deficits are often permanent because the CNS does not 
demonstrate a robust ability to regenerate lost tissue. 
In contrast to the absence of bona fide regeneration in the mammalian CNS, 
many non-mammalian vertebrates demonstrate robust regeneration that facilitates 
profound functional recovery after CNS injury. The difference in the regenerative 
potential between mammalian and non-mammalian vertebrates has been attributed to 
particular aspects of the injury-induced cellular response. In this section, we review the 
pathophysiology following injury to the vertebrate CNS, comparing the cellular 
responses inhibiting regeneration in mammals to those facilitating regeneration in non-
mammalian vertebrates. Based on this understanding of the cellular behaviors 
necessary for successful CNS regeneration, we will explore the possibility that the 
mammalian CNS has a latent capacity to regenerate. 
For the sake of the subsequent discussion, it is worth defining several terms 
involved in the injury response. As defined in one of the standard textbooks on medical 
pathology (page 100) 29, Tissue “[r]epair, sometimes called healing, refers to the 
restoration of tissue architecture and function after an injury. (By convention, the term 
repair is often used for parenchymal and connective tissues and healing for surface 
epithelia)… Repair of damaged tissues occurs by two types of reactions: regeneration 
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by proliferation of residual (uninjured) cells and maturation of tissue stem cells, and the 
deposition of connective tissue.” Organs are composed both of parenchyma, which 
refers to the functional tissue, and of stroma, which refers to the structural tissue; all 
organs are lined by an epithelium, which is a type of connective tissue that lines the 
surface of organs. Regeneration refers to the recovery of an organ’s function, which can 
refer to any of several pathways; for the scope of this dissertation, we are exclusively 
concerned with epimorphic regeneration, which is the recreation of the original structure 
and function of the damaged structure(s) through the proliferation of stem cells. 
Pathophysiology of CNS injury inhibits regeneration in mammals 
CNS injury induces a cellular response that protects the surrounding tissue from 
the damaging molecular milieu within the lesion site30-32. The etiology of the primary 
injury initiating this secondary cellular response can be either hemodynamic or 
traumatic: hemodynamic instability from prolonged ischemia or infarction (i.e. a stroke) 
causes tissue necrosis through severe metabolic stress; mechanical impact from 
traumatic injury causes tissue necrosis and axon disconnection through physical 
damage to cell membranes, and also through traumatically-induced hemorrhage. 
Common to the pathophysiology of both hemodynamic and traumatic injury is a local 
disruption of the blood-brain barrier (BBB), the immunogenic response through which 
the necrotic tissue is removed, and the cellular response within the CNS that protects 
the surrounding healthy tissue by sequestering the immune response within the lesion 
site33, 34. However, this initially protective cellular response to both hemodynamic and 
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traumatic injury ultimately resolves into the same maladaptive glial scar that becomes a 
physical and biochemical impediment to any spontaneous attempt at regeneration33, 35. 
Limited recovery can occur over time because adaptive plasticity allows the 
remaining neural circuitry in the adult CNS to assume some of the function of the tissue 
lost to injury, and communication between disconnected nuclei can be partially restored 
as it is rerouted through remaining fiber tracts36-39. However, complete functional 
recovery requires restoring the original physiology of the damaged tissue, including both 
the local cytoarchitecture and the passing fiber tracts, through four basic functions 
(Figure 1.1) 35, 40: 1) each of the cell types present within the damaged tissue, including 
both neurons and glia, must be replaced and functionally incorporated into the 
remaining neural circuitry, 2) disconnected axons, including those projecting past the 
lesion from distant nuclei and those from newly-generated neurons within the lesion, 
must be capable of sprouting, 3) axons must sprout past the lesion and through the 
distal intact parenchyma, following local cues to their original target nuclei, and 4) axons 
must be able to reestablish their appropriate connections within their target nuclei. In the 
mammalian CNS, robust regeneration does not occur because these four fundamental 
functions are either absent or inhibited. 
Although the mammalian CNS does not spontaneously regenerate, it does 
demonstrate a limited capacity for each of the cellular behaviors necessary for 
regeneration. The adult mammalian brain does contain neural stem cell populations that 
continue to divide throughout life, but they are only located in discrete regions and do 
not demonstrate the robust neurogenesis necessary for regeneration following an injury. 
Previous research has shown that axons have an inherent ability to sprout; however the 
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intact parenchyma of the mammalian CNS is not conducive to sprouting, as severed 
retinal ganglion cell axons cannot regenerate through the distal portion of the optic 
nerve but are readily able to sprout through a peripheral nerve graft41-44. Furthermore, 
axons sprout towards the lesion after axotomy, but in vivo imaging demonstrates that 
they ultimately turn away and fail to regenerate after repeated efforts to pass the 
lesion45, 46. Nonetheless, axon terminals demonstrate local plasticity within their target 
nuclei that facilitates synaptic remodeling underlying both learning in the adult CNS and 
limited functional recovery after injury, which suggests that regenerating axons would be 
able to restore their original connections if they were able to regenerate past the lesion 
and reach their original targets36, 47, 48. This abortive regenerative effort is due to a 
cellular response at the lesion site, which is initiated by BBB disruption and cellular 
injury, that is inhibitory to axon sprouting35, 49-52. However, the fact that each of the 
cellular behaviors necessary for regeneration is expressed following injury suggests that 
a latent and inducible capacity for regeneration may be conserved in the adult 
mammalian CNS. 
BBB disruption at the lesion site allows an influx of neutrophils and macrophages 
that, while necessary to remove the necrotic tissue, release cytokines, enzymes, and 
reactive oxidative species that are actively toxic to the CNS parenchyma45, 53. 
Astrocytes contain this immune response by forming a physical barrier around the 
lesion site, which is necessary to reestablish the BBB (Figure 1.2); without this 
astrocytic response, these toxic metabolites produced by phagocytes would cause the 
lesion to expand, thereby exacerbating the effect of the initial injury32, 54. However, by 
sequestering the immune response within the lesion, this astrocytic response causes a 
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pseudocystic cavity to form as the necrotic tissue is removed (Figure 1.3). This acellular 
glial scar lacks a solid extracellular matrix (ECM) and thus does not have a physical 
substrate to support axon sprouting; moreover, damage to the microvasculature makes 
the lesion site avascular and the penumbra (the tissue immediately surrounding the 
lesion) ischemic, which represents a further barrier to the tendency of axotomized axons 
to spontaneously sprout. In addition to this physical barrier, astrocytes also molecularly 
modify the tissue around the glial scar, depositing chondroitin sulfate proteoglycans 
(CSPGs) in the ECM that further inhibit axon sprouting49, 50, 55-57. 
Although the lesion site represents both a physical and biochemical barrier for 
regeneration, it is clearly not an insurmountable obstacle: the CNS does not form a glial 
scar after injury in embryonic and immature mammals, and instead demonstrates a 
substantial regenerative capacity58, 59. Furthermore, focal lesions to the CNS of adult 
non-mammalian vertebrates are often healed through complete regeneration, even 
though the same variety of cells are present in these animals as are found in the injured 
mammalian CNS60. By understanding why the lesion environment inhibits regeneration 
neither in young mammals nor in non-mammalian vertebrates, it may be possible to 
therapeutically modify the injured mammalian CNS to create a response more 
conducive to regeneration. 
Physiology of CNS regeneration in non-mammalian vertebrates 
In contrast to the mammalian CNS, the CNS in many non-mammalian 
vertebrates demonstrates a robust regenerative response following injury. Axons 
regenerate across the lesion site and reconnect with their original targets, facilitating 
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functional recovery after spinal cord transection in zebrafish61 (Figure 1.3) and in the 
freshwater turtle Trachemys dorbignyi62, 63. Tail amputation in Urodele and Anuran 
amphibians includes loss of the caudal portion of the spinal cord, and the spinal cord 
completely regenerates new tissue that becomes functionally integrated into the 
remainder of the CNS64-66. The brain also demonstrates regeneration following a stab 
wound in zebrafish67, 68, and both Anuran and Urodele amphibians regenerate large 
portions of their brain after complete resection69, 70. The injured non-mammalian 
vertebrate CNS also supports robust neurogenesis through which the injured tissue is 
replaced, and these new cells are able to restore the original neural circuitry by 
reconnecting with the same targets as the original cells had prior to the injury68-71. 
Radial glia, which are found throughout the adult CNS in non-mammalian 
vertebrates, are the predominant cell type that facilitates axon regeneration and 
neurogenesis underlying regeneration following injury. Interestingly, radial glia are 
functionally equivalent to, and express genetic markers associated with, both astrocytes 
and ependymal cells in the mature mammalian CNS72, 73. Radial glia also express 
markers of mesenchymal cells (a description of which can be found on page 19) 
including smooth-muscle actin (Acta2), fibronectin, and several epithelial-mesenchymal 
transition transcription factors (slug, Zeb1, Zeb2); Zeb1 is necessary to maintain radial 
glia neurogenesis, while embryonic morphogens found in the spinal cord (Sonic 
hedgehog, Shh; and retinoic acid, RA) can cause radial glia to differentiate into 
subclasses of neurons72, 74. 
In addition to being orthologous to astrocytes and ependymal cells in the adult 
mammalian CNS, radial glia in the adult non-mammalian CNS also express markers 
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associated with radial glia in embryonic non-mammalian vertebrates, as well as with 
both radial glia and immature astrocytes in the embryonic mammalian CNS73, 75, 
suggesting that they remain in an immature state throughout adulthood. Moreover, 
radial glia in the adult non-mammalian vertebrates CNS continue to demonstrate 
behaviors that are typically associated with neural development in the embryonic brain, 
which are also those that we have previously established are necessary for 
regeneration: neurogenesis, and facilitating axon outgrowth59, 72, 76. Specifically, a 
subset of radial glia constitutively sustain neurogenesis throughout the adult non-
mammalian vertebrate brain, and all radial glia retain a quiescent ability to function as 
pleuripotent neural progenitor cells (NPCs) that is regulated through the Notch signaling 
pathway67, 77, 78; thus, radial glia near the lesion are the source of new neurons and glia 
that are necessary to regenerate the damaged parenchyma67. Radial glia begin to 
migrate towards the lesion within hours of an injury76, 79 where they reestablish the 
BBB80 and, after an initial 48 hour delay, they begin to proliferate68. Additionally, they 
extend their processes across the lesion to form a highly aligned cellular bridge79, which 
facilitates regeneration by promoting neovascularization80 and by guiding axons as they 
sprout across the lesion towards their original target61.   
Throughout the injury response, radial glia demonstrate consistent changes in 
their genetic profile that emerge concurrently with their cellular behaviors that facilitate 
regeneration. Radial glia express Glial Fibrillary Acidic Protein (GFAP) in the adult 
Urodele and Teleost brain; upon spinal cord injury, GFAP expression decreases while 
vimentin and nestin, which are markers of immaturity and pleuripotent progenitors 
respectively, increase64. As Nestin expression increases, an increasing proportion of the 
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radial glia daughter cells subsequently differentiate into neurons, with this neurogenesis 
being regulated through Notch signaling78. Moreover, radial glia require activation of the 
signaling pathways associated with the morphogens transforming growth factor beta 
(TGF-β) and Wnt to control proliferation and progenitor cell fate during regeneration81, 
82. Thus, radial glia are sufficient to provide a source of new neurons in the regenerating 
non-mammalian vertebrate CNS, and they are sufficient to guide regeneration of 
damaged axons past the lesion site and to their original targets. Together, this shows 
that radial glia are the crucial cell type that facilitates CNS regeneration in non-
mammalian vertebrates; as radial glia are orthologous to mammalian astrocytes, 
astrocytes may have a similarly important role in regulating regeneration in mammals. 
Regenerative physiology is conserved in the mammalian CNS 
CNS regeneration in non-mammalian vertebrates requires radial glia to facilitate 
the proper targeting of regenerating axons, and to replace the damaged parenchyma by 
producing new neurons and glia. The mammalian CNS also contains radial glia, but 
they are only present during development and they differentiate into astrocytes as the 
CNS matures. While there is debate about whether the radial glia in non-mammalian 
vertebrates are technically astrocytes, both of these cell types, which are characterized 
by robust GFAP expression, are genetically and functionally orthologous to each other. 
Given that radial glia facilitate regeneration in non-mammalian vertebrates, the 
astrocytic response to injury is likely to be similarly critical in determining the 
regenerative potential of the mammalian CNS. 
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Many of the astrocytic behaviors expressed throughout their injury response are 
strikingly similar to those through which radial glia facilitate regeneration, but the injury-
induced response in mammalian astrocytes ultimately inhibits regeneration. Both 
astrocytes and radial glia begin to migrate towards the lesion within hours of the initial 
injury79, 83, 84. Furthermore, both astrocytes and radial glia at the lesion border begin to 
proliferate after an initial delay, and the rate of proliferation peaks after 48 hours; 
astrocyte proliferation subsequently declines, while radial glia continue to proliferate at 
this elevated rate over at least seven days after the injury79, 85-88. The fate of their 
daughter cells is remarkably different between these cell types: astrocyte proliferation is 
predominantly gliogenic and these cells form a barrier that inhibits axon sprouting89, 90, 
while radial glia proliferation is neurogenic and provides both a source of neurons for 
regeneration and a substrate that axons use for sprouting88. These cells also 
demonstrate divergent injury-induced morphologic changes: astrocyte processes 
hypertrophy and they up-regulate certain cytoskeletal elements associated with 
maturity91, 92; in contrast, radial glia assume a bipolar morphology resembling their 
shape during embryogenesis, and they down-regulate cytoskeletal elements associated 
with maturity and up-regulate those elements associated with immaturity64, 93. The fact 
that both radial glia and astrocytes demonstrate many of the same initial behaviors that 
develop along a similar timeline after injury suggests that both cell types respond to a 
similar signal that initiates their response to injury. Consequently, the divergent effect 
that astrocytes and radial glia have on facilitating regeneration is likely due to 
differences in the ways in which these individual cellular behaviors are subsequently 
regulated throughout the reparative response. 
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 Although mammalian astrocytes do not facilitate overt CNS regeneration after 
injury, experimental evidence demonstrates that they retain a latent regenerative 
potential. While mammalian astrocytes do not facilitate axon sprouting after injury in 
vivo, multiple growth factors have been shown to make them more permissive to axon 
outgrowth in vitro94-97. Astrocytes themselves are a source of some of these factors, 
including fibroblast growth factor (FGF) 2, which has an autocrine effect inducing 
astrocytes to promote neurite outgrowth98 and also acts directly on neurons to enhance 
outgrowth and branching in vitro99. FGF-2 is also produced by reactive astrocytes 
around the lesion site in vivo100 and has been shown to promote axon sprouting 
following injury101, suggesting that astrocytes can facilitate axon outgrowth in adult 
mammals given the appropriate molecular cues. Furthermore, while mitogenic and 
neurogenic growth factors are not robustly induced in the injured mammalian CNS, 
FGF-2 is induced upon injury in regenerating non-mammalian vertebrates where it 
drives proliferation and neurogenesis throughout regeneration88, 102. In addition to being 
able to promote neurite outgrowth, mammalian astrocytes – similarly to radial glia – 
have a latent neurogenic program. While astrocytic neurogenesis is repressed through 
Notch signaling in vivo77, 103-105, they can produce astrocytes, oligodendrocytes, and 
neurons in vitro106, which suggests that the signaling environment within the CNS 
actively inhibits neurogenesis. The fact that astrocytes can be induced to promote axon 
sprouting and undergo neurogenesis strongly supports the notion that astrocytes retain 
a regenerative potential, and that they may be able to facilitate robust regeneration after 
CNS injury in mammals if this pathways regulating regeneration can be identified and 
appropriately targeted. 
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During embryonic development, immature astrocytes and radial glia facilitate 
neurogenesis and axon sprouting throughout the mammalian CNS. In embryonic 
vertebrates, radial glia expressing GFAP, Vimentin, and two astrocyte-specific 
glutamate transporters (GLAST and GLF-1) are the first cells to differentiate from 
neuroepithelial stem cells, and they function as the pleuripotent progenitors that give 
rise to astrocytes, neurons, and oligodendrocytes72, 107. Radial glia help guide migrating 
neuroblasts to their appropriate brain regions108, 109 where their differentiation is 
specified by local inductive cues from master regulatory genes (e.g. Shh in the ventral 
floor plate of the spinal cord induces differentiation into dopaminergic lower motor 
neurons) 72, 73, 110, 111. Towards the end of neurogenesis, radial glia produce astrocytes, 
which facilitate embryonic axon outgrowth and targeting by modifying the ECM, 
including depositing some of the same CSPGs that they produce after injury112-115. In 
contrast to their inhibitory role after injury, certain CSPGs produced by astrocytes 
promote axon outgrowth in the embryonic CNS116, which suggests that CSPGs interact 
with other signals within the CNS to determine whether their effect on axon sprouting is 
inhibitory or excitatory. As astrocytes in the developing mammalian CNS demonstrate 
each of the same behaviors that radial glia express during both embryogenesis and 
regeneration in non-mammalian vertebrates, immature mammalian astrocytes may also 
be able to facilitate CNS regeneration in mammals. 
Immature astrocytes lose the ability to facilitate axon outgrowth and function as 
NPCs as the CNS matures into adulthood. In the immature CNS, astrocytes and radial 
glia facilitate regeneration58, 59, 117; concurrent with the ontogenetic decline in 
regenerative potential is the differentiation of radial glia into astrocytes at the end of 
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embryonic development, and the absence of robust regeneration in the adult 
mammalian CNS has been attributed to the inability to induce a signaling environment 
through which astrocytes can revert to an immature phenotype60, 97. Paralleling this 
ontogenetic decline in regeneration is a decrease in the magnitude of injury-induced 
proliferation and neurogenic fate of these cells85, 89, 90; reintroducing growth hormones 
present in the juvenile brain enhances proliferation, drives neurogenesis, and promotes 
functional recovery following injury118-121. The fact that both neurogenesis and axon 
outgrowth are enhanced by treating mature mammalian astrocytes with signaling 
molecules from the embryonic brain suggests that recreating the signaling environment 
within the immature CNS might be able to stimulate regeneration in adult mammals. 
Conclusion 
It is clear that astrocytes play a crucial role in determining the regenerative 
potential in the mammalian CNS: their response to injury inhibits regeneration in adults, 
but they facilitate regeneration in immature and embryonic animals. Moreover, 
regeneration in non-mammalian vertebrates is facilitated by radial glia, which are 
orthologous to mammalian astrocytes. Although mature astrocytes do not facilitate 
robust regeneration in the mammalian CNS, they retain a latent ability to demonstrate 
the same behaviors necessary for axon sprouting and neurogenesis during 
embryogenesis. Thus, recreating the signaling environment within the developing 
mammalian CNS may induce astrocytes to revert to an immature phenotype through 
which they could facilitate complete regeneration by recapitulating the same 
mechanisms by which the CNS originally developed. 
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Epimorphic regeneration recapitulates embryonic development 
The ultimate goal of therapies and rehabilitation for CNS injury is complete 
functional recovery, which requires restoring the axon tracts, neurons and glia, and 
each of their connections that were destroyed by the lesion. In the previous section, we 
identified astrocytes as crucial determinants for regeneration in the CNS, and we 
established that they can be induced to express each of the behaviors through which 
their orthologous cell types facilitate regeneration in other vertebrate clades. In this 
section, we explore the physiology of spontaneous regeneration in non-mammalian 
vertebrates to try and understand why CNS regeneration is absent in mammals despite 
the presence of these physiologic mechanisms through which it might proceed. The 
facts that this neural circuitry develops spontaneously during embryogenesis and that 
many vertebrate species can completely regenerate this same circuitry following 
substantial injuries belie the notion that this circuitry is so extraordinarily complex as to 
be fundamentally incapable of regeneration. Indeed, regeneration in non-mammalian 
vertebrates is successful because it replaces the damaged tissue through recapitulating 
embryonic development, a process known as “Epimorphic Regeneration.” The 
physiology of embryogenesis is conserved among all vertebrates, so it may be possible 
to activate epimorphic regeneration in injured mammalian tissues if the stimulus through 
which these developmental pathways are reactivated upon injury in non-mammalian 
vertebrates can be identified. 
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Non-mammalian vertebrates demonstrate epimorphic regeneration 
Non-mammalian vertebrates are able to completely regenerate injured or 
amputated tissues because the injury reactivates the same physiologic mechanisms 
through which these structures originally develop during embryogenesis (Figure 1.4). 
Just as embryogenesis begins with totipotent progenitors that gradually differentiate into 
increasingly mature cells as development progresses, a population of progenitors 
accumulates at sites of injury and supports regeneration in non-mammalian 
vertebrates122. While progenitors are omnipresent in the embryo, they are not equally 
ubiquitous adult animals. Instead, in vertebrates that regenerate, terminally 
differentiated mesenchymal cells – those cells composing connective tissues such as 
the lymphatic system, circulatory system, and musculoskeletal system – dedifferentiate 
into pluripotent progenitors123, 124. Upon injury, adjacent epithelial cells migrate into the 
lesion site where they form a wound epithelium that functions as the apical ectodermal 
cap (AEC) and induces underlying mesenchymal cells to dedifferentiate and form a 
mass called a regeneration blastema125. New tissue develops as cells within the 
blastema proliferate, and gradients of morphogenic molecules guide their differentiation 
into the full complement cell types that were present in the original structure123, 125, 126. 
As epimorphic regeneration progresses, these newly differentiated cells form tissues 
and organs that are anatomically and physiologically indistinguishable from the original 
tissue that was present prior to the injury. 
Newly-produced progenitor cells require extracellular spatial signals to define the 
rostrocaudal (RC), mediolateral (ML), and anteroposterior (AP) body axes; these signals 
guide morphogenesis of new structures throughout regeneration127. These morphogens, 
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which are conserved during embryogenesis and regeneration, provide spatial cues that 
cells use to determine their 3-dimensional location within the developing embryo128-130. 
For example, morphogen gradients determine whether the developing limb bud will 
generate a forelimb or a hindlimb based on the relative location of the limb bud within 
the RC axis; ectopic limb formation, either from a transplanted limb bud or from 
induction of supernumerary limb buds, results in the formation of an additional limb that 
assumes distinct forelimb or hindlimb anatomy based on the position of the limb bud 
along the RC body axis of the embryo130-132. Preservation of left-right symmetry and the 
appropriate orientation of the new limb on the body indicate that the regeneration 
blastema can detect the ML and AP axes of the limb, respectively125. Thus, these 
vertebrates demonstrate a profound capacity for spontaneous regeneration because 
injury induces the morphogens that pattern all three body axes within the regenerating 
structure. 
Vertebrate regeneration is limited neither to a distinct clade nor to a particular 
type of tissue. Beyond the Urodele limb, the widespread evidence of regeneration in 
different tissues and across different clades illustrates the profound evolutionary 
importance of regeneration133, 134. Teleost fish, another common model of regeneration, 
also demonstrate regeneration following amputation of their fins135-137. Beyond the limb, 
many vertebrates can regenerate their jaw138, 139, eyes140, skin141, and tails64. Even 
injuries that would prove severely debilitating – if not fatal – in humans can often be 
healed by regeneration in other vertebrate species. For example, zebrafish can 
regenerate their hearts after more than 40% of the ventricular wall is removed by 
amputation142, 143. Urodeles also demonstrate profound cardiac regeneration, which was 
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incidentally discovered when animals whose hearts had been completely bisected for 
blood collection defied researchers’ expectations that the animals would die and instead 
recovered completely within a week of the procedure144; subsequent research 
demonstrated that the heart could regenerate up to 50% of its structure following 
amputation, with formation of a clot within 30 minutes, initial regeneration of myocardial 
fibers within 2 hours, and restoration of circulation within 5 hours145. 
CNS regeneration is also widespread among vertebrates, demonstrating that the 
mechanisms to functionally restore injured tissue are retained in adult animals. Many 
vertebrates, including examples among such disparate clades as Teleosts, Urodeles, 
and Reptiles, functionally reconnect their spinal cord following a complete transection62, 
79, 146. Xenopus tadpoles and adult Urodeles are both able to regenerate portions of their 
spinal cord that are lost after tail amputation64, 147. The retina, which is an extension of 
the CNS within the eye, also regenerates retinal pigment epithelium and ganglion cells 
following ablation in Teleost fish77, 148-150 and both Anuran151 and Urodele78, 152, 153 
amphibians; moreover, retinal ganglion cell axons regenerate through the optic nerve to 
the optic tectum after either axotomy in the optic nerve or ablation of the retina154-158. 
Furthermore, the neural circuitry within the adult CNS can be replaced, as Teleost fish 
regenerate following a telencephalic stab wound67, and Anuran amphibians regenerate 
large portions of the cortex following resection69. In each of these examples, 
regeneration is facilitated by radial glia, which recapitulate their neurogenic and axon 
guidance roles through which they facilitate embryogenesis71, 73, 77, 93, 150. Mesenchymal 
cells in peripheral tissues facilitate epimorphic regeneration, and radial glia, which 
express mesenchymal cell markers72, facilitate CNS regeneration through re-
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development. Thus, CNS regeneration in non-mammalian vertebrates may be an 
example of epimorphic regeneration.  
Among all of these examples, regeneration is a spontaneous process that begins 
immediately upon injury and forms of a new structure that is anatomically and 
physiologically indistinguishable from the original uninjured tissue. Moreover, while the 
specific cells that facilitate regeneration vary among each tissue, the cellular behaviors 
underlying regeneration are conserved among the disparate vertebrate species and 
across each of the tissues in which it has been studied. Many disparate vertebrates 
express epimorphic regeneration and fossil evidence demonstrates that amphibians 
were capable of limb regeneration over 300-million years ago, which suggests that 
epimorphic regeneration is a phylogenetically early adaptation that evolved in a 
common vertebrate ancestor133, 134, 159, 160. Thus, the physiology underlying epimorphic 
regeneration is likely conserved among all vertebrates in which it is observed. 
Epimorphic regeneration is conserved among all vertebrates 
During development, a small number of signaling molecules define the principal 
body axes and regulate tissue patterning in the embryo. These morphogens, which are 
called master regulatory genes, are conserved among diverse tissue types and across 
all vertebrates110, 127. For example, Shh defines dorso-ventral (DV) patterning and 
regulates limb outgrowth161-164; FGF regulates limb bud morphogenesis165, 166; RA 
specifies the posterior-ventral-proximal portion of the embryo131, 167; Wnt signaling is 
necessary for body axis extension in the mouse168 and both DV and AP axis formation 
in the Xenopus embryo167; TGF-β contributes to longitudinal organization in the CNS110; 
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and both Notch and bone morphogenic protein (BMP) contribute to cellular 
differentiation128, 169. Gradients of these morphogens specify a Cartesian coordinate 
system that defines bilateral body axes in all vertebrates, and the extraordinary diversity 
in structures among different species is thought to be a function of differences in their 
concentration, distribution of their gradients, and duration of expression127, 168, 170. 
The profound regenerative potential in non-mammalian vertebrates is facilitated 
by the injury-induced expression of the same master regulatory genes that underlie 
embryogenesis171. Indeed, Shh regulates regeneration of the spinal cord and limb in 
axolotl126, 163, and of the limb in Xenopus tadpoles172; FGF regulates regeneration of the 
myocardium and fin in zebrafish143, 173-175, and of the limb and tail in Xenopus176, 177; RA 
regulates regeneration of the limb in axolotl178, and of the fin in zebrafish179; Wnt 
regulates regeneration of the limb and tail in Xenopus176, 177; TGF-β is necessary to 
initiate regeneration of the limb in axolotl180; Notch regulates cellular differentiation 
necessary for regeneration of the tail in Xenopus tadpoles181, of the retina in axolotl78, 
and of the heart in zebrafish182, 183; and BMP regulates limb and tail regeneration in 
Xenopus147, 176, 177. The role of embryonic physiology in regeneration is further 
underscored by certain vertebrate species in which immature animals are highly 
regenerative but lose this ability once they mature and developmental physiology 
becomes dormant. For example, Xenopus laevis regenerate their limbs and tail when 
they are tadpoles, but they lose this regenerative ability after they progress through 
metamorphosis and become adults; axolotl are closely related to Xenopus, but they 
retain an immature phenotype similar to that of the Xenopus tadpole and they continue 
to regenerate in adulthood125, 147, 159. Together, these observations support the notion 
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that epimorphic regeneration is a recapitulation of embryogenesis, and that the injury-
induced expression of master regulatory genes necessary for regeneration is widely 
conserved. 
Given that ontogenetic physiology is conserved among all vertebrates, the basic 
physiologic mechanisms of regeneration must also be conserved regardless of whether 
the particular vertebrate species retains the ability to access these developmental 
programs and facilitate regeneration into adulthood. Indeed, although different cell types 
support regeneration in each tissue, the same set of master regulatory genes drives 
epimorphic regeneration by inducing a conserved series of cellular behaviors176: 
migration, dedifferentiation, proliferation, and differentiation. Following limb amputation, 
TGF-β and RA are necessary to initiate regeneration in successfully regenerating 
animals179, 180. FGF and Wnt induction creates a gradient that stimulates epithelial cell 
migration towards the lesion site, where they form a wound epithelium within hours of 
the initial injury136, 166, 184. Beneath the wound epithelium, FGF and Wnt induces 
mesenchymal cell dedifferentiation into pleuripotent progenitors136, 176, 177, 185, possibly 
by inhibiting Notch signaling167. These progenitors form a regeneration blastema, where 
BMP and RA stimulate proliferation that causes the blastema to expand throughout 
regeneration179, 186. BMP, Shh, and RA gradients define a Cartesian coordinate system 
that signals the RC, AP, and ML axes of the regenerating structures126, 161, 177, 181, 187. 
While the mechanisms of epimorphic regeneration are most thoroughly studied using 
models of the vertebrate limb (including the zebrafish fin), the cellular mechanisms of 
regeneration and the families of signaling molecules that orchestrate them are also 
conserved in other tissues. Regeneration of the zebrafish ventricular myocardium 
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requires the injury-induced expression of FGF, Notch, TGF-β, RA, and Shh: these 
master regulatory genes induce cardiomyocyte dedifferentiation into a regeneration 
blastema at the wound edge where these cells proliferate, migrate into the damaged 
tissue (or, in the case of amputation, into the clot that forms at the wound edge), and 
then transdifferentiate into new cardiomyocytes135, 182, 183, 188-190. Epimorphic 
regeneration of the vertebrate lens and jaw has also been shown to require the 
induction of FGF, RA, TGF-β, Wnt, and Shh138, 139. Among these regenerating species, 
induction of these master regulatory genes is necessary for regeneration, and 
interfering with these signaling pathways can block regeneration.  
Differences in regenerative potential among vertebrates are associated with 
differences in the master regulatory genes and concomitant cellular behaviors induced 
upon injury. Manipulating these master regulatory genes restores regeneration by 
inducing these cellular behaviors in those tissues where regeneration does not 
spontaneously occur. Limb amputation in axolotl induces increased expression of FGF 
and stimulates directional epithelial cell migration towards the injury where a wound 
epithelium forms within hours, creating a structure resembling the AEC from which the 
limb develops during embryogenesis, and the axolotl limb completely regenerates184. In 
contrast, wing amputation in the chick does not induce increased FGF expression, there 
is minimal epithelial cell migration towards the injury, a wound epithelium forms only 
after multiple days, and the wing does not regenerate; however, adding FGF to the 
injury site stimulates epithelial cell migration thus enhancing the rate of wound 
epithelium formation, the resulting wound epithelium develops characteristics of the 
AEC, and chick wing regenerates166. Cardiac muscle necrosis and ventricular 
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amputation both induce Wnt and FGF expression in zebrafish, which is necessary for 
regeneration through stimulating cardiomyocyte dedifferentiation142, 143, 188. In contrast, 
cardiac regeneration induces neither Wnt nor FGF expression in mice, cadiomyocytes 
do not dedifferentiate, a regeneration blastema does not form, and the mouse heart 
does not regenerate after injury; however, Wnt expression stimulates cardiomyocyte 
dedifferentiation in vitro, suggesting that this signaling pathway may be able to promote 
the formation of a regeneration blastema in vivo191. Retinal regeneration in Urodeles 
and Teleosts requires the transdifferentiation of Müller glia (the resident radial glia 
population in the retina) into stem cells, and directly into retinal pigment epithelial cells, 
through a Notch-regulated pathway77, 78, 150; similarly, transdifferentiation of mature 
astrocytes and differentiation of NPCs after SCI in zebrafish requires the expression of 
Wnt through which neurogenesis is released from Notch-mediated inhibition, and cell 
fate is determined by expression of Shh and Wnt after injury126, 192. In contrast, SCI or 
tail amputation in mice or rats does not induce Shh or Notch expression, astrocytes do 
not dedifferentiate into NPCs, and the rodent spinal cord does not demonstrate robust 
regeneration33, 35; however, adult astrocytes express a latent Notch-regulated 
neurogenesis program in adults103, and adding FGF after injury induces astrocyte 
transdifferentiation and progenitor cell differentiation into neurons100, 193-195. Thus, 
master regulatory genes are sufficient to induce epimorphic regeneration in those 
tissues and species where regeneration does not spontaneously occur. The 
extraordinary degree of conservation among these master regulatory genes supports 
the notion that all vertebrates retain a latent ability to regenerate and suggests that a 
similarly robust regenerative potential is also conserved within mammals. 
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Latent epimorphic regenerative potential is conserved in mammals 
Mammals retain a latent regenerative potential into adulthood because they 
express the same physiologic mechanisms during embryogenesis that facilitate both 
embryogenesis and regeneration in non-mammalian vertebrates. That mammals have 
conserved the physiology underlying regeneration is apparent in their ontogenetic 
decline in regenerative potential58, 196, 197, which is similar to that in certain non-
mammalian vertebrates, and in the sporadic instances of regeneration observed among 
diverse mammalian species where the same cellular behaviors and physiology are 
expressed. For example, spiny mice shed large portions of their skin through autotomy 
as a defense mechanism to escape predation, and this wound heals by regenerating 
fully functional skin198. Following autotomy, epidermal cells migrate from the wound 
margin and form a wound epithelium and a regeneration blastema within 24 hours; Wnt 
and BMP expression both increase after injury, recreating the signaling environment 
during embryonic skin development, and sustaining the cellular proliferation and 
differentiation necessary to regenerate the underlying dermis, cartilage, sebaceous 
glands, and hair follicles throughout the new skin198. In contrast, rat skin wounds take 5-
7 days to re-epithelialize, which subsequently heals through the deposition of a 
collagenous scar rather than through regeneration199. Deer antlers undergo an annual 
cycle of shedding and regrowth through the activation of stem cells in the pedicle 
periosteum, which is a form of epimorphic regeneration as these multipotent periosteal 
stem cells form a regeneration blastema that produce bone, vasculature, and an 
epidermis with functional sebaceous glands and hair follicles200-202. Evidence from 
microarray studies suggests that the FGF signaling pathway is up-regulated in 
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regenerating antlers, and in vitro studies demonstrate that FGFs maintain a high rate of 
proliferation in cells cultured from the mesenchymal growth zone of the regenerating 
antler203, 204. In certain young mammals, an amputation of the digit distal to the distal 
interphalangeal (DIP) joint can heal by complete regeneration. Digit regeneration in 
neonatal mice proceeds through endrochondrial ossification, which recapitulates 
embryonic development of the digit. BMP signaling regulates digit regeneration: 
regeneration can be induced in non-regenerating digits by applying exogenous BMP, 
while Noggin, which inactivates BMP by binding to it, inhibits regeneration197, 205. Digit 
regeneration is also found in humans, where finger amputation distal to the DIP joint 
consistently heals by complete regeneration of the skin, muscle, vasculature, nerves, 
and bone196. The expression of regeneration among different mammalian tissues and 
species demonstrates that the physiology of epimorphic regeneration is conserved in a 
latent state among all mammals. Thus, it may be possible to stimulate regeneration in 
non-regenerating tissues by manipulating these same physiologic pathways. 
Conclusion 
Ontogenetic physiology is conserved among all vertebrates. Epimorphic 
regeneration recapitulates embryogenesis, so all vertebrates – including mammals – 
must retain this physiology regardless of their ability to spontaneously regenerate. A 
small number of master regulatory genes regulate morphogenesis of each tissue 
throughout the embryo; these genes control the same set of behaviors – migration, 
proliferation, and differentiation – in each of the tissue-specific cell types responsible for 
development. Epimorphic regeneration also requires these same cellular behaviors, 
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which are regulated through the injury-induced expression of these master regulatory 
genes; the timing over which these behaviors emerge ultimately determines the 
regenerative potential.  
In peripheral tissues, mesenchymal cells mediate regeneration in response to 
these morphogens. Radial glia express markers of mesenchymal cells, and they 
facilitate regeneration in the non-mammalian vertebrate CNS through the same cellular 
behaviors induced by the same master regulatory genes that induce peripheral 
regeneration. Astrocytes, the mammalian ortholog to radial glia, are crucial to wound 
repair; while they do not spontaneously facilitate regeneration, master regulatory genes 
can induce each of the behaviors necessary for regeneration. Thus, astrocytes retain a 
latent ability to regenerate, even though their obstreperous response to injury actively 
inhibits the spontaneous attempt of axons to regenerate. 
Epimorphic regeneration emerges spontaneously within a variety of vertebrates, 
so there must be a signal associated with the injury in regenerating tissues that induces 
the expression of these master regulatory genes. Consequently, it is reasonable to 
postulate that the failure of certain vertebrates to regenerate is due to a lack of this 
injury-induced signal. Epimorphic regeneration relies on ontogenetic physiology, which 
is conserved among all vertebrates, so all vertebrates should be capable of epimorphic 
regeneration if the signal from the injury that induces these master regulatory genes can 
be identified. 
Physiologic electric fields regulate embryogenesis and regeneration 
Endogenous electric fields (EFs) are physiologically produced in all biological 
systems and influence the activity of many different cell types through electrostatic 
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interactions with individual cellular components ranging from small ions through 
biological macromolecules. Electricity was first demonstrated to have an effect on 
biologic activity in the 18th century when Luigi Galvani, with dramatic aplomb, made a 
dead frog leg jump by connecting its sciatic nerve to a source of electricity206. In the 
early 19th century, Matteucci demonstrated that tissues produce their own bioelectricity 
by showing that a dead frog leg would contract if its sciatic nerve was placed over an 
incision made in the muscle from another frog207. In 1855, Kollicker and Mueller found 
that, when the motor nerve to a frog’s leg was placed over a beating heart, the leg 
kicked with each heartbeat208, demonstrating that the heart spontaneously produced 
bioelectricity. This electrical activity from the heart was first measured through the skin 
by Ludwig and Waller in the 1880s using a “capillary electrometer” 209. Hans Berger 
applied this same technique to the head, leading to the development of the 
electroencephalogram210, which definitively demonstrated that the brain produces 
spontaneous electrical activity. Electrical activity has been subsequently demonstrated 
in all tissues, and multiple clinical tools, including the electrocardiogram (EKG) and the 
electroencephalogram (EEG), measure these bioelectric fields because their magnitude 
and polarity vary as a function of tissue physiology. 
Endogenous bioelectric fields have been identified as a putative signal upstream 
of the master regulatory genes that regulates morphogenesis during development and 
regeneration. Elevated EFs are associated both with body patterning during 
embryogenesis, and EFs of sufficient magnitude are both necessary and sufficient for 
epimorphic regeneration in many non-mammalian vertebrates. As EFs have also been 
measured in the mammalian CNS, this suggests that EFs may also have a physiologic 
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effect on the cellular response to injury in the mammalian CNS, and that EF-based 
therapy may be able to promote regeneration. 
Physics of electric fields 
Two charges exhibit an electrostatic interaction between themselves because 
each charged particle has a region around it within which it is able to influence other 
charged particles or objects. Coulomb’s Law describes the magnitude of the force 
created by this interaction: 
𝐹 = 𝑘𝑞!𝑞!𝑟!   
where F is the electrostatic force, k is a constant, q1 and q2 are the two charges, and r is 
the distance between the two charges. Newton’s third law states that, for every action, 
there is an equal and opposite reaction: when a charge creates an electrostatic force on 
a second charge, that second charge creates an equal and opposite electrostatic force 
on the first charge. Therefore, a single charge in space cannot generate an electrostatic 
force: if q2 = 0 Coulomb’s law predicts there would be no electrostatic force, and there is 
no second charge to satisfy the requirement of Newton’s third law that an equal and 
opposite charge be created. However, a single charge still has a region of electrical 
influence around it, which is defined as its electric field (E): 
𝐸 = 𝑘𝑞!𝑟!   
EFs for an individual charge can also be defined as 
𝐸 = 𝐹𝑞!  
which is a ratio of the electrostatic force between any two charges, and the second 
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charge involved in creating said force. It is worth noting that these charges can either be 
free electrons or ions; as the scope of this discussion covers biological systems, which 
are composed of aqueous environments, we are principally concerned with ions. 
As a result of the force created by electrostatic interactions, EFs cause ions or 
molecules with a net charge move (a process called electrophoresis), while neutral 
molecules containing electrical dipoles (i.e. local separation of charges within the 
molecule but no overall charge) align their dipole in an EF. EFs are vectors and as such 
convey information about their magnitude and direction throughout their region of 
influence. EFs can either be static or dynamic: a static EF is one where charges are 
separated on either side of a physical barrier and do not travel between these poles; a 
dynamic EF is one where moving charges (i.e. an electrical current) induces an EF in 
the space around it. Electrostatic field strength is determined by the magnitude of the 
voltage gradient (V) and the distance (d) of separation: 𝐸 = ∆𝑉 𝑑; electrodynamic field 
strength is determined by the resistivity of the medium (ρ), the ionic current (I), and the 
cross-sectional area (A): 𝐸 = 𝜌𝐼 𝐴. As Newton’s second law states, a particle that 
experiences a force (F) will undergo an acceleration (a) in proportion to its mass (m): F 
= ma. Therefore, a charged particle will accelerate in an external EF, but the extent to 
which it will move depends on the ease of mobility of the charge in its external medium. 
At the extremes of the spectrum, the external medium can be a conductor, which allows 
completely free movement of a charge, or it can be an insulator, which restricts 
movement of a charge. Biological samples contain both conductors and resistors, which 
are created through the complex arrangements of cell membranes, the extracellular 
matrix, and the macromolecules holding each of these components together211. 
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Cells physiologically produce and detect bioelectric signals 
Physical properties of the tissue determine the magnitude of bioelectric fields that 
are produced by physiologic gradients in the transepithelial electrical potential (TEP) 
through the relationships of E = ΔV/d and E = ρI/A. Voltage gradient (ΔV) is a function of 
the TEP, which is determined by the metabolic activity in the cell (i.e. the number of ion 
transporters and their rate of activity) and by the resistivity of the medium; resistivity of 
the medium is the ability of the epithelium, or tissue parenchyma to resist the movement 
of ions; distance of charge separation is a function of the epithelial thickness, which 
often varies across the tissue; ionic current is affected by the magnitude of the voltage 
gradient, and also on the ability of the ions to diffuse; and cross sectional area is a 
function of the size of the tissue or, when the ionic current is across the epithelium, the 
portion of the epithelium supporting paracellular ion diffusion. These physical properties 
convert physiologic metabolic processes into EFs, which, because electrogenic ion 
transport is universal among cells, are omnipresent throughout all tissues. 
All cells selectively segregate ions across their membranes, either by active 
transport up their concentration gradient or through ion channels that allow facilitated 
diffusion down their gradient. Ions, by definition, are charged molecules, so an electrical 
gradient is established when ion transport results in a net movement of charge across 
the membrane (Figure 1.5). Cellular activity that establishes electrical gradients is called 
electrogenic, and electrogenic activity is universal among cells because all cells use 
such electrochemical ion gradients for myriad metabolic processes. Electrogenic ion 
transport establishes a trans-membrane electrical potential (Vm) across the cell’s 
plasma membrane, which is often characteristic for a given cell type212. Vm is generally 
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constant because these electrogenic transporters are often uniformly distributed across 
the cell membrane, but local variations in Vm can arise over distances as short as 2 µm 
when they are segregated into domains by lipid rafts or anchored to the cytoskeleton213; 
if opposite ends of the cell are organized into distinct regions, as can happen across 
epithelial cells which are organized into apical and basolateral domains, the resulting 
variation in Vm can create a trans-cellular voltage spanning the entire cell. 
Electrogenic activity is also a hallmark of tissues because all tissues are lined by 
cells containing a non-random distribution of membrane proteins that sustains a steady 
trans-cellular transport of metabolites and, thus, a trans-cellular ionic current (Figure 
1.5F). These cells function as a barrier that regulate access of metabolites and 
molecules into and out of the tissue. In general, these cells are called epithelial cells, 
which can be derived from ectodermal, mesodermal, or endodermal tissues. Epithelial 
cells line most tissues, including the ventricular surface within the CNS; a notable 
exception is that the sub-pial surface of the CNS is lined by astrocytic end-feet that 
create the BBB which, while not a technical epithelium, regulate metabolite transfer into 
and out of the CNS similarly to how epithelia function in other tissues. In general, 
epithelial cells concentrate their sodium-potassium pumps (Na+/K+-ATPase) within their 
basolateral membranes, while sodium (Na+) channels are concentrated in their apical 
membrane. The Na+/K+-ATPase is electrogenic because it pumps 3 Na+ out of the cell 
while importing only 2 K+, resulting in the net loss of 1 + charge for each adenosine 
triphosphate molecule (ATP) expended. As the intracellular Na+ concentration 
decreases, a concentration gradient drives Na+ diffusion from the tissue through the Na+ 
channel and into the cell. Together, the basolateral Na+/K+-ATPase and apical Na+ 
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channels support a steady inward Na+-ion current, which creates a large 
electrochemical Na+ gradient (Figure 1.6); tight junctions prevent paracellular ion 
diffusion, so the Na+ gradient is sustained214, 215. Epithelial cells are oriented such that 
their individual trans-cellular voltage drops are aligned so they produce a large TEP. 
The magnitude of the TEP is determined by the metabolic rate of the Na+/K+-ATPases, 
and local variation in the TEP among epithelial cells creates EFs within the tissue. 
Although EFs originate at the periphery of the tissue, they spread throughout the entire 
parenchyma. Tissues are composed of ions and charged proteins, and EFs can 
influence biologic systems through electrophoresis and dipole alignment of charged ions 
and diffusible proteins. However, the influence of EFs throughout tissues is generally 
limited to the extracellular space because high plasma membrane capacitance causes 
intracellular EFs to decrease 1000x. 
Extracellular EFs influence cellular activity both indirectly through effects on 
extracellular soluble molecules and directly through electrostatic interactions with 
membrane proteins. EFs cause electrophoresis of soluble molecules in the extracellular 
matrix, creating concentration gradients that, in turn, can serve as directional cues for 
cells to follow. EFs also cause electroosmosis216 of extracellular ions (Figure 1.8), with 
negatively-charged anions moving towards the positive pole of the EF and positively-
charged cations moving towards the negative pole of the EF; those charged membrane 
proteins that are capable of lateral diffusion through the membrane (i.e. that are not 
anchored to the underlying cytoskeleton) passively diffuse along with these extracellular 
ions and become redistributed to either the positive or negative pole of the cell. 
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Cells can also respond to extracellular EFs directly because EFs induce a trans-
cellular voltage drop, which affects the cell’s resting membrane potential and polarizes 
the cell by establishing depolarized and hyperpolarized domains at opposite ends of the 
cell such that the poles are parallel to the extracellular EF217-219. These electrochemical 
effects allow cells to transduce the magnitude and direction of the applied EF through 
multiple distinct mechanisms. Cells transduce the EF magnitude by inducing a 
proportional depolarization of the cell membrane, causing a change in the opening 
probability of voltage-gated channels that activates intracellular second messengers. 
EFs also cause a polarized redistribution of membrane proteins, and the extent of this 
redistribution is proportional to the magnitude of the EF; as those membrane proteins 
with constitutive activity become increasingly concentrated at one area of the cell, the 
amount of this basal activity can become sufficient to cause a local activation of the 
downstream second messengers. EF-induced electroosmosis can transduce non-
directional cues if the activated second messenger system is, for example, mitogenic218; 
electroosmosis can also facilitate transduction of the directional component of the EF 
vector by causing excitatory membrane proteins to redistribute to one pole of the cell 
while inhibitory proteins redistribute to the opposite pole (Figure 1.8) 220-222. Another way 
cells can transduce the directional component of the EF is through depolarization and 
hyperpolarization of the membrane potential at opposite ends of the cell, which can 
result in activation and inhibition of certain voltage-gated channels. Together, each of 
these biophysical mechanisms allow cells to transduce extracellular EFs through 
multiple complex pathways, and the specific physiologic mechanisms depend on the 
particular extracellular proteins present in the tissue, the membrane proteins expressed 
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in the cell, basal activity of these membrane proteins, and the extent to which both the 
extracellular and the membrane proteins can diffuse. Thus, EFs may result in the same 
behavioral consequences on different cell types through completely independent 
physiologic pathways. 
Examples of established EF-transduction pathways 
Extracellular EFs, whose physiological effects have largely been studied using 
purified cell populations in vitro, influence the activity of both immature and terminally 
differentiated cells from all three embryonic germ layers. Many different pathways have 
been shown to contribute to cellular EF transduction for each cellular behavior, but the 
precise pathways responsible for specific behaviors have not been fully elucidated and 
are likely to vary among different cell populations. The best-studied example of EF 
transduction is electrotaxis (i.e. EF-induced directional migration), where electroosmosis 
of constitutively active membrane proteins to opposite ends of the cell causes increased 
activation of phosphoinositide-3-kinase (PI3K) at the leading end and phosphatase and 
tensin homologue (PTEN) at the lagging end of the cell, where they have excitatory and 
inhibitory effects on migration, respectively; interestingly, these second messengers 
have been implicated in electrotaxis in epithelial keratinocytes, hippocampal neurons, 
and neutrophils, but the specific receptors responsible for activating this common 
pathway vary221, 223-232. 
A comprehensive study by Tseng and colleagues (2010) elucidated a pathway by 
which cells can respond to the magnitude of the EF independent of its orientation147. 
They demonstrated that EFs induce extracellular Na+ currents that open voltage-gated 
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sodium channels (NaV), which activates the Salt Inducible Kinase (SIK) in direct 
proportion to its rising intracellular concentration147. SIK is a Na+-dependent member of 
the AMP-activated protein kinase (AMPK) family that modifies transcription and 
translation of downstream effector molecules, including Notch147, to drive regeneration 
through re-development233, 234. Interestingly, they also found that SIK is not involved in 
embryogenesis, suggesting that it may be part of a signaling pathway that reactivates 
developmental mechanisms to drive regeneration after injury. Furthermore, the SIK 
protein that they manipulated in Xenopus demonstrates sequence homology with a 
family of SIKs that was first identified in rats235 and has subsequently been 
demonstrated in mammalian astrocytes236. Thus, SIK physiologically links bioelectric 
fields and scalar cellular responses through a second messenger system that is 
conserved among regenerating and non-regenerating vertebrates. 
Another way calls can transduce EFs is through EF-induced depolarization and 
hyperpolarization of opposite ends of the cell. This is thought to contribute to directional 
neurite outgrowth that is towards either the anode or the cathode of the applied EF 
depending on the particular type of neuron being explored237-239. Cellular morphology is 
also thought to be affected by the trans-cellular voltage drop induced by EFs, as 
astrocytes, Schwann cells, and fibroblasts align their processes perpendicularly to an 
applied EF, possibly to minimize the voltage drop across their membranes240-243. 
Elevated EFs also affect differentiation in cardiomyocytes and neurons, likely through 
inducing changes in membrane potential244, 245. Together, this demonstrates that 
bioelectric fields are produced throughout tissues as a consequence of physiologic 
epithelial cell activity, and that these EFs are able to regulate cellular activity. 
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Bioelectric field intensity varies throughout life 
Endogenous bioelectric fields vary in magnitude throughout life because changes 
in physiology affect the physical properties of the tissue. EF production begins early in 
development: fucoid eggs produce polarized electrical signaling shortly after fertilization 
when they are still unicellular246, focal ionic currents are produced by the fertilized 
Xenopus egg during initial cleavage247, and epithelial cells in vertebrate embryos begin 
producing directional trans-cellular ion currents that sustain EFs beginning early during 
development248-253. EFs are typically elevated during embryogenesis because the 
epithelial cells sustain the same transcellular ion currents that they do in adult tissues, 
but the epithelium is thinner during development because the tissue is not fully 
formed215, 249; a smaller epithelium means the same voltage gradient occurs over a 
shorter distance, so the EF is higher. Additionally, the electrical resistivity of developing 
tissue is lower than it is during adulthood because there are fewer intercellular tight 
junctions between epithelial cells and the ECM in the tissue parenchyma is not fully 
formed, which further contributes to higher EFs within developing tissues (Figure 1.7C). 
During embryogenesis, a voltage drop of 90 mV is sustained across the developing 
axolotl neural tube; the presumptive neuroepithelium is initially 50 µm wide because it 
composed of only several cells, so this trans-neural-tube potential (TNTP) results in an 
electric field as high as 1800 mV/mm215, 249. As neurogrenesis progresses, the EF within 
the neural tube decreases because the tissue thickens but the TNTP remains constant. 
EFs also increase during embryogenesis when epithelial tight junctions break down at 
sites of high cellular activity, decreasing resistance to paracellular ion diffusion, 
increasing the ionic currents, and inducing robust EFs253-255; this happens at the AEC in 
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the developing embryo, and these large EFs have been shown to predict the site of limb 
bud formation in frog, chick, and mouse embryos248, 250, 252, 253. Once development is 
complete, EFs become much lower because the adult tissues become electrically 
insulated as new epithelial tight junctions are formed that increase electrical resistance 
to ionic currents256-259. 
Physiologic EFs are a necessary signal that regulates cellular behaviors during 
embryogenesis. The developing embryo produces EF gradients in the RC, ML, and AP 
axes that contribute to embryonic morphogenesis by directing cellular behaviors215, 248, 
255, 260. High EFs are produced across the developing neural tube that are strongest in 
the sub-ependymal layer, which is the location of embryonic neurogenesis; inhibiting 
EFs either with pharmacologic antagonists or by using an implanted electrode to inject a 
counter-current causes gross abnormalities in neural tube development and can prevent 
closure of both the rostral and caudal neural pores261, 262. Similarly, robust EFs are 
necessary for vertebrate limb development: high EFs precede initial outgrowth of the 
limb bud248, 263, 264, and limbs develop abnormally if the EFs are inhibited either by 
pharmacological antagonists or by applying a countercurrent through an implanted 
electrode249, 250, 261, 262. Thus, physiologic EFs within the vertebrate embryo are both 
necessary and sufficient to stimulate development. 
EFs have also been measured in adult tissues in many vertebrate species. Ionic 
currents have been measured across the mammalian skin265, respiratory epithelium266, 
cornea267, 268, and brain269. Amphibians sustain an inward ionic current across the skin 
that varies in magnitude across different regions of the body270. Similar ionic currents 
and electrical potentials have also been measured in human skin, revealing that human 
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skin produces a TEP that varies in magnitude across the body256, 257, 271, 272. Although 
ionic currents and electrical potentials have been measured in a variety of adult 
vertebrate tissues, demonstrating that EFs have a role in regulating physiological 
activity in adults is more difficult than it is in developing animals. In adult tissues, cell 
populations typically do not demonstrate overt migration, proliferation, dynamic changes 
in protein expression, or marked changes in morphology. It is far more difficult to test 
the hypothesis that low EFs regulate cellular activity in adult tissues: the hypothesis is 
that the stimulus will not induce a response, but absence of evidence is not evidence of 
absence. However, one study has shown that a low dcEF (3-5 mV/mm) is present in the 
rostral migratory stream (RMS) in the adult CNS, which is a path through which nascent 
neuroblasts produced in the sub-ventricular zone (SVZ) migrate to the olfactory bulb. 
Low EFs have not been shown to elicit robust behavioral responses on other cell types 
in vitro, which makes intuitive sense: low EFs are found in adult tissues, so they should 
not be able to induce dramatic cellular behaviors in these mature cell populations. 
However, neuroblasts in vitro migrate cathodally upon exposure to a 3.5 mV/mm EF, 
which is the same direction in which neuroblasts are known to migrate in the adult CNS 
where EFs of this strength are present269. This suggests that, similarly to their role in the 
embryonic CNS, physiologic EFs may regulate cellular activity in adult tissues. 
Injury-induced electric fields regulate wound healing and regeneration 
Physiologic EFs are produced in embryonic and adult tissues, and the magnitude 
of these EFs reflects the physiologic properties of the developing tissues. Injury also 
induces a robust increase in EFs because epithelial damage creates an aqueous bridge 
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that short-circuits the trans-epithelial electrical resistance; this changes the physical 
properties of the tissue, instantly causing the TEP to collapse to 0 mV and consequently 
inducing large EFs between the lesion and the surrounding tissue (Figure 1.7). 
Kirchoff’s Current Law states that the current entering any point has to be the same as 
the current leaving that point, such that the algebraic sum of currents in a network being 
zero; the ionic current at the injury site reverses direction and establishes a current loop 
with the intact tissue at the lesion margin, so the total current flux through the lesion 
must be equal to the total current flux through the surrounding tissue. The intact tissue 
can be thought of as a concentric area surrounding the lesion site with a cross-sectional 
area of 2πr (assuming that there is only current parallel to the plane of the epithelium), 
where r is the distance from the injury site; given that the total current I is constant 
throughout the circuit, the current density (µ) through any given part of the tissue 
decreases as the distance from the injury site increases. Moreover, Kirchoff’s Voltage 
Law states that the net voltage change through a circuit is 0, and Ohm’s Law states that 
the Resistance = V/I; as the surrounding intact tissue occupies a greater area than the 
injured tissue with a lower I at any individual point, the V within the healthy tissue must 
be smaller than that within the injury site. Thus, both the ionic current density and the 
voltage change within the tissue must vary spatially throughout the tissue, being low at 
the periphery and increasing substantially throughout the tissue approaching the lesion. 
The injury-induced EF is a function of changing electrical resistance across the 
damaged epithelium, so it passively emerges instantly upon injury and is sustained 
throughout the entire repair process. As the TEP remains unchanged across the 
surrounding intact epithelium, the voltage gradient between the injury site and the 
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uninjured tissue must be larger in magnitude than those EFs typically found within intact 
tissues, and these EFs must be radially oriented between the lesion and the surround. 
Because these elevated EFs emerge automatically upon injury and are inherently 
directional with a vector directly towards the lesion, they are an ideal cue both to initiate 
the cellular response to injury and to direct surrounding cells to the lesion site. For 
tissues with an inward constitutive current, including the skin and cornea, the lesion site 
becomes the cathode of the injury-induced EF; epithelial keratinocytes, epidermal 
fibroblasts, and corneal fibroblasts, all of which are necessary for a regenerative healing 
response in their respective field, migrate towards the cathode upon exposure to an EF 
in vitro223, 228, 230, 273, suggesting that these injury-induced EFs recruit these cells to the 
lesion site in vivo. 
The magnitude of injury-induced EFs is correlated with the regenerative potential 
of the injured tissue. EFs increase 50-100 fold in upon limb or tail amputation in axolotl, 
and this depolarization is sustained throughout the entire duration of regeneration270, 274, 
275. Tail amputation in Xenopus tadpoles induces robust ionic currents that are 
sustained throughout regeneration but, after tadpoles progress through metamorphosis, 
limb amputation induces a smaller current and the structure does not regenerate276-278. 
Skin puncture in axolotl also induces strong EFs that are sustained throughout healing, 
during which time fully functional skin is regenerated141, 279. In contrast, skin wounding in 
mice induces smaller ionic currents, and the skin heals by forming a collagenous scar 
rather than regenerating fully functional skin265. In rats and cows, corneal injury induces 
an EF increase within the tissue surrounding the lesion; in rats, pharmacologically 
modifying the EF intensity causes a proportional change in the rate of wound healing 
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that occurs267, 268. Together, this shows that injury-induced EFs are more robust in those 
tissues that demonstrate epimorphic regeneration than they are in tissues that fail to 
regenerate. Moreover, these data suggest that the magnitude of these injury-induced 
EFs is closely associated with the regenerative potential of the tissue. 
Elevated EFs are necessary and sufficient to stimulate epimorphic regeneration 
in injured tissues. Large ionic currents emerge from the amputated stump of the newt 
forelimb, and these currents persist throughout epimorphic limb regeneration270,	  274. 
Newt limb regeneration can be inhibited by attenuating these injury-induced EFs 
through either pharmacological or physical antagonists280,	  281, demonstrating that the EF 
itself, rather than any of the individual ions composing the associated injury current, is 
necessary for regeneration. In Xenopus tadpoles, a Na+ current induced by tail 
amputation is necessary for regeneration, and regeneration can be blocked by either 
injecting a countercurrent through an electrode or by genetically knocking out the 
sodium channel that allows the current’s creation147,	  276. In adult frogs, limb amputation 
produces relatively low EFs and the wound heals through a scar formation without 
robust regenerative outgrowth; enhancing the injury-induced EF through implanted 
electrodes promotes regenerative wound healing that is much more robust than the 
healing in animals without a functional stimulating electrode277,	  278,	  282. Interestingly, 
although mammalian limbs do not regenerate after amputation and heal instead by scar 
formation, Robert Beck showed that electrical stimulation of the wound in rats promotes 
regenerative outgrowth of the amputation site with partial restoration of histologically 
normal tissue replete with vasculature, bone, and skin if the cathode of the applied EF is 
at the amputation site283,	  284. Together, this further supports the notion that endogenous 
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bioelectric fields are a main component of the signaling environment in injured tissue 
that regulates repair, and are both necessary and sufficient to induce regeneration. 
The CNS produces extracellular EFs 
Physiologic EFs have been measured throughout the mammalian CNS for over 
100 years285. Richard Caton was the first person to measure EFs in the mammalian 
cerebral cortex when, in 1875, he demonstrated that the exposed cerebral hemispheres 
of rabbits and monkeys produce electrical phenomena286. Adolf Beck subsequently 
demonstrated that the spontaneous rhythmic electrical activity in the brain changed 
upon exposure to light, suggesting that this activity provides insight into the underlying 
function of the brain287. The first recording of these extracellular electric fields in living 
animals was made in 1912 by Ukrainian physiologist Vladimir Vladimirovich Pravdich-
Neminsky, who measured evoked potentials in dogs288. Hans Berger invented the 
electroencephalogram (EEG) to measure this spontaneous electrical activity, and he 
used it to record the first human EEG in 1924210. The EEG measures extracellular EFs 
on the cortical surface using electrodes attached to the surface of the scalp with a 
conducting adhesive. By comparing the electric potential between two different 
electrodes, EFs can be calculated between different points of the brain. For clinical 
measurements, electrodes are typically applied in a standard configuration, and either 
the “absolute” EF is measured by comparing the individual electrode’s voltage to a 
ground electrode positioned far from the recording electrode, or relative EFs are 
measured between two locations within the cortex. These readings are often reported 
as voltages but, because they rely on differences in voltage at two electrodes separated 
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in space, there must be a voltage gradient (i.e. an EF) between the two locations. These 
voltages arise because the cytoarchitecture of the brain is highly organized, so 
synchronous activity among populations of cells results in large changes in the local 
electrical potentials. Even though the ions sustaining the electrical currents are relatively 
free to diffuse through the brain, the steady cellular activity and the highly organized 
cytoarchitecture result in local dcEFs that, cumulatively, are robust enough to be 
measured by the recording electrodes on the skin. 
At the basic level, EEGs infer extracellular EFs within the brain parenchyma from 
recordings taken on the skin; while the 5 layers of tissue composing the scalp, the 
cranium, 3 layers of dura, and CSF separate the electrical activity in the brain 
parenchyma from the recording electrodes, the electrical signals produced by neural 
activity are so strong that these surface electrodes are able to filter out the ambient 
electrical noise and provide an accurate measurement of the surface cortical activity. 
Each pair of electrodes used to record an EEG measurement is called a lead, and only 
the change in electric potential in the vector parallel to the lead will be recorded; any 
component of electric activity perpendicular to the lead axis does not contribute to the 
difference in electric potential between the leads because the axis perpendicular to the 
lead vector falls along an isoelectric line for that lead and thus cannot be measured. 
EEG leads are arranged to measure electrical activity with an axis of measurement 
through the center of the head, which means that the EEG preferentially measures the 
portion of the cerebral cortex that is parallel to the skull (i.e. the outermost portion of the 
gyri), while the electric fields from cortical surface within the sulci cannot be measured 
because they are perpendicular to the electrodes. Moreover, the sulci are, necessarily, 
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anatomically arranged so that they are opposite each other, with the net result being 
that electrical activity in adjacent sulci cancels each other out. Nonetheless, EFs have 
been measured throughout the entire brain using electrocorticography, which uses a 
grid of electrodes applied directly to the surface of the brain to record electrical field 
potentials with much greater resolution than can be achieved with an EEG. 
EEG and electrocorticography measurements are limited to the surface of the 
cerebral cortex, but subsequent research has demonstrated that extracellular EFs are 
present throughout the entire mammalian brain. Electrophysiological recording 
techniques for field potentials measure the voltage at an electrode implanted 
somewhere within the brain and compare it to a reference point either elsewhere within 
the brain, or in a bathing solution outside the brain; similarly to the EEG, these 
measurements produce a voltage recording that represents the net electrical activity of 
all cells within a certain distance (the recording sensitivity) of the electrode, and this field 
potential can be converted into an EF when compared to the recorded voltage at 
another recording electrode located at a known distance from the first. Multiunit 
extracellular electrodes are similarly implanted in the brain; they have a greater 
sensitivity than electrodes used for recording field potentials, so they are used to 
measure action potential activity from multiple axons within the region of the recording 
electrode. All of these recordings are traditionally used to measure action potential 
firings from increasingly small populations of cells, which result in alternating current 
(AC) signals of varying frequency. Nonetheless, these recording methodologies also 
consistently demonstrate a background dcEF in the CNS parenchyma, as the resting 
extracellular potential as compared to ground is not 0. (Of note, the EEG can also 
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measure dcEFs, although these measurements are not currently of clinical use and so 
are only typically recorded in experimental protocols.) However, experiments employing 
these techniques rarely report the extracellular dcEFs because they were developed to 
measure populations of axons firing action potentials; the measurement of interest for 
these types of recordings is the difference between electrical activity during the action 
potential and at rest, so the resting electric potential (i.e. the steady-state dcEF) is 
typically subtracted out of the measurement as the recordings are being made so that 
the baseline reading is 0 (using a direct current (DC) offset through a filter in the 
preamplifier that is attached to most electrophysiology set-ups). 
Although dcEFs have been consistently disregarded as little more than 
background noise, a growing number of studies has specifically sought to measure 
these endogenous electrical signals. Physiologic EFs have been found in the vertebrate 
CNS during embryogenesis249, 251, 252, in adulthood269, and following injury289. While it is 
clear physiologic EF strengths in the CNS vary in magnitude similarly to how EFs vary 
in peripheral tissues – high during developing and following injury, low in mature tissues 
– the precise magnitudes of these EFs have been less thoroughly explored because 
their measurements are more difficult to obtain. Shi and Borgens demonstrated that the 
axolotl neural tube maintains a voltage of 40-90 mV across itself249, while Hotary and 
Robinson measured a voltage of 21 ± 2 mV across the Xenopus neural tube251. A 
recent study by Cao and colleagues (2013) used an ex vivo preparation to demonstrate 
that a low EF of 2 – 5.7 mV/mm is present in the rostral migratory stream of the adult 
mouse brain, and that this EF is likely sustained due to a constitutive inward Na+ current 
of 1.5 ± 0.6 µA/cm2 across the pial surface in the SVZ of the lateral ventricles and a 
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constitutive outward Na+ current of 1.6 ± 0.4 µA/cm2 across the surface of the olfactory 
bulb (OB) 269. These ionic currents are produced by asymmetric distributions of the 
Na+/K+-ATPase in the lining of the brain, with the transporters located along the 
basolateral domain of ependymal cells in the SVZ and along the apical domain of 
astrocyte end feet in the glia limitans of the olfactory bulb269. Assuming that the outward 
ionic current over the intact olfactory cortex is representative of the direction of ionic 
current across the entire mammalian cortex, and knowing that the ionic current changes 
direction upon injury, this suggests that the orientation of an injury-induced EF in the 
mammalian brain would place the anode at the lesion site while the cathode would be in 
the surrounding intact tissue. A subsequent study used an ex vivo preparation to 
demonstrate that the EF within adult mouse SVZ is 31.8 ± 4.5 mV/mm, but they 
measured this EF within a slice culture 300 µm thick so this reported EF seems to be 
more representative of a reading from an injured brain than one from an uninjured 
brain290. While the EF strength has not been measured upon injury in the mammalian 
brain, a group from the lab of Richard Borgens used an ex vivo guinea pig SCI model to 
explore how extracellular EFs change in the injured CNS. By measuring the ionic 
current density around the spinal cord before and after a complete transection, they 
found that the injury induced an initial 100-fold increase in over 60 seconds, but that the 
EF decayed to a 10-fold increase that was sustained for at least the subsequent hour291. 
However, the Borgens lab’s experiment suffered from the same problem as did those 
experiments from by Cao: they used an ex vivo model to measure electrical activity 
within the allegedly-intact spinal cord, neglecting the fact that removing the spinal cord 
from the animal is itself a severe injury that disconnects the tissue from its vascular 
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supply and disrupts its epithelia (for a further discussion of the problems of using ex vivo 
models and invasive recording techniques for measuring EFs, see Chapter 4: 
Considerations when measuring bioelectricity, page 174). Nonetheless, these biased 
studies suggest that the embryonic CNS produces EFs about 100-fold greater than 
those in the adult CNS, and that injury induces only a 10-fold increase in EFs over 
baseline. The reported change in EF intensity induced by injury in the mammalian CNS 
is similar to the magnitude of EFs induced by injury in other mammalian tissues. While 
neither the CNS nor peripheral tissues typically demonstrate robust regeneration in 
mammals, therapeutic EFs have been shown to promote regeneration in several 
peripheral tissues, suggesting that therapeutic EFs may similarly be able to promote a 
regenerative cellular injury response in the injured mammalian CNS. 
Extracellular EFs regulate cellular physiology in the CNS 
Physiologic dcEFs have been measured throughout the mammalian CNS, and 
EFs of these intensities influence the behavior of multiple neuronal and glial cell types in 
vitro269, 290, 291. Many cell types from the CNS respond to exogenous EFs, but the 
magnitude of EFs used in these studies often far exceeds the physiologic range 
reported in the CNS, which <10 mV/mm in the rostral migratory stream269, and up to 50 
mV/mm in the hippocampus (sustained only for several minutes following an evoked 
potential) 292. Upon exposure to extracellular EFs in culture ranging from 4-1,000 
mV/mm for 3-20 hours, neurons from the Xenopus laevis neural tube preferentially grow 
towards the cathode and retract from the anode237, 239, 293-295. The rate of cathodal 
neurite outgrowth of Xenopus laevis neurons is dependent on Ca2+296. The orientation of 
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EF-induced neurite outgrowth likely involves multiple mechanisms as some studies 
demonstrate that this directionality is Ca2+ dependent297 while other groups have found 
that neurite outgrowth remains directional even in Ca2+-free media298; spinal neurites 
have also been shown to mediate EF-induced neurite outgrowth through acetylcholine 
receptors in their growth cones, which are activated through autocrine acetylcholine 
release299. Neurons from dorsal root ganglia (DRGs) in chick embryos also increase 
their rate of outgrowth300 and preferentially grow towards the cathode of an EF of 15-
140 mV/mm over 3.7-6.3 hours294. Mammalian neurons similarly increase neurite 
outgrowth length parallel to an applied EF with a preference towards the cathode293, 
and outgrowth is further improved by co-culture with Schwann cells301 or astrocytes240.  
While the general conclusions from these studies are that neurons preferentially 
extend neurites towards the cathode and retract those facing the anode, the effects are 
often mixed, suggesting that there may be a heterogeneous response to EF exposure 
that depends on the sub-type of neuron tested. This is reinforced by observations that 
PC12 cells, which are a neuronal cell line derived from the rat adrenal medulla, extend 
neurites towards the anode over 48 hours’ exposure to 5-100 mV/mm EF302, while 
neurite outgrowth from neurons derived from embryonic zebrafish is unaffected by a 
100 mV/mm EF after 20 hours303. EFs may also interact with the culture media and 
substrate to affect the orientation of Xenopus laevis neurite outgrowth239, and 
chemoattractive and repulsive effects of CSPGs are modified by dcEFs in vitro304. 
Moreover, the substrate through which neurites sprout interacts with EFs to determine 
the orientation of these sprouting neurites. DRG neurites project parallel to the polarity 
of a 50 mV/mm EF, and they will follow the orientation of their culture substrate when 
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grown without an EF; if the DRG is cultured on a substrate oriented perpendicularly to 
an EF, the substrate cue overrides the 50 mV/mm EF and the neurites will grow 
perpendicularly to the EF orientation305. Interestingly, a 50 mV/mm EF increases the 
length of neurite outgrowth regardless of whether the DRGs are on a substrate growing 
with an orientation parallel or perpendicular to the EF orientation, showing that the EF 
effect on neurite outgrowth is independent of the orientation of the substrate305. 
Neuronal populations vary throughout the CNS and send projections to unique 
downstream targets through specific fiber tracts composed of different combinations of 
ECM molecules. The heterogeneity of EF effects on the rate and direction of neurite 
outgrowth, and the dependence of neurite outgrowth on the ECM substrate and on the 
morphology of glial cells within the parenchyma, may facilitate the development of the 
complex CNS cytoarchitecture: the same physiologic EFs may interact with the ECM to 
create precise signaling cues that guide different subpopulations of neurons to grow in 
different directions through different tracts within the CNS. 
EFs also affect NPCs within the vertebrate CNS. NPCs from the mouse and rat 
migrate cathodally on exposure to EFs as low as 3 mV/mm, and the speed and 
directedness of this migration increases as EFs increase up to 400 mV/mm269, 290, 306-308. 
EFs induce membrane asymmetry in NPCs through electroosmosis of membrane 
receptors, and they require the Wnt-GSK3β signaling pathway to transduce the EF 
signal into an electrotaxic response309. Interestingly, a 3-5 mV/mm dcEF was recently 
been reported in the RMS, a pathway through which neuroblasts migrate from their 
place of origin in the SVZ to their destination in the OB, of adult rats oriented with the 
anode in the SVZ and the cathode in the olfactory bulb; as this is the same direction as 
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neuroblasts migrate on exposure to the same EF intensity in vitro, it suggests that this 
physiologic EF may be contributing to guiding neuroblast migration in vivo269. EF 
intensity also affects NPC differentiation with 115 mV/mm and 437 mV/mm EFs 
promoting neurogenesis while 46 mV/mm does not alter the normal gliogenesis from 
hippocampal NPCs244, 310, and EFs have recently been shown to stimulate neuronal 
differentiation from human mesenchymal stem cells311. 
Astrocytes respond to EFs by aligning their processes perpendicularly to the EF 
vector at strengths above 100 mV/mm, and the extent of process alignment increases 
as the EF strength increases240, 241, 293. EFs affect astrocyte glycolysis, decreasing 
metabolic rate at 50 mV/mm, having no effect at 100 mV/mm, and increasing the rate of 
glycolysis above 150 mV/mm312. Only one study has explored EF effects on microglia, 
and it has demonstrated that EFs of 100 mV/mm increase the number of processes on 
the cells, and that these processes are oriented perpendicularly to the EF293. 
Meanwhile, the effect of EFs on NG2 cells and on oligodendrocytes has not been 
explored. Thus, it is clear that multiple cells from the mammalian CNS respond to EFs, 
and that this response depends on the EF intensity and the extracellular signaling 
environment. However, these studies have not explored whether physiologic EFs 
contribute to the cellular response to injury and the regenerative potential in the CNS. 
Although the ability of EFs to induce cellular behaviors associated with 
regeneration has not been explored in vivo, circumstantial observations suggest that 
EFs may be involved in certain cellular responses to injury. NPCs migrate 
physiologically from the SVZ to the OB, but they can be redirected to migrate towards 
sites of cortical injury313, 314; as the cortical EFs presumably demonstrate a similar 
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change in EF magnitude upon injury to that change observed in other tissues (see page 
48), this injury-induced EF may direct NPC migration. In spite of the NPC migration 
towards the lesion site, there is not robust neurogenesis upon injury in the mammalian 
CNS74, 121. Elevated EFs are sufficient to drive neurogenesis from NPCs244, 310, but EFs 
produced by the non-regenerating tissues such as the mammalian cortex are known to 
be lower than those EFs found in regenerating tissues215, 227, 315. As NPCs undergo 
electrotaxis at much lower EFs than are necessary to drive neurogenesis244, injury-
induced EFs in the mammalian cortex may be robust enough to drive NPC electrotaxis 
to the lesion site but insufficient to induce neurogenesis from NPCs once they arrive at 
the injured tissue. Assuming that physiologic EFs are involved in the NPC response to 
injury, this suggests that elevating the EFs at the lesion site would cause a more robust 
NPC migration and that it would also stimulate neurogenesis among NPCs at the lesion.  
In vivo evidence supports the hypothesis that therapeutic EFs may promote 
regeneration when used in the mammalian CNS. Fehlings & Tator (1992) used axon 
tracing to show that dcEFs promoted functional recovery of acutely injured spinal axons 
following clip compression injury in a rat model of SCI, and that the polarity of the 
applied EF was important to this effect316. A series of studies by the Borgens lab 
showed that applied EFs promote recovery of the cutaneous trunci muscle (CTM) reflex 
in 25% of guinea pigs following spinal cord hemisection (0% of control guinea pigs 
demonstrated improvements) 317; qualitative observations showed that guinea pig 
sensory neurons projected axons towards a spinal cord hemisection and that EF 
application promoted their regeneration past the lesion and then through their original 
tract318. In this study, the applied EF was oriented with the cathode rostral along the 
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spinal cord, and they emphasized sensory neurons because they previously found that 
spinal neurites preferentially projected towards the cathode. In a subsequent study, they 
reversed the orientation of the applied dcEF every 15 minutes following spinal cord 
transection in dogs under the assumption that all neurites project towards the cathode, 
so that the periodic EF reversal would promote outgrowth of all neurites (remember, 
according to the in vitro studies, EF-induced neurite cathodal outgrowth is faster than 
anodal retraction); while they found that dcEFs improved functional recovery after both 
6 weeks and 6 months of treatment, the sample size was small and they did not 
histologically evaluate the impact of EFs on axon regeneration319. Using rats, Borgens 
found that oscillating extracellular EFs after a spinal cord transection improved astrocyte 
alignment perpendicularly to the lesion site, and that the applied EF (technically a 40 µA 
current, with the EF neither measured nor calculated) decreased the number of GFAP+ 
astrocytes at the lesion site320. However, these studies apply extraordinarily low EF 
intensities in vivo without measuring the magnitude of the EFs that are actually induced 
by this application at the lesion site, and these treatments are attempted in spite of the 
fact that neither the magnitude nor the physiologic role of injury-induced EFs in the 
cellular response to injury have been elucidated in the mammalian CNS. Moreover, the 
studies that reverse the orientation of the applied EF every 15 minutes do not apply EFs 
in a way that recreates the physiologic signaling environment that would otherwise allow 
regeneration to proceed spontaneously; instead, they use EFs to try and artificially 
promote axon regeneration by taking advantage of the fact that spinal axons 
preferentially grow towards the cathode faster than they retract from the anode. 
Although these studies have found that EFs promote axon regeneration, the EFs are 
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not applied in a way that recreates the physiologic lesion environment. Thus, these 
experiments do not actually test the hypothesis that physiologic EFs activate the 
otherwise latent physiology that would allow for spontaneous regeneration. 
Conclusion 
We have seen that bioelectric fields are physiologically produced in all tissues – 
including the CNS – in both mammalian and non-mammalian vertebrates, and that 
these endogenous EFs vary in intensity as a function of physiologic state. Evidence 
strongly suggests that elevated EFs are both necessary and sufficient to influence 
embryonic development and epimorphic regeneration in multiple vertebrate species. 
Moreover, EFs regulate a consistent series of behaviors – migration, proliferation, and 
differentiation – in a diverse variety of cell types from different tissues and germ cell 
layers. Physiologic EFs have been found in the mammalian CNS, and elevated EFs 
regulate these same behaviors in cells from the CNS; however, the EF intensities 
explored in these experiments have not generally been within the range previously 
demonstrated in the CNS, and effects of physiologically-relevant EF intensities have not 
been explored. Furthermore, therapeutically-applied EFs appear to promote histological 
and functional recovery after CNS injury, but these approaches did not attempt to 
recreate the physiologic EFs found in the CNS of regenerating animals. Thus, evidence 
suggests that endogenous EFs have the potential to serve as an important signal that 
regulates the cellular response to injury and determines the regenerative potential in the 
injured mammalian CNS, but the relevance of physiologic EF intensities on cellular 
activity needs to be explored. 
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Chapter Conclusions  
Although mammals do not spontaneously regenerate, they retain a latent 
regenerative potential through which each of the cell types involved in wound repair can 
be stimulated to promote regeneration. Epimorphic regeneration proceeds through 
specific cellular behaviors – migration, proliferation, dedifferentiation, and differentiation 
– that are fundamentally important for regeneration. These behaviors are regulated by 
injury-induced expression of master regulatory genes: differences in the injury-induced 
expression of master regulatory genes, and the cellular behaviors that they stimulate, 
are associated with differences in regeneration; and master regulatory genes can 
induce regeneration in tissues where it is typically not expressed. 
Endogenous electric fields are elevated at sites of injury and they have been 
shown to regulate each of the cellular behaviors necessary for epimorphic regeneration. 
Elevated EFs are necessary and sufficient to stimulate both embryogenesis and 
epimorphic regeneration in mammalian and non-mammalian vertebrates alike. This 
suggests that EFs may be the stimulus that initiates and regulates these processes, 
either by acting upstream of the master regulatory genes and inducing their expression, 
or by direct electrostatic interactions with the cellular receptors that transduce these 
genes. Physiologic EFs and their role in repair and regeneration have largely been 
studied in peripheral tissues; endogenous EFs have also been measured in the 
mammalian CNS, which suggests that physiological EFs similarly regulate wound repair 
and regeneration in the mammalian CNS. However, there is a remarkable dearth of 
evidence exploring the effect of physiologic EFs on each of the cellular behaviors 
necessary for the injury response and regeneration in the CNS. 
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The work presented in this dissertation was conducted with the overarching 
hypothesis is that the role of EFs in regulating wound repair and regeneration in 
peripheral tissues is conserved in the mammalian CNS. Specifically, we hypothesized 
that physiologic EFs induce a cellular response to injury characteristic of that observed 
in vivo, and EF intensities associated with regenerating tissues would modify the cellular 
response towards one associated with regeneration. We chose to explore how EFs 
influence astrocytes, because the astrocytic response to injury is a key determinant in 
CNS regeneration, and because astrocytes facilitate regeneration in non-mammalian 
vertebrates through the same behaviors required for epimorphic regeneration in the 
periphery. We describe experiments in which we explore the role of EFs associated with 
intact, injured mammalian, and regenerating non-mammalian vertebrate tissues on 
regulating behaviors in cortical and cerebellar astrocytes in chapters two and three, 
respectively. In chapter four, we explore an approach to measure bioelectricity in the 
mammalian brain longitudinally after injury. While we were also interested in the 
mechanisms by which astrocytes transduced these behaviors, these studies are limited 
to an exploration of behaviors as the question of underlying physiology is ancillary to 
that of whether physiologic EFs induce the necessary astrocytic response: if EFs do not 
induce the behaviors necessary for regeneration, the mechanisms by which astrocytes 
transduce EFs are irrelevant. Instead, we discuss the physiologic implications of our 
findings together with the evolutionary origins of EFs and regeneration in chapter five, 
where we explore the concept of bioelectricity as a unifying force that regulates 
development and regeneration among all vertebrates. 
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Figure 1.1: Requirements for CNS regeneration 
A simplified illustration of how injury to the CNS disrupts neural circuitry, using 
spinal cord injury as an example. (A) In the intact spinal cord, lower motor neurons 
(diamonds) receive descending projections from upper motor neurons through the 
corticospinal tract, as well as local connections between spinal interneurons (filled 
circles). (B) After a focal injury, the original neural circuitry is disrupted both because 
neurons within the lesion site have been damaged, and also because axons in the 
corticospinal tract passing through the lesion site have been disconnected from their 
original targets. Functional recovery through the complete regeneration of the original 
neural circuitry requires four basic steps: 1) each of the cell types present within the 
damaged tissue (in this example, the lower motor neurons and the interneurons) must 
be replaced, 2) disconnected axons, including those projecting past the lesion from 
distant nuclei and those from newly-generated neurons, must be capable of sprouting, 
3) axons must sprout past the lesion and through the distal intact parenchyma, following 
local cues to their original target nuclei, and 4) axons must be able to reestablish their 
appropriate connections within their target nuclei. (This image was modified from Ben-
Hur, 201040 and is reprinted here under the “fair use” limitation in title 107 of the U.S. 
copyright law.) 
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Figure 1.2: Astrocytic response to CNS injury and the glial scar 
An illustration and matching image GFAP-immunolabeled astrocytes, illustrating 
the morphological changes that astrocytes undergo as they become reactive; the 
images are aligned such that the illustrations are directly over their matching 
immunolabeled counterparts. (A) Healthy astrocytes in the intact parenchyma. (B) 
Reactive astrocytes become hypertrophic, developing thicker processes and increasing 
their expression of certain cytoskeletal elements, including GFAP (notice the brighter 
staining in the immunolabeled images). (C) Astrocytes in the glial scar border (white 
notched arrow) are hypertrophic and extend their processes circumferentially around 
the lesion; this response restricts immune cells (yellow cells in the illustration) to the 
lesion site, but it also prevents axons from sprouting past the lesion border. (The 
immunolabeled images are from unpublished observations in the Colello lab. The 
illustration in this image was modified from Sofroniew, 200933 and is reprinted here 
under the “fair use” limitation in title 107 of the U.S. copyright law.) 
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Figure 1.2: Astrocytic response to CNS injury and the glial 
scar 
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Figure 1.3: Comparison of astrocytes in wound repair among vertebrates 
The astrocytic response to injury results in the formation of a chronic glial scar 
that inhibits axon regeneration in mammals, while astrocytes in non-mammalian 
vertebrates facilitate axon regeneration. (A, B) 3 weeks after a contusive spinal cord 
injury in the rat, astrocytes, which are immunolabeled for the intermediate filaments 
vimentin (A) and GFAP (B), surround the lesion site; these astrocytes form a barrier 
past which axons cannot sprout so, instead of regenerating, this cystic cavity resolves 
into a chronic glial scar. In contrast, 3 weeks after a complete spinal cord transection in 
zebrafish (C-F), astrocytes expressing both GFAP (C) and nestin (D) migrate into the 
injury site and extend elongated processes across the lesion cavity. (E, F) Astrocytes 
(immunolabeled for GFAP, red) function as a cellular bridge that facilitates axon 
regeneration (green) past the injury site. (The immunolabeled images in panels A and B 
are from unpublished observations in the Colello lab. The images in panels C-F are 
modified from Goldshmit et al, 201279 and are reprinted here under the “fair use” 
limitation in title 107 of the U.S. copyright law.) 
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Figure 1.4: Mechanisms of epimorphic regeneration 
Certain vertebrates, including Urodele amphibians, demonstrate robust 
epimorphic regeneration. (Top left) A newt is shown several months after tail 
amputation, demonstrating complete regeneration of a new tail past the amputation 
plain (indicated by the black line) with the new tail being anatomically and histologically 
indistinguishable from the original tail (gross anatomical images before amputation are 
shown at the top right). The basic cellular processes underlying epimorphic 
regeneration are conserved among all of the tissues and species in which these 
regenerative processes have been studied. These processes are illustrated for the 
Urodele amphibian limb, and matching gross anatomical images of the regenerating 
newt tail corresponding to these illustrations are shown. Immediately upon amputation, 
epidermal cells from the wound margin (indicated in yellow) migrate to the wound and 
cover it in a wound epithelium. The wound epithelium, which assumes the same 
function as the apical ectodermal cap during embryonic limb development, induces 
mesenchymal cells to dedifferentiate into pleuripotent progenitors (light blue). These 
progenitors form a cell mass called a Regeneration Blastema immediately beneath the 
wound epithelium and replace the amputated tissue through sustained proliferation. As 
the regenerating limb elongates, progenitor cells at the base of the blastema re-
differentiate into cells from both ectodermal and mesodermal lineages, replacing the full 
complement of tissues and structures that were originally present. (The illustration was 
modified from Stewart et al, 2007123, and the images of the newt tail were modified from 
McLean & Vickaryous, 201165; both sets of images are reprinted here under the “fair 
use” limitation in title 107 of the U.S. copyright law.) 
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Figure 1.5: Electrogenic cellular ion transport produces bioelectricity 
(A-C) An illustration of the physiologic mechanisms of electrogenic ion transport 
across cell membranes. Two Na+/K+-ATPases are shown in a portion of the cell 
membrane, as are only those cations (Na+ and K+) together with their counter-ions (Cl-) 
that are transported. (A) A hypothetical starting point where there is an equal number of 
anions and cations both on the intracellular and extracellular compartments. (B) The 
Na+/K+-ATPases transport 3 Na+ ions out of the cell and 2 K+ ions into the cell; this 
results in a net loss of 1 positive charge for every cycle of transporter (C), which 
produces a negative trans-membrane electrical potential (inside of the cell relative to the 
outside). If a Na+ channel present in the cell membrane opens, Na+ diffuses through the 
channel down its electrochemical gradient and across the cell membrane. (D) When the 
Na+/K+-ATPases are uniformly distributed around the cell, the entire cell develops a 
relatively uniform membrane potential. (E) If the cell is organized into distinct domains, 
the transmembrane potential and concentration gradients may not be uniform across 
the cell. For example, in epithelial cells (F), Na+/K+-ATPases are concentrated in the 
basolateral domain and produce an electrochemical gradient just across this portion of 
the membrane (F, left). (F, center) Na+ diffuses down the resulting concentration 
gradient into the cell through Na+ channels, which are concentrated in the apical 
domain, and the outside of tissue consequently develops a negative charge. (F, right) 
Continued transport of Na+ across the basolateral membrane sustains this net Na+ 
current across epithelial cells and into the tissue, and produces a tissue-positive trans-
epithelial electrical potential (VTEP). 
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Figure 1.6: Physiology of electric field generation by tissues 
An illustration demonstrating how electrogenic ion transport across epithelial cells 
and physical properties of tissues result in the formation of endogenous electric fields. 
Three adjacent epithelial cells are shown bound together through tight junctions 
(indicated by the green ovals); consequently, distinct apical and basolateral domains 
form that segregate different membrane proteins and result in a net inward Na+ current 
(see Figure 1.5F for further details). (A) Across the intact epithelium, these tight 
junctions prevent paracellular ion diffusion, so the net inward current is sustained. Upon 
injury to the epithelium (B), damage to the cells decreases this resistance and allows 
Na+ to diffuse down its electrochemical gradient, resulting in a reversal of the current at 
the lesion site. (C) During embryogenesis, tight junctions disappear at sites of rapid 
tissue growth, so resistance to paracellular ion diffusion decreases and results in large 
currents being produced. 
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Figure 1.7: Magnitude of electric fields in injured tissues 
Epithelial damage short-circuits the trans-epithelial potential and allows Na+ to 
diffuse down its electrochemical gradient across the epithelium and out of the tissue. 
Within the tissue, large EFs develop between the intact tissue at the margin of the 
lesion and the lesion epicenter; the intact tissue becomes the anode of this injury-
induced EF because it sustains its inward-positive TEP, while the lesion site becomes 
the cathode because the TEP collapses to 0 mV upon injury. The total charge must be 
conserved, so a current loop develops between the wound and the surrounding tissue 
such that the total current traveling through the lesion site (IW) must be equal to the total 
current traveling through the surrounding healthy tissue (IT) such that ΣIW – ΣIT = 0. 
Because the intact tissue has a greater surface area, less current travels through any 
individual point of intact tissue than through the wound. Consequently, the EFs are 
greatest at the wound, and decrease in magnitude with distance. The relationship 
between the relative magnitude of the injury-induced EF within the tissue and the 
distance from the lesion epicenter (r) is illustrated by the graph. 
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Figure 1.8: Cellular transduction of electric fields by electroosmosis 
(A) An illustration of a cell with membrane proteins randomly distributed 
throughout its membrane, and a uniform distribution of Na+ and Cl- ions in the 
surrounding environment. The exemplar membrane proteins are ligand receptors 
responsible for chemotaxis, with receptors mediating a chemoattractive effect (green)  
having a relative positive charge while those receptors mediating a chemorepulsive 
effect (red) have a relative negative charge. (B) The cell is exposed to an external 
electric field, with the anode (+) towards the right side of the cell and the cathode (-) 
towards the left of the cell; the lines indicate the orientation of the EF vector, which is 
the direction that a freely-diffusible positive charge would move within the electric field. 
(C) The external EF interacts with the ions around the cell, creating electrostatic forces 
on each ion (the direction of which is indicated by the dashed arrows). As a result of the 
electrostatic force created by the external EF, Na+ and Cl- ions redistribute towards the 
cathode and anode, respectively (D); this results in an accumulation of anions and 
cations at opposite ends of the cell, which, in turn, results in an electrostatic force acting 
on the charged membrane receptors (indicated by dashed lines). (E) As a result of the 
electrostatic forces between the ions and the membrane proteins, the membrane 
proteins undergo lateral diffusion through the membrane to opposite faces of the cell, 
resulting in a non-random distribution of these proteins such that chemoattractive 
receptors accumulate towards the anodal side of the cell while chemorepulsive 
receptors accumulate cathodally. (F) An illustration demonstrating how a stronger 
external EF results in a greater redistribution of these membrane proteins. Illustration by 
Matthew Baer, using ChemBioDraw v. 13.0.  
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Chapter 2:  Cortical Astrocytes 
Chapter overview 
The previous chapter provides a review of CNS injury, establishing that the CNS 
in all vertebrates has a latent regenerative potential, and emphasizing the role of 
astrocytes and radial glia in determining whether tissue repair occurs through scar 
formation or regeneration. In summary, physiologic EFs regulate cellular physiology, 
and the magnitude of EFs induced by injury determines whether wound repair occurs 
through scar formation or epimorphic regeneration: a 50-100 fold increase is necessary 
to stimulate epimorphic regeneration, while a 10-fold increase is associated with scar 
formation. A 10-fold EF increase has been found in many mammalian tissues, including 
the CNS, and experimentally increasing these EFs has been shown to enhance 
regenerative outcomes in peripheral tissues. With this in mind, we hypothesized that the 
role of EFs in regulating wound repair and stimulating regeneration is conserved in the 
mammalian CNS. Consequently, physiologic EFs should induce a cellular response 
characteristic of that seen in vivo, and EFs elevated above those found physiologically 
in the mammalian CNS should alter this response to induce a more regenerative 
outcome. As the astrocytic response to CNS injury in mammals is crucial in determining 
the reparative outcome, we exposed cortical astrocytes to EF intensities associated with 
intact and injured mammalian tissues, as well as to those EF intensities measured in 
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regenerating non-mammalian vertebrate tissues, to determine whether physiologic EFs 
regulate astrocytic behaviors in the intact CNS, stimulate behaviors associated with 
their characteristic response to injury, and modify this injury response towards one 
associated with regeneration. 
 
(Except for a portion of the methods, a portion of the results, Figure 2.3 and 
Figure 2.7, and table 2.1, this chapter is included in a manuscript in submission in: Baer 
ML, Henderson SC, Colello RJ. Elucidating the Role of Injury-Induced Electric Fields 
(EFs) in Regulating the Astrocytic Response to Injury in the Mammalian Central 
Nervous System. PLoS One; Manuscript submitted for publication.) 
Introduction 
The mammalian central nervous system (CNS) demonstrates limited functional 
recovery following traumatic injury, in large part because of the astrocytic response to 
the injury35, 60. In contrast, many non-mammalian vertebrates demonstrate a profound 
capacity to regenerate their tail64 and spinal cord after amputation88, reconnect their 
spinal cord after complete transection63, 93, and even replace large regions of their brain 
lost to injury69. Common among both groups of vertebrates, injury to the CNS induces 
an astrocytic response that has been well documented and is characterized by 
directional migration to the lesion site, by an enhanced rate of proliferation, and by 
changes in morphology79, 83, 91, 321, 322. Each of these behaviors occurs in a similar 
temporal profile, relative to the onset of the injury, for both phylogenies86, 87. Unique 
among regenerating species, astrocytes also form a cellular bridge across the lesion 
consisting of highly-aligned bipolar processes that guide sprouting axons past the injury 
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site79, 323. The absence of regeneration in mammals, despite the highly conserved 
astrocytic behaviors that occur following injury, suggests that all vertebrates use a 
conserved stimulus to induce the injury response and that this stimulus does not reach 
the threshold necessary to induce regeneration in mammals60. If this is the case, this 
stimulus would be an ideal therapeutic target whose modification to recreate the 
environment present in regenerating tissues may enhance regeneration in the 
mammalian CNS. 
One stimulus candidate found within the injury site that may direct astrocyte 
behavior is direct-current extracellular electric fields (EFs). EFs are produced by spatial 
variations in epithelial cell ion pump activity (see Chapter 1: Cells physiologically 
produce and detect bioelectric signals, page 33), which create voltage gradients within 
tissues. EFs have been measured in many different vertebrate tissues and have been 
shown to directly regulate multiple cellular behaviors227, 324. For example, ionic currents 
ranging from 1 to 1000 µA/cm2 have been recorded in intact, injured, and developing 
tissues and have been shown to influence cellular migration243, 273, 325, proliferation232, 
326, 327, differentiation245, 328, metabolism312 and process formation237, 239, 294 in a variety 
of ectodermally and mesodermally-derived cell types in vitro214, 215. These currents, 
which are low in mature tissues and are elevated during development and after injury at 
the site of growth or other cellular activity, generate corresponding electric fields that 
generally range from 1 to 200 mV/mm and have been reported to be as great as 1800 
mV/mm249, 269. During embryogenesis, elevated EFs are necessary for limb 
development and neurulation124, 249-252. EFs also increase after injury, and a 50-100-fold 
increase is necessary for limb and tail regeneration in non-mammalian vertebrates123, 
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274, 279, 329. Moreover, inhibiting EFs blocks regeneration275, 281, 330, 331, whereas 
regeneration can be stimulated in non-regenerating amphibians by experimentally 
increasing EFs at the amputation site277, 283, 284, 319, 332-334. Studies have also established 
that EF’s are present in the mammalian CNS269, 290, 291. Although EFs have not been 
measured in the mammalian CNS in vivo, ex vivo recordings of the mammalian brain 
demonstrate that low (3.5-5 mV/mm) EFs are present within the rostral migratory 
stream, and that EFs of this magnitude can direct neuroblast migration in vitro269. 
Furthermore, slice culture induces approximately a 10-fold increase of these EFs to 
31.8 ± 4.5 mV/mm290, and spinal cord injury has been shown to induce a rapid 10-fold 
increase in current density ex vivo291. As EFs and current density are proportional to the 
resistivity of the tissue335, it is reasonable to assume that injury to the CNS induces a 
similar elevation in EF intensity. Together, these studies suggest that the physiologic 
EFs produced by the injured CNS may be capable of, and consequently responsible for, 
driving the astrocytic response to injury. Moreover, the EF intensities recorded in 
regenerating tissues in non-mammalian vertebrates may represent an intensity 
threshold that is necessary to induce astrocytic behaviors more favorable for 
regeneration in the mammalian CNS. 
Previous work from our lab and others has shown that EFs elevated at levels 
associated with non-mammalian vertebrates cause mammalian astrocytes to assume a 
bipolar morphology and align their processes240, 241, which is consistent with their 
demonstrated morphological changes during regeneration in vivo. Furthermore, we 
have shown that the processes of these EF-exposed astrocytes are significantly more 
permissive to neurite outgrowth240. Similarly, Schwann cells exposed to high EF’s 
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produce processes that are more conducive to neurite outgrowth301. However, it is 
unclear whether EFs contribute to the astrocytic response in the injured mammalian 
CNS. In the current study, we tested the hypothesis that the EFs produced 
physiologically by the injured mammalian CNS are sufficient to induce behaviors 
associated with the astrocytic injury response. Furthermore, we hypothesized that 
increasing these EFs to levels found in regenerating non-mammalian vertebrates would 
stimulate a more robust behavioral response, and that only these elevated EFs would 
cause morphological changes that are closely associated with regeneration in vivo. Our 
findings in this study suggest that injury-induced EFs are an important stimulus for the 
astrocytic response to injury, and that EFs may represent a novel target to enhance the 
regenerative potential in the mammalian CNS. 
Methods 
Cell source and culture methods 
Rat cortical astrocytes harvested from the cerebral cortex of animals at post-natal 
day 2 (P2) were purchased from ScienCell (cat # R1800). Cultures have greater than 
99% purity as determined with GFAP immunolabeling by ScienCell; all of the astrocytes 
used for these experiments came from the first five passages after the initial thaw. 
Astrocyte cultures were maintained according to the protocol recommended by 
ScienCell. Briefly, astrocytes were thawed into poly-L- lysine (ScienCell # 0413) coated 
T75 culture flasks containing astrocyte media (pH 7.4; ScienCell AM-a 1831) 
supplemented with 2% fetal bovine serum (FBS; ScienCell # 0010) and 1% 
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penicillin/streptomycin (ScienCell # 0503). Cultures were maintained in a humidified 37 
degree Celsius (°C) incubator with a 5% carbon dioxide (CO2) atmosphere, and culture 
media was changed every 2-3 days. Once the cultures reached confluence, 
approximately 5,000 astrocytes were sub-cultured into each EF chamber (see 
description below) for migration, proliferation, and morphology experiments. For 
proliferation assays, the nucleotide anologue bromo-deoxyuridine (BrdU; Invitrogen, cat 
# 00-0103 diluted 1:100 in astrocyte media) was added to the culture for the last 6 hours 
of the electric field exposure. Each experiment was replicated at least three times using 
cortical astrocytes derived from different animals (different lot numbers of astrocytes 
were purchased from ScienCell), with all cells used in a given experiment being sister 
cultures derived from the same passage.  
Electric field application and chamber design 
Electric field chambers were constructed in a similar manner to those described 
by Babona-Filipos et al (2012) and Song et al (2007), with some modifications (Figure 
2.1) as described below308, 330. EF chambers were coated with fibronectin (ScienCell # 
8248) for 30 minutes, rinsed twice with deionized water, and allowed to dry. For EF 
experiments lasting longer than 24 hours, culture media and salt bridges were 
completely replaced every 24 hours. Constant-current electric fields were applied to the 
cells by connecting the EF chamber to a power supply; the anode and cathode 
determine the orientation of the electric field and are indicated in figures as either A/C or 
+/-, respectively. The magnitude of the electric fields were calculated according to the 
formula 𝐸 =   𝜌𝐼 𝐴, where E is the electric field strength (millivolts per millimeter; 
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mV/mm), the resistivity of the media (ρ) was measured as 700 Ohm-millimeters (Ωmm), 
and the cross-sectional area of the electric field chamber (A) is calculated in mm2 
(Figure 2.1B). EF strength is controlled by specifying the applied current and by 
changing the cross-sectional area of the cell culture chamber (by using coverslip 
spacers of different thicknesses, or by changing the width of the cell culture chamber). 
Two constant current power supplies were used, including Bio-Rad 1000 Power Pack, 
and Stoelting Precision Current Source 51413, in order to provide the full range of 
currents needed for these experiments. Ammeters in series with the electric field 
chambers were used to monitor the value of the applied current throughout the 
experiments. The power-packs were connected to Ag/AgCl electrodes (made by 
washing silver wire, Alfa Aesar 45852, in an HCl/HNO3 solution for 15 seconds and then 
rinsing it in dH2O), which were immersed in 50 mL flasks containing Steinberg Solution; 
these were connected to the electric field chambers through salt bridges made from a 
2% agarose solution suspended in 2 mL plastic pipets that were bent into a U shape. 
EF chambers were constructed using 50 x 7 mm glass-bottom petri dishes (Ted 
Pella, #14027) (Figure 2.1). Acid-washed 22 mm x 22 mm - 1.5 coverslips (average 
thickness 0.17 mm) were cut into two equal rectangles (11 mm x 22 mm) using a 
diamond knife. These coverslips were adhered to the bottom of the petri dish with hot 
dental wax to create a 10 mm x 22 mm x 0.17 mm central chamber and then sterilized 
under a UV light for at least 30 minutes. 5000 astrocytes were seeded onto these 
chambers and allowed to adhere to the dish overnight (at least 16 hours). At the start of 
the experiment, a 22x22-1.5 coverslip was used to create a roof for the EF chamber by 
using sterilized silicone vacuum grease (Dow corning # 1966898-0712) to seal it to the 
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cut coverslip spacers on either side of the cell culture lane. Double-sided tape placed 
over the coverslip roof on either end of the lane created wells for additional culture 
media; the junction between the double-sided tape and the edges of the petri dish were 
made water-tight by sealing the gaps with additional silicone vacuum grease. We 
applied an electric field of 0, 4, 40, or 400 mV/mm throughout the entire experiment by 
delivering a constant current of either 0, 10, 100, or 1000 µA. It is important that a good 
seal is maintained so that the only aqueous connection between the wells on either end 
of the culture dish is through the central trough containing the cells; otherwise, the 
applied current may leak around the area where the cells are, which would cause the 
actual applied electric field to be less than the calculated EF. 
Time-lapse imaging 
Electric field chambers were placed on a Zeiss AxioObserver Z1 inverted 
microscope (Carl Zeiss, Jena Germany) equipped with a fully automated and 
programmable Mährhäuser scanning stage, an Axiocam MRm camera, and a stage 
incubator system that regulates temperature, O2, and CO2 throughout the experiment. 
The cell culture chamber was placed on the stage, heated to 37°C, and the incubation 
chamber was maintained with a humidified 5% CO2 environment at 37°C. A 20x 0.8 
numerical aperture (NA) Plan-Apochromat objective lens was used to acquire images 
with differential interference contrast (DIC) optics every 3 minutes for the duration of the 
experiment, and these images were subsequently stitched together into time-lapse 
videos. Image acquisition was automated using the Zen Blue (2012, version 1.1.2.0) 
software package. We began imaging the first time-lapse video approximately 16 hours 
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after the cells were seeded into the EF chambers. Cells were imaged for at least 30 
minutes prior to the start of the electric field to establish baseline cellular behavior, and 
then for at least 12 hours after electric field onset. As only one dish could be imaged at 
a time and each experiment ran for 15 hours, the last group that was imaged had been 
growing in the EF chamber for up to 36 hours longer than the first culture had been. To 
control for potential sequence effects (i.e. cells changing their responsiveness to EF 
exposure as a function of the length of time that has elapsed since they were sub-
cultured into the EF chamber), the order in which the cells were exposed to each of the 
EF strengths was varied between experiments. We also directly tested whether the 
delay between sub-culturing the cells and beginning the EF exposure had any effect on 
the cellular response to the EF by exposing sister cultures to 40 mV/mm for 12 hours 
beginning either 16 or 48 hours after sub-culturing into the EF chamber. We found no 
evidence to suggest that this delay affected the response to the EF exposure, so data 
were pooled across experiments for the analysis. 
Optimizing migration analysis 
Note: this section was not included in the publication in which the rest of this 
chapter was first printed; it was added to the thesis to further explain the rationale for 
the experimental design. 
We used pilot studies of astrocytes exposed to either 0 or 400 mV/mm to 
empirically determine the optimal frequency with which we would measure cell location 
to calculate velocity throughout these experiments. The time-lapse videos, which we 
described more fully above (page 82), revealed that astrocytes demonstrate a baseline 
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degree of movement with random direction in vitro, and that they responded to EF 
exposure within minutes (a detailed discussion of how EFs affect astrocyte migration 
can be found on page 97). In our initial attempt to measure astrocyte migration, we 
sampled cell position once every hour beginning at the time the EF was turned on; 
consequently, the first time point for which we could measure speed (as speed is 
calculated from a change in position over a certain period of time) was 1 hour after the 
start of the experiment and there was already a statistically significant difference 
between those astrocytes exposed to 0 mV/mm and those in the 400 mV/mm groups. 
We realized that we needed to modify our experimental design and methods of analysis 
so that we could demonstrate that the cell populations had the same baseline speed at 
the start of the experiment, and so that we could determine just how quickly the 
astrocytic response to EF exposure occurs. However, the optimal frequency for 
measuring cells is limited by the random measurement error caused by the imprecision 
in our tracking. Specifically, each cell is tracked by manually selecting the location 
corresponding to the center of its nucleus; this measurement is approximate and, thus, 
there is some variability in the location. As cell position is tracked with increasing 
frequency, the cells have less time to move so their displacement diminishes, but the 
amount of measurement error is constant so the proportion of the calculated cell speed 
that is represented by sampling error increases. However, at the other extreme of 
insufficient frequency, cells displaying randomly-directed migration may travel along a 
much greater path length than their net displacement over the tracking interval would 
indicate. Thus, an optimal measuring frequency would optimize the temporal resolution 
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of cell tracking while minimizing the proportion of the calculated speed represented by 
sampling error. 
In order to empirically determine the optimal measurement frequency for cell 
tracking, we tracked each astrocytes used in this analysis every 3 minutes over the first 
60 minutes of the experiment. We calculated the cell speed from these measured 
positions, using the location in every 1, 2, 5, 10, or 20 frames to calculate the cell speed 
with a frequency of 3, 6, 15, 30, or 60 minutes, respectively. (Each DIC image in the 
time-lapse videos was taken 3 minutes apart.) Because the astrocytes exposed to 400 
mV/mm demonstrated an initial change in speed that plateaued within 30 minutes of EF 
onset (see Electric fields affect the speed of cortical astrocyte migration, page 97), we 
used the calculated cell speed over the last tracking interval (i.e. the last 3, 6, 15, 30, or 
60 minutes of the first hour). As the same cell was used to calculate the cell speed for 
each of the tracking intervals, and as these cells were tracked over time, the data reflect 
a repeated measures design.  
We tested the null hypothesis that there would be no significant measurement 
error at any of our measuring intervals against the alternative hypothesis that at least 
one of our sampling intervals would result in measurement error as measured either by 
an change in the standard deviation of the measured speeds or by an increase in the 
mean speed measured with a given interval. We used two different statistical 
approaches to test the overall hypothesis that certain tracking intervals would result in 
measuring error that would significantly affect the measured cell speed. We tested the 
null hypothesis that the sampling interval would have no effect on the mean cell speed 
against the alternative hypothesis that measurement frequency would cause sampling 
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error that would affect mean speed using a standard least squares analysis with a 
mixed-effects linear regression model to analyze whether the tracking interval 
influenced the measured velocity. The regression equation used for this analysis is: 𝑌!" = 𝛽! +𝒩(0,𝜎!!)+ 𝜖!"   
 where Yij is the estimated cell speed for each observation (i) at each tracking interval 
(j); βj is the coefficient parameter representing the mean value of cell speed at each 
tracking interval; 𝒩(0,𝜎!!) represents the normal distribution of mean cell speeds for 
each cell, which we are using to estimate their variance (σb2) only; and 𝜖!" represents 
the error function of each observation (i) around the mean value for each factor level (j), 
which is synonymous with the within-groups variance and is also known as the normal 
distribution. We also tested the null hypothesis that measurement error does not vary 
among the different tracking intervals against the alternative hypothesis that more 
frequent measurements would cause an increase in measurement error; this error is 
reflected in the standard deviation of the observed cell speeds, and we used normal 
quantile plots with 95% confidence intervals to assess whether the studentized 
residuals of the model’s predicted values are normally distributed (i.e. the z-score of the 
difference between each actual and predicted measurement based on our regression 
model). We then compared these residuals between tracking intervals using a Levene 
test centered at the sample mean with a threshold of significance of α = 0.05. 
We ran separate regression models for cells exposed to 0 and 400 mV/mm 
because we were using this study to make inferences about differences in speed as a 
function of EF strength. In this model, we treated the tracking interval as an ordinal fixed 
variable and each cell was treated as a continuous random variable. The model 
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calculates an overall F-statistic for the fixed effect (i.e. the tracking interval) from which it 
calculates a p-value for the overall significance of the inferential statistic; the model also 
estimates both the cell speed for each tracking interval and the difference in cell speed 
between adjacent intervals (e.g. between 3 and 6 minutes, but not between 3 and 15 
minutes), and then it calculates a t-score and p-value for each difference. The F-statistic 
and parameter estimates in this mixed-model approach correspond to the F-score and 
post-hoc tests that are traditionally associated with a 1-way ANOVA and we interpreted 
these statistics in the same way (the mixed-effect model has the added statistical 
benefit of accounting for the fact that the speed calculated at different tracking intervals 
from the same cell would exhibit some degree of dependence). We controlled for type 1 
error using α = 0.05 as our threshold of significance for the overall model, and for each 
parameter estimate (note, the p-value reported for each parameter estimate is adjusted 
for multiple comparisons because the regression model accounts for multiple 
comparisons when calculating the individual parameter estimates). We performed 
standard regression diagnostics to assess deviations from the model’s assumptions that 
would affect the predictive nature of the model (notably, we are using this model for 
inferential statistics, but we evaluated the predictive assumptions because we used one 
of these assumptions to evaluate effects of measurement error). We calculated the cell 
speeds that are predicted by the model (based on the tracking interval), and calculated 
the studentized residuals (i.e. the difference between the actual measured velocity and 
the measured velocity predicted by the model, normalized such that the predicted value 
= 0 and the standard deviation around the predicted value, which is equivalent to the 
error, is equal to 1; 𝑡! =    !! !!!!! where ti is the studentized residual, σ and ε represent 
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the estimated population parameters of the standard deviation and error function, 
respectively, and hii represents the leverage of each residual (the relative weight of each 
measurement on the entire model)). We assessed the assumption that the residuals are 
normally distributed by plotting the studentized residuals for each tracking interval with a 
Normal Quantile Plots (QQ-plots) with a 95% confidence interval (CI); the error function 
was determined to be normally distributed if the residuals fell within the 95% CI. We 
then tested the hypothesis that the tracking interval would affect the magnitude of the 
error by using the Levine test to assess heteroscedasticity (i.e. differences in standard 
deviation) among each of the tracking intervals using the actual residual values (not 
studentized); we used α = 0.05 as our threshold of significance, so that a p-value < 0.05 
indicates that the standard deviation is statistically different among at least one of the 
groups. As part of this analysis, we will report the overall F-statistic for the regression 
model, the estimated cell speed for each tracking interval (mean ± standard error of the 
mean), the parameter coefficients (mean ± standard error of the mean) with their t-score 
and p-value, and the F-ratio and p-value for the Levene test; the data are visually 
represented using box-plots. The data analysis and graphing were completed using the 
packages ggplot2336, reshape337, multcomp338, car339, and nlme340 with the statistical 
software R341 to calculate the regression model, evaluate the model assumptions, 
calculate the Levene test, and graph the data. 
Migration analysis 
To analyze astrocyte migration, time-lapse videos were imported into ImageJ and 
analyzed using the plugin MTrackJ342. To track each cell, the point corresponding to the 
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center of each cell’s nucleus was manually selected in every 5th frame (15 minutes) 
throughout the 12-hour experiment; these positions were used to calculate the 
magnitude of the velocity (i.e. speed) and the direction of migration at each 15-minute 
interval (Figure 2.2). At least 8 fields of view were required for each experiment, and a 
minimum of 30 cells were tracked for each time point for each experiment, resulting in 
an overall n ≥ 90 cells for each EF strength at each time point once data for all 3 
experiments were pooled. All data on cell tracking produced by MTrackJ for the 
migration analysis were compiled in Microsoft Excel 2011, saved as comma separated 
values files, and then imported into the statistical program R341. All data analysis was 
performed using R (including the packages Circular343, Ggplot2336, Pastecs344, 
Reshape337, and Multcomp338), with RStudio345. The vector representing each cell’s 
velocity was broken down into the speed and direction components, and each 
component was analyzed individually. Mean cell speed was compared at each time 
point for statistical significance using a 1-way ANOVA with Tukey HSD post-hoc tests, 
with an overall threshold for significance at each time point of p = 0.05. The ability of 
each EF to induce directional cell movement was assessed at each time point using 
Rayleigh’s test, using a p-value = .05 with a Bonferroni correction for the number of 
comparisons (196 comparisons: 4 EF levels; 49 time points). For those EF strengths 
and time points where there was directional migration we measured the mean direction 
of alignment (µ ± SEM), the dispersion of direction about the mean angle with the 
concentration parameter (κ), and the circular standard deviation. 
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Analysis of EF effects on the orientation of the axis of cell division 
To determine whether the EF exposure aligned the axis of cell division, each 
mitotic event in the time-lapse live cell videos was identified. The orientation of the axis 
of cell division was measured by drawing a line between the centers of each of the 
daughter nuclei in the first frame where the two daughter nuclei are distinctly 
identifiable. Image analysis was completed using the program Fiji346. The angle of this 
line relative to the axis of the electric field was measured. Alignment of the mitotic axis 
was determined for each EF strength using a Rayleigh’s test, using p < 0.01 as the 
threshold for determining significance (p < 0.01 was chosen as a conservative 
adjustment for multiple comparisons based on a nominal p  < 0.05 for 4 different 
groups). If the sample showed statistically significant alignment, the mean angle, 
concentration parameter (κ), and angular standard deviation are reported. 
Immunocytochemistry 
Cells from each independently-derived population were immunolabeled for 
GFAP, vimentin, and nestin to determine the purity and maturational state of the 
astrocyte population. For immuno-labeled astrocytes after EF exposure, cells were 
rinsed with ice-cold phosphate-buffered saline (PBS) (pH 7.4) and then fixed with 4% 
paraformaldehyde in 0.1M PBS for at least 12 hours. Cells were washed 3 times with 
PBS, blocked and permeabilized (4% normal goat serum, 0.5% bovine serum albumin, 
and 1% Triton X100 in 0.1M PBS) for 30 minutes at 25°C, and then incubated with the 
primary antibodies diluted in the blocking solution either for 2 hours at 25°C or overnight 
at 4°C. Cells were then washed 3 times with PBS, incubated with fluorescent-tagged 
 91 
 
secondary antibodies (diluted in PBS) for 2 hours, counter-stained with DAPI (NucBlue 
Fixed Cell ReadyProbes kit, diluted per manufacturer’s instruction; Molecular Probes # 
R37606), and mounted under glass coverslips with Vectashield (Vector Labs # H-1000). 
For cells stained for BrdU, an additional acid wash series was used to expose the BrdU 
for antibody binding prior to the start of the immunolabeling protocol: cell DNA was 
denatured for 10 minutes in 1N HCl on ice, 10 minutes in 2N HCl at 25°C, and 20 
minutes in 2N HCl at 37°C, and then neutralized with 0.1M borate buffer for 10 minutes 
at 25°C. Primary antibodies used in the immunocytochemistry studies included the 
following: mouse IgG1k anti-BrdU (1:1,000; Dako # M0744), polyclonal rabbit anti-GFAP 
(1:5,000; Dako # Z0334), polyclonal chicken IgY anti-Vimentin (1:1,000; Millipore # 
AB5733), mouse IgG1 anti-Nestin (1:1,000; clone rat-401, Millipore # MAB353). 
Secondary antibodies used were Goat IgG anti-rabbit Alexa-488 (Molecular Probes # A-
11008), Goat IgG anti-chicken IgG Alexa-568 (compatible with chicken IgY primary 
antibody; Molecular Probes # A-11041), and Goat IgG anti-mouse Alexa-647 (Molecular 
Probes # A-21236). All secondary antibodies were diluted at 1:200. All cells except 
those stained for BrdU were counterstained with DAPI NucBlue Fixed Cell Stain 
(Molecular Probes, # R37606). 
Confocal microscopy 
Immuno-labeled cells were imaged by laser-scanning confocal microscopy (LSM-
710, Zeiss, Jena, Germany) configured around an AxioObserver 21 (inverted) stand 
with a motorized XY stage. Image acquisition was performed using the Zen Black 
edition (Carl Zeiss, 2011; 64 bit, version 8.1.5.484) software package. 16 bit images 
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were acquired with a 20x/0.8 NA plan apochromat objective lens, with a pixel dwell time 
of 0.99 µsec and a pixel size of 0.13 µm2. Images were acquired using 4x line 
averaging, with simultaneous scanning of the 405 Diode and 633 HeNe lasers, and a 
sequential scan for the 488 Argon and 561 DPSS lasers. The 488 laser line was also 
used to generate a transmitted light DIC image. At least 5 fields of view (424.84 µm2) 
were acquired for each condition (EF strength x time), and each experiment was 
repeated at least 3 times. Detector windows for each channel were adjusted to assure 
no cross talk between channels as follows: 405 nm (410 – 483 nm), 488 nm (492 – 560 
nm), 561 nm (580 – 629 nm), and 633 nm (637 – 735 nm). 
Image analysis 
Images were imported into Fiji (an ImageJ distribution built for the Life Sciences; 
http://fiji.sc/Fiji) 346 for quantifying cellular and nuclear morphology. To assess alignment 
of cell processes, gray-scale images of vimentin expression were analyzed using the 2D 
Fast Fourier Transform (FFT) algorithm and Oval Profile plugin (authored by Bill 
O’Connell, http://rsb.info.nih.gov/ij/plugins/oval-profile.html) as described previously347-
349. The 2D FFT produces an image that is the graphical representation of the spatial 
frequencies of the original images, which is related to directionality. With the Oval 
Profile Plugin, the radial summation of pixel intensities is used to determine whether 
these pixels are randomly distributed around the axis (i.e. are unaligned), or show 
clustering around a particular orientation (i.e. demonstrate alignment). The pixel 
intensities (in arbitrary greyscale units) are normalized for each image by dividing the 
value at each angle measure by the minimum radial pixel intensity sum for that image 
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and then subtracting 1). Normalized pixel intensities for each angle measure in the oval 
profile are averaged across all images acquired from each group, and then those 
averaged values were normalized again. A graphical representation of orientation in the 
original image is obtained by plotting the summed pixel intensities between 0° and 180° 
(the directionality information is axial and does not distinguish between objects pointing 
in opposite directions; the data were plotted from 0° to 360° because double-plotting the 
data helped aid in visualizing directionality). It should be noted that the FFT image was 
first rotated 90° counterclockwise because the results of the FFT yields frequencies 
orthogonal to those in the original image. In our experiments, this rotation also defines 
the direction of the electric field application along the 0-180° axis (horizontal). 
Fluorescence microscopy and proliferation assay 
Digital images of BrdU-immunolabeled cells were acquired with a 25x/0.8 NA 
Plan-Neofluar objective lens using DIC optics and a GFP filter cube (filter set FS 38HE, 
Zeiss, Jena Germany) using a Zeiss Axiovert 200 inverted microscope (Zeiss, Jena 
Germany) equipped with a Hamamatsu ORCA ER CCD camera, Colibri LED 
illumination unit (blue, green, red), and a white light LED. Image acquisition was 
performed using the Zeiss Axiovision (version 4.8.2 sp1) software package. At least 20 
fields of view were randomly acquired for each slide, allowing at least 1,000 cells to be 
counted for each group. The number of BrdU-positive or negative cells were counted 
using the Cell Counter plugin for Fiji (authored by Kurt De Vos, 
http://rsb.info.nih.gov/ij/plugins/cell-counter.html). For each time point within each 
experiment, we evaluated our hypothesis that EFs induce increased proliferation 
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against the null hypothesis that EFs have no effect on proliferation using a test of 
homogeneity of proportions; if a significant effect was detected, we then performed 
individual X2 tests between EF strengths to determine which specific groups were 
different. Results from individual experiments were used to develop a sense of trends of 
how EFs affect proliferation over time. To evaluate the effects that EF exposure has on 
proliferation at each time point among all of the experiments, we compiled the 
percentage of BrdU-positive cells from each of the individual experiments and 
compared these percentages between EF exposures using a Kruskal-Wallis test (using 
a threshold of significance of p < 0.05 at each time point) with nonparametric 
comparisons between each EF exposure and the 0 mV/mm control at each time point 
using the Dunn Method for Joint Ranking. 
Statistical analysis 
All data analysis and graphing were performed using R (including packages 
Ggplot2, Pastecs, Reshape, and Multcomp) 336-338, 341, 344, with RStudio345. Directional 
data were evaluated using the Rayleigh test, which tests the research hypothesis of 
non-random directionality against a null hypothesis of random directionality based on 
the test statistic of the mean resultant vector (R). Circular statistics, including the 
circular mean direction (µ), circular standard deviation, and concentration parameter (κ) 
were calculated using the R package Circular343. For all experiments, the nominal 
threshold for significance was set at *p < 0.05, unless otherwise noted. Unless 
otherwise noted, data are reported as mean ± SEM. All figures were prepared using the 
ImageJ plugin FigureJ350. 
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Results 
Characterizing the cortical astrocytic population 
The cortical astrocytes (rat primary cultures) used in these experiments were 
purified populations (>99%) as verified by the provider (ScienCell), with GFAP 
immunolabeling. Immunofluorescence labeling against GFAP, vimentin, and nestin, as 
well as morphological characteristics as visualized with DIC microscopy, were used to 
evaluate the purity and maturation of these astrocytes before each experiment (Figure 
2.4). These cultured astrocytes expressed GFAP at varying levels of intensity, while 
vimentin and nestin were more consistently expressed in all cells. Morphologically, the 
astrocytes included both bipolar and lamellipodial morphologies. Together, this 
confirmed that >99% of the cells were astrocytes at varying degrees of maturation. 
Optimizing the migration analysis protocol 
Note: this section was not included in the publication in which the rest of this 
chapter was first printed; it was added to the thesis to further explain the rationale for 
the experimental design. 
To determine the optimal interval to track astrocytes for migration measurements, 
we measured cell speed with different tracking frequencies (every 3, 6, 15, 30, or 60 
minutes), and compared mean speeds measured among each group using a mixed-
effects generalized linear regression model. We found that there was a statistically 
significant difference among the mean cell speeds measured with each tracking interval 
for astrocytes exposed to 0 mV/mm (n = 31 in each tracking interval, F4 = 24.7501, p = 
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5.995 x 10-15), and the Tukey-HSD post hoc test demonstrated that there was a steady 
increase in the mean speed as the tracking interval increased (summarized in Figure 
2.3 and Table 2.1); we found a similar trend towards increasing astrocyte speed 
measured as the tracking frequency increased for astrocytes exposed to 400 mV/mm (n 
= 44, F4 = 14.7062, p = 2.362 x 10-10). Together, these results demonstrate that 
sampling error may affect the accuracy of the estimated mean cell speed. Each 
individual post-hoc comparison made with the Tukey-HSD test is reported in Table 2.1; 
the estimated differences for each comparison are reported, along with the t-score and 
adjusted p-values. The estimated group differences are also graphically demonstrated 
in Figure 2.3, where the measured migration speeds are plotted separately for 0 and 
400 mV/mm. From this analysis of the means, there is no difference between tracking 
intervals of 30 or 60 minutes, but the mean speed begins to increase at intervals of 15 
and 6 minutes, and becomes robustly larger in both groups at 3 minutes. In reviewing 
the model assumptions, we found that the residuals were normally distributed within 
each of the tracking intervals; however, the Levene test demonstrated 
heteroscedasticity among the different tracking intervals both with 0 mV/mm (F4 = 
4.5879, p = 0.001597) and with 400 mV/mm (F4 = 2.8128, p = 0.02637), thus 
suggesting that measurement error significantly affects the precision of the measured 
cell speed. We calculated the standard deviation (SD) of the residuals for each tracking 
interval and found that there was a steady increase in SD with an interval of 3 minutes 
for astrocytes exposed to either 0 or 400 mV/mm, the SD for astrocytes tracked every 6 
minutes in 400 mV/mm was slightly above the SDs for 15, 30 and 60 minutes (0 
mV/mm: 3 min = 17.782; 6 min = 8.466; 15 min = 7.911; 30 min = 9.071; 60 min = 
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7.568. 400 mV/mm: 3 min = 15.570; 6 min = 10.788; 15 min = 10.000; 30 min = 9.109; 
60 min = 10.049). Together, these results clearly demonstrate that a tracking interval of 
3 minutes is prone to significant error; a 6 minute interval also appeared to have some 
error, although it was considerably less than 3 minutes; the lower measured mean and 
SD for cells tracked every 15 minutes indicated to us that the effect of measurement 
error was adequately controlled with this sampling interval. Thus, we determined that a 
tracking interval of every 15 minutes would provide us with the greatest temporal 
resolution without creating a significant component of measurement error and we used 
this interval for each of the cell migration experiments described hereafter. 
Electric fields affect the speed of cortical astrocyte migration 
To test our overall hypothesis that electric fields are capable of directing the 
astrocytic response to injury, we explored how EF exposure affects each of the 
behaviors that astrocytes characteristically display after injury in both mammalian and 
non-mammalian vertebrates. The first of these behaviors is migration, as astrocytes 
must move towards the lesion as they are recruited to restore BBB integrity and isolate 
the lesion environment from the surrounding healthy tissue. To assess the extent to 
which EFs influence astrocyte migration, time-lapse DIC live cell microscopy was used 
to record the astrocytic response to dcEF exposure over a 12-15 hour period. The 
migration of astrocytes following exposure to EF intensities associated with intact (4 
mV/mm), injured mammalian (40 mV/mm), and injured non-mammalian vertebrate 
tissues (400 mV/mm) were compared to an untreated control (0 mV/mm). No evidence 
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of cell death was found during these experiments as a function of either EF exposure or 
of phototoxicity from repeated exposure to light. 
Time-lapse videos show that, in the absence of any EF, astrocytes displayed 
heterogeneous morphologies (bipolar, stellate and lamellipodial) and displayed non-
directional movement. Cells exposed to 4 mV/mm showed similar morphologies but 
demonstrated reduced speed as compared to astrocytes cultured in the absence of any 
EF. In contrast, time-lapse videos showed that cells exposed to 40 mV/mm or 400 
mV/mm responded rapidly to the EF exposure, with the entire cell population migrating 
towards the anode of the EF within the first hour of the EF exposure. 
To qualitatively evaluate the EF-induced effect on migration, the paths of 
migration over the first six hours of EF exposure were plotted for individual astrocytes; 
the starting position was normalized to the origin of the graph (0, 0), and the direction 
was displayed relative to the orientation of the EF (Figure 2.5). An analysis of the mean 
speeds for astrocytes exposed to each of the EF intensities showed that the mean 
speed of cells in the control group (0 mV/mm) did not change over time (data not 
shown), and that there were different effects on speed for each of the EF exposures 
(Figure 2.6A). Differences in cell speeds were compared among all EF exposure groups 
at each time point using a 1-factor ANOVA with a Tukey-HSD post-hoc test (Figure 2.6B 
graphs this analysis for cells at the start of the experiment, and after 30 minutes and 4 
hours of EF exposure). We found that the mean cell speed was equivalent among all 
groups prior to the EF onset (0 mV/mm: 13.4 µm/hr; 4 mV/mm: 14.3 µm/hr; 40 mV/mm: 
16.5 µm/hr; 400 mV/mm: 14.9 µm/hr; 1-factor ANOVA: p = 0.20) (Figure 2.6B, left 
panel). However, astrocytes exposed to 40 and 400 mV/mm displayed a rapid increase 
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in migration speed within 30 minutes of EF exposure as compared to astrocytes 
exposed to 0 or 4 mV/mm (mean speed: 0 mV/mm: 12.7 µm/hr; 4 mV/mm: 14.9 µm/hr; 
40 mV/mm: 22.3 µm/hr; 400 mV/mm: 21.5 µm/hr; 1-factor ANOVA: p = 1.1 x 10-6; 
Figure 2.6B, middle panel). Interestingly, astrocytes exposed to 40 mV/mm sustained 
this increased speed for only one hour and returned to the baseline speed 1.75 hours 
after the EF onset. Similarly, astrocytes exposed to 400 mV/mm initially increased their 
migrational speed to that observed for astrocytes exposed to 40 mV/mm, but this initially 
robust increase in speed was sustained for over 4 hours, after which time it returned 
towards baseline while maintaining an increased speed that hovered between 
significant and a non-significant trend. Cells exposed to 4 mV/mm did not show an initial 
change in migration speed upon EF exposure, but the mean speed decreased relative 
to cells exposed to 0 mV/mm beginning 3.5 hours after the EF onset and persisting for 
the remainder of the experiment. Thus, EF strengths comparable to those present in 
intact tissue induced cortical astrocytes to decrease their speed, whereas EFs 
intensities comparable to those present in injured mammalian tissue initiated a rapid 
increased speed of migration by these cells. This migrational response was more 
pronounced and sustained in astrocytes exposed to EF intensities associated with 
regenerating tissues in non-mammalian vertebrates.  
As the migrational assays were done sequentially, it was necessary to assess 
whether the time interval between when the cells were sub-cultured in the EF chamber 
and when EF exposure began had any effect on the cellular responsiveness to the 
electric field. Consequently, sister cultures were exposed to 40 mV/mm for 12 hours, 
beginning either 16 or 48 hours after the cells were sub-cultured into the EF chamber, 
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and migration speed was assessed. No difference in the mean migration speed 
between these groups was found (Figure 2.7), indicating that the sequence in which 
groups were exposed to each EF within an experiment does not serve as a confounding 
variable in these study. 
Electric fields are a directional cue for cortical astrocyte migration 
Having demonstrated that EF exposure alters cell speed in an intensity- and 
time-dependent manner, we assessed the extent to which EFs also serve as an 
orientational cue by causing directional migration. Directionality was assessed for each 
EF intensity at each time point using Rayleigh’s test (which tests the hypothesis of a 
non-random direction about a circle against the null hypothesis of a random direction), 
using an overall p-value = 0.05 with a Bonferroni correction for the total number of factor 
levels analyzed (196 comparisons: 4 EF levels at each of 49 time points). No directional 
migration was detected by astrocytes exposed to EF intensities of either 0 or 4 mV/mm. 
Interestingly, astrocytes displayed anodally-directed migration after 1.5 hours of 
exposure to 40 mV/mm, while this same anodally-directed migrational response only 
took 30 minutes to emerge for astrocytes exposed to 400 mV/mm (Figure 2.8). Once it 
emerged, directional migration continued throughout the remainder of the recording 
period. Moreover, cells exposed to 400 mV/mm moved with greater precision towards 
the anode as compared to astrocytes exposed to 40 mV/mm, which displayed a greater 
migrational dispersion. This was evident by a smaller circular standard deviation, and a 
larger concentration parameter (κ) of directional migration (data not shown). 
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As EFs rapidly induced directional migration by cortical astrocytes, we next set 
out to determine whether the cells remained sensitive to changes in the extracellular EF 
orientation. This was tested by exposing cells to 400 mV/mm for 6 hours, and then 
reversing the polarity of the EF exposure for another 6 hours (Figure 2.8, right panel). 
We found that, upon reversing the direction of the EF, cells stop moving towards the 
position that used to be the anode within 15 minutes, and reestablished directional 
migration towards the new anode position within 2 hours. This 2-hour loss of 
directionality occurred while the cells were reorienting to the new direction of the 
imposed EF, during which time half of the population turned left and the other half 
turned right (as indicated by the phase-shift in the directionality data, Figure 2.8). 
Together, these results indicate that the cells are capable of detecting the external EF 
and move towards the anode, with the strength of the EF affecting the directionality and 
speed of migration. As the lesion site within the CNS becomes the anode of the injury-
induced EF (see discussion in Chapter 1, page 48), EFs may be contributing towards 
astrocyte migration towards the lesion site in vivo. 
Electric fields induce cortical astrocyte proliferation 
After an injury, astrocytes around the lesion site proliferate with a well-described 
time course that begins within 24 hours of the injury, peaks after 48 hours, and begins 
to decline by 72 hours86. This newly-proliferating population helps reestablish the 
damaged BBB, and serves to replenish some of the cells lost to injury. We tested the 
hypothesis that EFs associated with injured tissues (40, 400 mV/mm) may actually drive 
this proliferative response. Specifically, astrocytes were exposed to an EF of either 0, 4, 
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40, or 400 mV/mm for either 12, 24, 48, or 72 hours to determine whether EFs can 
induce astrocyte proliferation, and whether this effect mirrors the temporal profile of the 
proliferative response of astrocytes following injury in vivo. BrdU was added to the 
culture media for the last 6 hours of the EF exposure, and proliferating cells were 
identified using BrdU immunocytochemistry (Figure 2.9A-D). Cells were counted as 
either BrdU-positive or negative, and the percentage of BrdU-labeled cells was 
calculated for each group (16 groups: 4 EF strengths x 4 time points) within each 
experiment (Figure 2.9E). At all 4 time points, 5-10% of cells exposed to 0 mV/mm were 
BrdU-positive, and there was no statistically significant difference in BrdU labeling of 
these cells over time (X23 = 6.68, p = 0.828). This was also the case for cells exposed to 
4 mV/mm where, at each time point, 5-10% of cells were BrdU-positive. Likewise, 
astrocytes exposed to either 40 or 400 mV/mm did not display changes in proliferation 
after 12 hours of exposure. This persisted for 24 hours of exposure, when a non-
significant trend towards increased proliferation began to emerge (X23 = 4.4643, p = 
0.2155). This trend towards increased proliferation for astrocytes exposed to 40 and 
400 mV/mm is non-significant likely because there was a robust increase in proliferation 
only in a subset of the experimental groups exposed to 40 and 400 mV/mm for 24 hours 
and the non-parametric statistical test used for these comparisons was too conservative 
to detect a difference given the relatively small sample size that we had; however, this 
suggests that EFs-induced proliferation begins to emerge as early as 24 hours, but that 
the effect does not fully emerge until a slightly later time point. By 48 hours of exposure 
to either 40 or 400 mV/mm EF, there was a statistically significant effect on proliferation 
(X23 = 13.5526, p = 0.0036), with a significant increase in astrocytes exposed to 40 
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mV/mm (p = 0.0088) and 400 mV/mm (p = 0.0481) relative to 0 mV/mm. This 
proliferative effect persisted through 72 hours of EF exposure, but only for cells exposed 
to 400 mV/mm (p = 0.0386); proliferation in cells exposed to 40 mV/mm had returned to 
baseline (p = 0.1452) within this period of time. Thus, EFs are capable of stimulating 
proliferation by astrocytes in an intensity- and time-dependent manner. The time-
dependent manner in which astrocyte proliferation is affected mirrors that observed for 
astrocytes at sites of injury to the CNS. Moreover, only an EF intensity of 400 mV/mm 
maintained significant astrocyte proliferation through the 72-hour exposure period, 
suggesting that this EF intensity is most effective at facilitating cell replacement 
following injury. 
One additional observation that was apparent in the time-lapse videos of 
astrocyte cultures exposed to 400 mV/mm EF is that the axis of division was related to 
the orientation of the electric field vector. As the orientation of division is known to 
influence cellular activity351, we set out to determine the extent to which EF exposure 
influences the axis of division in mammalian astrocytes. Using the DIC time-lapse 
videos, mitotic cells were identified and the angle of the axis of division was measured 
relative to the EF vector by drawing a line between the two daughter nuclei in the first 
frame where they became distinctly visible (Figure 2.10A-D). The distribution of these 
axes relative to the EF vector are plotted for each EF strength (Figure 2.10E), with the 
axial data double-plotted on the x-axis relative to the anode (A) and cathode (C) to 
assist in visualizing the clustering of mitotic events perpendicularly to the EF vector. 
Using the Rayleigh test for alignment, we found that EF exposure aligned the axis of cell 
division for cells exposed to 400 mV/mm (n = 124, R = 0.3740, p = 2.93 x 10-8), with a 
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mean direction µ ± SEM = 82.1 ± 3.53°, κ = 2.71, and SD = 39.7° (the EF axis runs from 
0° to 180°; 90° is perpendicular to the EF vector). We found that there was no significant 
alignment for cells exposed to 0 mV/mm (n = 176, R = 0.1127, p = 0.1071), 4 mV/mm (n 
= 186, R = 0.1071, p = 0.1183), or 40 mV/mm (n = 260, R = 0.0437, p = 0.6092). 
Electric fields alter cortical astrocyte morphology 
Having shown that EFs can control behaviors that are necessary for the initial 
astrocytic recruitment to the injury response, we tested the hypothesis that EFs can also 
regulate the hypertrophic and morphologic changes characteristic of the astrocytic 
response to injury in non-regenerating and regenerating animals, respectively. 
Following an injury, astrocytes in non-regenerating animals characteristically up-
regulate the expression of the intermediate filament GFAP, relative to the intermediate 
filaments vimentin and nestin, while astrocytes in regenerating animals do not undergo 
this hypertrophic change. As this response generally emerges only after several days, 
we exposed astrocytes to 0, 4, 40, or 400 mV/mm for 72 hours, and then used 
immunofluorescence labeling for GFAP, vimentin, and nestin to determine whether EFs 
affect hypertrophy (Figure 2.11A-L). We found that astrocytes exposed to 4 mV/mm, 
which is an EF intensity associated with uninjured tissues, expressed low levels of 
GFAP, with greater intensity of both vimentin and nestin. However, astrocytes exposed 
to 40 mV/mm displayed elevated levels of both GFAP and vimentin, suggesting that 
EFs associated with injured mammalian tissues caused robust hypertrophy. 
Interestingly, we found that GFAP and vimentin expression in astrocytes exposed to 
400 mV/mm were unchanged compared to that observed for astrocytes exposed to 4 
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mV/mm. Thus, EFs associated with injured mammalian tissues are sufficient to induce a 
hypertrophic response characteristic of reactive gliosis, while those associated with 
regeneration induce no such change. 
Having found that EF strengths associated with non-regenerating tissues induce 
cytoskeletal hypertrophy of astrocytes, we next set out to determine whether EFs 
associated with regeneration induce morphological changes in astrocytes consistent 
with their regenerative phenotype in vivo. Our group and others have shown that 
astrocytes align their processes perpendicularly to a 500 mV/mm applied EF within 24 
hours while 10 mV/mm has no effect, and we have previously shown that these EF-
aligned astrocytes enhance the extent of neurite outgrowth compared to unaligned 0 
mV/mm controls240, 241. Our time-lapse videos from the migration studies indicate that 
EF exposure to 400 mV/mm induces astrocytes to transform into a bipolar morphology 
and to align their processes within the first 12 hours of EF exposure. In the current 
study, we exposed astrocytes to 0, 4, 40, or 400 mV/mm for either 12 or 72 hours and 
performed FFT analysis for alignment on vimentin immunolabeled images to determine 
how quickly alignment occurs, whether this alignment is consistent over time, and 
whether physiologic EFs found at the injury site in mammals affect process alignment 
(Figure 2.11M-O). Astrocytes exposed to either 4 or 40 mV/mm EF showed no change 
in their morphology at either 12 or 24 hours of exposure. However, astrocytes exposed 
to 400 mV/mm showed a robust alignment of their processes perpendicular to the EF 
orientation within 12 hours (not shown), and this alignment persisted through the 72 
hour EF exposure. These results confirmed that only EF intensities associated with 
injury in regenerating vertebrates induce dramatic changes in astrocyte morphology that 
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mirror those demonstrated by astrocytes within the injury site of regenerating animals 
following trauma. 
Discussion 
Studies that have aimed to elucidate signals for regeneration in non-mammalian 
vertebrates have demonstrated that the intensity of injury-induced electric fields (EFs), 
which are 50-100 fold greater than in uninjured tissues, represent a potent signal to 
drive tissue repair215, 222, 227, 329, 331, 352, 353. In contrast, in many mammalian tissues 
where limited regeneration occurs, injury-induced EFs are much lower in their intensity. 
Interestingly, when an exogenous EF is applied to injured mammalian skin or cornea, a 
more robust reparative response occurs123, 326, 334. Studies have shown that the 
mammalian CNS also produces EFs269, 290 that increase in their intensity upon injury291, 
so it is reasonable to assume the EFs could present an important signal to drive CNS 
repair. As the astrocytic response to CNS injury is crucial to its reparative outcome, we 
evaluated how astrocytes respond to three different EF exposures within the ranges 
previously recorded in intact tissues (4 mV/mm) 256, 269, injured mammalian tissues (40 
mV/mm) 267, 326, and highly regenerating non-mammalian vertebrate tissues (400 
mV/mm) 270, 279, 280, 354, 355. At the lowest EF strength, astrocytes displayed little change 
in their behavior. However, mammalian astrocytes rapidly responded to elevated EFs by 
displaying robust and sustained directional migration. The directionality and speed of 
this migration were dependent on the polarity and intensity of the EF, respectively. 
Astrocytes also displayed a robust proliferative response upon prolonged EF exposure. 
Interestingly, only EFs associated with regeneration induced morphological changes in 
astrocytes that mirror those that facilitate regeneration in non-mammalian vertebrates79. 
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Moreover, each of these astrocytic responses, which are necessary for CNS repair, 
developed along the same time line as has been reported following an injury in vivo33, 54, 
64, 79, 86, 321, 322. These novel findings suggest that injury-induced EFs are capable of, and 
may be responsible for, driving the astrocytic response at CNS injury sites, and that 
manipulating EF intensity may represent a therapeutic option to promote CNS 
regeneration. 
The apparent role of EFs in regulating CNS regeneration is consistent with 
evidence that EFs regulate regeneration in a range of non-mammalian vertebrate 
tissues and structures, including skin356, 357, bone358, cornea359, lens259, 360, spinal 
cord354, tail265, 276, and limb270, 274, 275, 278, 361. Injury to these tissues produces a 
substantial increase in EF intensity, and these EFs remain elevated until regeneration is 
complete. Furthermore, studies manipulating only the injury-induced electric field have 
shown that EFs are both necessary and sufficient to drive regeneration. Specifically, 
reducing or blocking EFs can attenuate or completely inhibit regeneration280, 281, 
whereas increasing EF intensities can promote regeneration277, 333. Regeneration is not 
ubiquitous among non-mammalian vertebrates: Anuran amphibians regenerate their 
tails when they are tadpoles but they lose this ability as they progress through 
metamorphosis, during which time there is a concomitant decrease in the intensity of 
their injury-induced EFs276, 278. However, experimentally increasing EFs at amputation 
sites in the adult frog induces regeneration147, 333. Injury-induced EFs have also been 
measured in mammalian tissues, including skin256, 257, 271, 272, 362, cornea267, 268, 326, 
lens363, and bone258, 364-366. In mammals, injury-induced EFs are consistently lower than 
that found in regenerating vertebrates, and experimentally increasing their intensity also 
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promotes regeneration in these tissues283, 284, 334, 367. Recent studies have also 
established that EFs are present in the mammalian CNS. Although EFs have not been 
measured in the mammalian CNS in vivo, ex vivo recordings of the mammalian brain 
demonstrate that low (3.5-5 mV/mm) EFs are present within the rostral migratory 
stream, and EFs of this magnitude can direct neuroblast migration in vitro269. 
Furthermore, slice culture induces a 10-fold increase in these EFs to 31.8 ± 4.5 
mV/mm290, and spinal cord injury has been shown to induce a rapid 10-fold increase in 
current density ex vivo291. As EFs and current density are proportional to the resistivity 
of the tissue, it is likely that injury to the CNS induces a similar elevation in EF intensity. 
Collectively, these studies suggest that, in a variety of tissues in both non-mammalian 
and mammalian vertebrates, the magnitude of injury-induced changes in electric fields 
represent a crucial determinant to that tissue’s regenerative potential. 
Within the vertebrate CNS, the extent of regeneration is largely determined by 
the astrocytic response to injury60. Common to all vertebrates studied, astrocytes 
quickly migrate towards the lesion site and begin to proliferate64, 79, 84, 321, 368. This 
migration and expansion of the astrocytic population is necessary to re-establish the 
BBB and to prevent the lesion from enlarging into the surrounding healthy tissue32, 54, 83. 
In mammals, astrocytes have been shown to hypertrophy91 following injury and release 
molecules that inhibit axon sprouting and limit regeneration35, 50. In contrast, astrocytes 
facilitate axon regeneration in non-mammalian vertebrates by assuming a bipolar 
morphology and creating a cellular bridge that guides sprouting axons across the lesion 
site79. These similarities and differences in astrocyte behavior among vertebrates 
suggests that a common signal may initiate these behaviors, but that the signal does 
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not reach the threshold in injured mammals to induce the astrocytic behaviors 
necessary for robust regeneration. Thus, modifying the mammalian astrocytic response 
towards that seen in successfully regenerating animals may improve regeneration in 
mammals. 
As EFs have been shown to influence the repair of a variety of tissues through 
their action on cells within these tissues123, 238, 353, it is reasonable to assume that EFs 
could also affect astrocytic behavior to induce a regenerative response in neural tissue. 
Our results are consistent with this notion: we found that EFs induce dramatic changes 
in astrocyte migration and proliferation, and that these effects are enhanced with 
increasing EF intensities. Indeed, astrocytes display rapid and sustained anodally-
directed migration during EF exposure at both 40 and 400 mV/mm, and migration 
induced by a 400 mV/mm exposure has a significantly greater speed and a more 
precise directionality than that induced by 40 mV/mm. Previous literature suggests that 
the injury site in the mammalian cortex would become the anode of the injury-induced 
EF269 (see discussion in chapter one, page 48). Thus, our results that EFs induce 
anodal migration are consistent with the hypothesis that EFs contribute to astrocyte 
migration towards the lesion site in vivo. Interestingly, our observations that astrocytes 
exposed to 4 mV/mm decrease their speed relative to cells not exposed to an EF 
suggest that EFs associated with intact tissues may represent a signal that astrocytes 
use to maintain their stability in vivo, as astrocytes in intact tissues are thought to 
remain relatively stationary within defined domains91. 
Just as astrocytes proliferate beginning two days after injury in both mammalian 
and non-mammalian vertebrates in vivo, we found that both 40 mV/mm and 400 
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mV/mm induce astrocyte proliferation in vitro that begins to increase after 24 hours of 
exposure and peaks at 48 hours. While 40 mV/mm and 400 mV/mm induce a similar 
degree of proliferation, proliferation is sustained for at least 72 hours with 400 mV/mm 
exposure but decreases towards baseline during this time frame in the 40 mV/mm 
exposures. This mirrors observations showing that proliferation among mammalian 
astrocytes peaks two days after injury and then decreases, while proliferation among 
astrocytes in regenerating non-mammalian vertebrates increases two days after injury 
and remains elevated for many more days. Lastly, astrocytes maintain a more 
heterogeneous morphology at lower field intensity exposures and, consistent with 
previous work from our lab and others240, 241, they uniformly transform to a bipolar 
morphology only when exposed to 400 mV/mm. Interestingly, we found that these 
morphological changes were independent of intermediate filament expression. 
Specifically, our immunolabeling suggested that 400 mV/mm did not induce changes in 
GFAP, vimentin, or nestin expression, while 40 mV/mm induced an increase in GFAP 
and vimentin expression that is consistent with a reactive astrocytic phenotype in 
mammals. These differences in astrocyte behavior and morphology induced by 40 
mV/mm and 400 mV/mm mirror the differences in astrocyte behavior following injury in 
non-regenerating and regenerating vertebrates in vivo. This suggests that physiologic 
EFs may direct the astrocytic response to injury in mammals, and that therapeutically 
enhancing these EFs to levels found in non-mammalian vertebrates may induce an 
astrocytic response that is more favorable to regeneration. Indeed, we have previously 
shown that astrocytes exposed to high EF strengths generate processes that are more 
permissive to neurite growth than those generated at low field strength exposures240. 
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Taken together, these findings suggest that EFs are capable of controlling a number of 
astrocytic behaviors that are necessary for the injury response in mammals and 
regeneration in non-mammalian vertebrates. Moreover, the degree of regenerative 
potential of astrocytes is a function of the EF strengths to which they are exposed. 
The pronounced effects that EFs have on astrocytic behavior are likely a 
consequence of nonspecific interactions with charged membrane proteins in a variety of 
physiological pathways222, 369, 370. The EF vector encodes both direction and intensity, 
each of which can be transduced independently. Although the mechanisms by which 
astrocytes transduce EFs have not been explored, research from other cell types 
suggests directional migration is a function of electroosmosis, through which external 
EFs drive non-anchored membrane receptors to accumulate at opposite ends of the cell 
(Figure 1.8) 221, 223, 232, 309, 371-373. The degree of membrane receptor clustering is 
proportional to the EF intensity, which is consistent with the increased precision of 
astrocyte migration we observed at the highest EFs tested. EF intensity may be 
transduced by astrocytes by creating a voltage drop across the cell that affects the cell 
membrane potential and causes ion channels to open335, 374. Interestingly, changes in 
membrane potential are involved in inducing tail regeneration in the Xenopus tadpole, 
which requires the voltage-gated sodium channel NaV1.2147. Regeneration is lost during 
metamorphosis when NaV1.2 expression declines, whereas transfecting human NaV1.5 
into these maturing tadpoles reestablishes regeneration. In Xenopus, increased 
intracellular sodium through NaV’s induces regeneration through several pathways, 
including Notch. Mammalian astrocytes also express the voltage-gated sodium channel 
NaV1.5, which stimulates both migration and proliferation after injury by increasing 
 112 
 
intracellular calcium (Ca2+) through a Na+/Ca2+ exchanger375. Interestingly, in non-
mammalian vertebrates, proliferating astrocytes are capable of producing neurons, 
thereby having an essential role in neurogenesis88. Mammalian astrocytes also have a 
capacity for neurogenesis, which is regulated by Notch signaling103, 376. Higher EFs may 
promote regeneration by inducing a neurogenic program in astrocytes through 
regulating Notch signaling, while the lower EFs generated in the injured mammalian 
CNS may not sufficiently activate NaV1.5 to regulate Notch-mediated neurogenesis in 
vivo. Taken together, these studies demonstrate that multiple physiologic pathways are 
involved in transducing the EF signal to drive the cellular response to injury through 
affecting migration, proliferation and morphology.  
We have shown that electric fields within the physiologic ranges reported in 
injured mammalian tissues, and in regenerating non-mammalian vertebrate tissues, are 
able to elicit multiple behaviors in astrocytes that are necessary for their normal 
response to injury. Furthermore, the difference in responses induced by 40 mV/mm and 
400 mV/mm closely correspond to the differences between astrocytic behaviors in the 
injured mammalian CNS and those in the regenerating non-mammalian vertebrate 
CNS. Assuming that our results reflect the signaling environment in vivo, this suggests 
that electric fields, which are induced immediately upon injury and remain elevated 
throughout wound healing, may represent an important astrocyte response signal to 
drive tissue repair. As specific astrocytic behaviors are induced by specific EF 
strengths, and as behaviors associated with regeneration are induced only at EF 
strengths greater than those reported in injured mammalian tissues, regeneration in the 
mammalian CNS may be improved by therapeutically supplementing the physiological 
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EFs produced at the injury site. Indeed, EF based therapy has been used successfully 
to enhance bone reunion following fractures in humans in clinical practice using an 
inexpensive, non-invasive application377-379. Together, this suggests that therapeutically-
applied EFs are a strong therapeutic candidate to promote regeneration in the 
mammalian CNS by inducing an astrocytic response more favorable to regeneration. 
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Figure 2.1: Electric field chamber 
(A) An illustration of the electric field chamber, showing how it is connected to the 
circuit that creates the electric field. Wells for cell culture media are created using 
double-sided tape on either end of the cell culture chamber; vacuum grease is used to 
prevent any media from leaking around these barriers. Salt bridges (2% agarose in 
astrocyte media) connect the EF chamber to Ag/AgCl electrodes immersed in a 
Steinberg electrolyte solution. The power supply drives a redox reaction at each of the 
electrodes, converting the electrical current into an ionic current through the electric field 
chamber with cations moving towards the cathode (negatively-charged electrode) and 
anions moving towards the anode (positively-charged electrode). (B) Enlarged view of 
the electric field chamber, illustrating how specific EFs are calculated and applied. The 
EF chamber is made by sealing glass coverslip spacers to the bottom of the culture 
chamber with dental wax. The lane between the coverslip spacers is coated with 
fibronectin, and then astrocytes are seeded onto the lane. At the start of the experiment, 
a glass coverslip is sealed on top of the spacers with a thin bead of silicone vacuum 
grease to create a roof. EF magnitude is calculated with the formula E = ρI/A, where ρ is 
the resistivity of the media (700 Ωmm), I is the applied current, and A is the cross-
sectional area of the EF chamber. The cross-sectional area (A) of the EF chamber is 
determined based on the thickness of the coverslip spacers (h), and the distance 
between the spacers (w). Varying the width between the coverslip spacers and the 
magnitude of the applied currents creates different EF strengths. (Note, Figure 2.1(A) 
was illustrated by Christina Delli Santi.) 
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Figure 2.1: Electric field chamber 
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Figure 2.2: Methods to analyze cell migration 
(A) A point in the center of each cell’s nucleus (gold arrow) is manually selected 
every 5 frames (15 minutes). (B) The change in position is used to calculate the speed 
(magnitude, r) and direction (θ) of migration relative to the anode and cathode at each 
time point. In the example in panel B, the velocity vector measured at the 6 hour time-
point corresponds to the cell’s measured displacement and direction over the previous 
15 minute interval. (C) The direction of cell migration relative to the anode and cathode 
is double-plotted over time. Starting at 0°, which is indicated by the gold line segment in 
(B) corresponding to the radius extending to (1, 0) on the unit circle, angle measures 
increase counterclockwise such that 90° corresponds to the anode, 270° corresponds to 
the cathode, 450° corresponds to the anode, and 630° corresponds to the cathode. On 
the directionality double-plots (C, D), the direction relative to the anode and cathode is 
plotted along the x-axis, and time is plotted along the y-axis beginning at 0:00 hours 
(when the EF is turned on), and increasing in 15-minute increments over 12 hours. For 
the example of cell velocity measured in (B), the cell is traveling at approximately 120° 6 
hours after the start of the EF. In the sample directionality double-plot (C), this data 
point is plotted along the line corresponding to the 6-hour mark both at 120° and at 
480°. This double-plotting helps visualize the directionality of the data. (D) A 
directionality double-plot of the full data set for cells exposed to 0 mV/mm. The uniform 
distribution of cell directions visually indicates the lack of directional migration for these 
cells. (Panel D corresponds to part of the same data that is displayed in Figure 2.8.) 
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Figure 2.3: Optimizing the measuring interval for cell tracking 
Astrocytes were exposed to either 0 or 400 mV/mm and a 20x DIC image was 
acquired once ever 3 minutes for 1 hour. Individual cells were tracked by manually 
selecting the position corresponding to the center of their nucleus in every frame. By 
selecting sub-sets of these tracking positions, the cell speed was calculated every 3, 6, 
15, 30, or 60 minutes throughout the first hour of EF exposure. We used a mixed-effects 
generalized linear regression model to test the hypothesis that the sampling interval 
used to track cells affected the measured cell speed by increasing the proportion of the 
measured cell displacement due to random error in manual tracking. Astrocytes 
exposed 0 and 400 mV/mm were analyzed separately, and box-plots summarizing the 
spread of data for cells tracked every 3, 6, 15, 30, or 60 minutes are shown. The box 
spans the middle two quartiles, and the central bar indicates the mean. We found that 
there was a statistically significant difference in the mean speed measured among the 
different tracking intervals (0 mV/mm: F4 = 4.5879, p = 0.001597; 400 mV/mm: F4 = 
2.8128, p = 0.02637). We used a Tukey-HSD post-hoc test to make individual 
comparisons between groups, and the results are indicated above the graphs. The 
letters above each graph indicate the statistically significant differences between the 
groups; groups are statistically significant (i.e. p < 0.05) if they do not share a letter. 
Note: statistically significant differences exist between groups that do not share a 
common letter (for a table detailing these data, see Table 2.1). 
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Figure 2.4: Characterizing the astrocyte population 
Representative confocal images used to characterize the astrocyte population 
based on immunolabeling. (A) GFAP, (B) vimentin, (C) nestin, and (D) an overlay show 
that the population is morphologically heterogeneous, consisting of both lamellipodial 
and process-bearing cells. The cells universally express all three markers, with the 
relative levels varying among the different cells, suggesting that our population includes 
astrocytes of varying degrees of maturation. Scale bar = 20 µm. 
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Figure 2.5: Paths of astrocyte migration over the first 6 hours of EF exposure 
To qualitatively evaluate the EF-induced effect on migration, the paths of 
migration over the first six hours of EF exposure were plotted for individual astrocytes; 
the starting position was normalized to the origin of the graph (0, 0), and the direction 
was displayed relative to the orientation of the EF with the cathode (+) at the top of the 
graph and the anode (-) at the bottom of the graph. 30 cells from each EF strength were 
randomly selected to be included in this plot (including more than 30 cells makes it 
difficult to discern individual tracks). X- and Y-units for the graph are in micrometers. 
These graphs demonstrate the different effects that each EF strength have on 
directional migration. 
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Figure 2.5: Paths of astrocyte migration over the first 6 hours of EF exposure 
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Figure 2.6: Electric field exposure affects cortical astrocyte migration speed 
(A) Astrocyte migration speed is plotted every 15 minutes for 12 hours. Within 30 
minutes of EF onset, cells exposed to both 40 and 400 mV/mm show a similarly rapid 
increase in mean speed. For cells exposed to 40 mV/mm, this is maintained for only the 
first 2 hours and then returns to the same speed as 0 mV/mm, while this is maintained 
in the group exposed to 400 mV/mm for over 4 hours. Initially, there is no effect on cells 
exposed to 4 mV/mm, but the mean speed begins to decrease after 3 hours. (B) Effects 
of EF exposure on speed were assessed at each time point. 3 representative time 
points are shown corresponding to the start of the experiment (0 hours), and 30 minutes 
and 4 hours after EF onset. Mean speed was compared between EF strengths at each 
time point with a 1-factor ANOVA followed by a Tukey-HSD post hoc test. There was no 
difference in mean speed between groups at the start of the experiment (F(3, 471) = 1.54, 
p = 0.20). There was a significant effect of EF exposure at both 30 minutes (F(3, 474) = 
10.5, p = 1.1 x 10-6) and 4 hours (F(3, 483) = 11.8, p = 1.8 x 10-7). The mean speed of 
cells exposed to 0 mV/mm did not significantly change over time. All data are expressed 
as mean ± SEM. #p = 0.0509; *p < 0.05; **p < 0.01; ***p < 0.001. 
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Figure 2.7: Assessing sequence effects on migration 
Sister cultures of astrocytes were used to test whether the delay between sub-
culturing astrocytes in the EF chamber and beginning the EF exposure affected the 
astrocytes’ migrational response to EFs. To test this, sister cultures were exposed to 40 
mV/mm for 12 hours, with the EF exposure beginning either 16 or 48 hours after cells 
were sub-cultured (corresponding to (1) and (2) indicated in the legend, respectively). 
Migrational speed for astrocytes in these groups is plotted every 15 minutes as mean ± 
SEM. The same pattern of change in migrational speed over time was observed for both 
groups: speed increased transiently over the first hour and returned to baseline after the 
second hour. This demonstrates that there is not a robust sequence effect on these 
experiments. 
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Figure 2.8: Electric fields induce directional migration 
Astrocytes preferentially migrate towards the anode of an applied electric field of 
40 or 400mV/mm. The direction of migration was measured for each cell every 15 
minutes over 12 hours relative to the anode (A, indicated in red) and cathode (C, 
indicated in blue) of the applied EF and plotted, with each dot representing the direction 
of migration of a single cell at each time point. The x-axis is double-plotted for each field 
strength to help visualize the directionality (see Figure 2.2 for a description of how these 
plots are generated). The random direction of cell movement in 0 and 4 mV/mm is 
visually displayed by the even distribution of data points along the x-axis. Directional 
migration towards the anode emerges in cells exposed to 40mV/mm after 1.5 hours. 
400 mV/mm induces anodally-directed migration after 30 minutes, which is more 
concentrated (greater concentration parameter, κ) towards the anode than it is for cells 
exposed to 40 mV/mm. If the polarity of the 400 mV/mm EF is reversed after 6 hours 
(panel labeled 400(R) mV/mm, time when current was reversed is indicated with the 
dashed gold line), cells reorient to the new EF vector over the following 2 hours. 
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Figure 2.9: Electric field exposure induces cortical astrocyte proliferation 
Proliferation peaks 48 hours after onset of the EF. A-D: Representative BrdU 
immunolabeling overlaid on 20x DIC images of cortical astrocytes 48 hours after 
exposure to 0 (A), 4 (B), 40 (C), or 400 (D) mV/mm; scale bars: 20 µm. The orientation 
of the applied EF is indicated in each image, with the anode (+) to the right of the image 
and the cathode (-) to the left. (E) Quantification of change in proliferation over time as a 
function of EF strength by comparing the % BrdU-positive cells to the total population of 
cells present. For all field strengths, there was no change in proliferation at 12 hours 
(X23 = 0.7400, p = 0.8638) or 24 hours (X23 = 4.4643, p = 0.2155) after exposure. The 
proliferation at 24 hours in groups exposed to 40 or 400 mV/mm is not significantly 
different from 0 in spite of the visual trend indicating an increase because the non-
parametric statistical test used for this evaluation is very conservative. By 48 hours after 
EF onset, there was a significant increase in proliferation (X23 = 13.5526, p = 0.0036) in 
astrocytes exposed to 40 mV/mm (p = 0.0088) and 400 mV/mm (p = 0.0481) relative to 
0 mV/mm, while 4 mV/mm had no effect on proliferation (p = 1.0000). After 72 hours, 
there was still an observed increase in proliferation (X23 = 13.0060, p = 0.0046), but only 
cells exposed to 400 mV/mm remain elevated (p = 0.0386) relative to 0 mV/mm (4 
mV/mm: p = 1.0000; 40 mV/mm: p = 0.1452). All data are expressed as mean ± SEM. 
Kruskal-Wallis test followed by individual nonparametric comparison post-hoc tests 
using the Dunn Method for Joint Ranking. *p < 0.05, **p < 0.01. 
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Figure 2.9: Electric field exposure induces cortical astrocyte proliferation 
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Figure 2.10: Electric field exposure aligns the axis of cell division 
(A-D) Mitotic cells (arrow, A) were identified in time-lapse DIC microscopy 
videos. The axis of division was defined for each cell by drawing a line through the 
center of each of the daughter nuclei (line, D) and measuring the angle of this axis 
relative to the applied EF (cathode (-) at the top of each image, anode (+) at the bottom 
of each image). The time (in minutes) of each image is provided to illustrate the duration 
of mitosis. Scale bar = 20 µm. (E) Frequency histograms representing the relative 
number of nuclei counted at each orientation relative to the anode (A) and cathode (C) 
(histogram bin width of 15°), with a density curve super-imposed on each graph. 
Nuclear alignment is double-plotted along the x-axis to aid in observing the alignment of 
these data. Each EF strength was evaluated for alignment with Rayleigh’s test, and 
found that only 400 mV/mm induced alignment (n = 124, R = 0.3740, p = 2.93 x 10-8), 
with a mean direction µ ± SEM = 82.1 ± 3.53°, κ = 2.71, and SD = 39.7° (the EF axis 
runs from 0° to 180°, with 90° being perpendicular to the EF vector). There was no 
significant alignment for cells exposed to 0 mV/mm (n = 176, R = 0.1127, p = 0.1071), 4 
mV/mm (n = 186, R = 0.1071, p = 0.1183), or 40 mV/mm (n = 260, R = 0.0437, p = 
0.6092). 
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Figure 2.11: EF effects on intermediate filament expression and morphology 
Representative confocal images of astrocytes after 72 hours’ exposure to 4, 40, 
or 400 mV/mm. (A-C) DAPI-labeled nuclei, with an overlay indicating the orientation of 
the electric field vector (+) and (-), corresponding to the anode and cathode, 
respectively. Immunolabeling for GFAP (D-F), vimentin (G-I), and nestin (J-L) show that 
only 40 mV/mm induces an up-regulation of vimentin and GFAP. (M-O) FFT analysis of 
normalized pixel intensity from vimentin-labeled images (averaged over 6-8 images) 
shows that astrocytes exposed to 4 and 40 mV/mm for 72 hours extend their processes 
in random directions, while only astrocytes exposed to 400 mV/mm display a strong 
preference for process alignment perpendicularly to the vector of the EF as indicated by 
the high peaks. All 4 graphs are plotted with the same scale on the vertical axis; the 
horizontal axis indicates directionality relative to the anode (+) and cathode (-). Scale 
bar: 50 µm. 
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Table 2.1: Optimizing the measurement interval for cell tracking 
Coefficient parameters for the Tukey-HSD post hoc tests, indicating the 
estimated difference (µm/hour) between each group, the t-score of the difference, and 
the adjusted p-value for the comparison. 
 
 
 
 0 mV/mm  400 mV/mm 
 Estimate t-score p-value  Estimate t-score p-value 
6 – 3 -11.654 -3.878 1.033 x 10-3  -8.154 -3.071 0.0183 
15 – 3 -18.271 -6.080 7.328 x 10-9  -9.907 -3.731 1.851 x 103 
30 – 3 -22.843 -7.601 1.192 x 10-13  -15.438 -5.814 5.050 x 10-8 
60 – 3 -26.962 -8.972 < 1 x 10-15  -18.679 -7.035 2.189 x 10-11 
15 – 6 -6.617 -2.202 0.1789  -1.752 -0.660 0.9648 
30 – 6 -11.190 -3.723 1.840 x 10-3  -7.284 -2.743 0.0477 
60 – 6 -15.309 -5.094 2.355 x 10-6  -10.524 -3.964 6.735 x 10-4 
30 – 15 -4.573 -1.522 0.5483  -5.532 -2.083 0.2271 
60 – 15 -8.692 -2.892 0.0312  -8.772 -3.304 8.708 x 10-3 
60 – 30 -4.119 -1.371 0.6466  -3.240 -1.220 0.7396 
(adjusted p values are reported, using the single-step method) 
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Chapter 3:  Cerebellar Astrocytes 
Chapter Overview 
In the previous chapter, we found evidence to support our hypothesis that injury-
induced EFs determine the regenerative potential in the CNS by affecting each of the 
astrocytic behaviors necessary for wound repair. However, our observations were 
limited to cortical astrocytes, but astrocytes demonstrate remarkable morphological and 
functional heterogeneity throughout different regions of the CNS. This heterogeneity 
among sub-populations of astrocytes suggests that the astrocytic response to injury 
may also vary among different regions within the mammalian CNS. Indeed, while 
reactive astrocytosis in the cortex is associated with the formation of a chronic glial scar, 
reactive astrocytes in the cerebellum do not reorganize into a similarly demarcated scar; 
moreover, there is evidence that certain neuronal cell types within the mammalian 
cerebellum regenerate. Similarly to how EFs drive behaviors associated with the 
astrocytic response to injury in the mammalian cortex, we hypothesized that EFs drive a 
reactive astrocytic phenotype in the cerebellum. Moreover, we hypothesized that the 
effect of EFs on cerebellar astrocytes would be different than that of EFs on cortical 
astrocytes, reflecting the difference in the injury response displayed by these two 
different populations of astrocytes. 
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Introduction 
The mammalian CNS is characterized by minimal regeneration because the 
astrocytic response to parenchymal injury results in the formation of a chronic glial scar 
that inhibits axon regeneration33, 35. However, astrocytes demonstrate remarkable 
heterogeneity in their response to injury across different regions of the brain380, 
suggesting that glial scar formation and axon regeneration may be similarly variable. 
Indeed, the cerebellum remains conducive to axon outgrowth, as climbing fiber axons 
from olivocerebellar neurons are able to sprout through the intact parenchyma to their 
original targets after being individually axotomized using laser dissection (a procedure 
that does not induce tissue injury or a reactive response) 47, and these same intrinsic 
regenerative properties allow them to regenerate after injury past the lesion site381; upon 
reaching their original targets, they functionally re-integrate into the remaining neural 
circuitry through local plasticity47, 381. Moreover, cerebellar astrocytes promote migration 
of new cerebellar neurons throughout the life of the animal382. The cerebellum, which is 
located in the hindbrain (Figure 3.1), is the phylogenetically oldest part of the 
mammalian brain, suggesting that its relatively greater inherent regenerative capacity 
may be a reflection of some vestigial phenotype that once facilitated regeneration in a 
common vertebrate ancestor. 
Interestingly, the heterogeneous astrocytic population in the cerebellum reflects 
the phenotypic origins of the structure: astrocytes in the granular layer demonstrate a 
stellate morphology that is similar to cortical astrocytes, while astrocytes in the Purkinje-
cell and molecular layers, which are eponymously known as Bergmann glia, more 
closely resemble immature astrocytes and radial glia (Figure 3.1B). Radial glia, which 
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are bipolar cells that span the entire width of the embryonic cerebellum, differentiate into 
Bergmann glia through as Shh and FGF-9 signaling382, 383. As they differentiate, radial 
glia retain their basal branch, and Notch signaling induces additional processes to 
develop such that Bergmann glia ultimately have 3-6 branches that traverse the 
molecular layer75, 107, 382. Bergmann glia express GFAP, but they are morphologically 
similar to radial glia384, and they express the immature/stem-cell intermediate filament 
Nestin and the transcription factor Sox2382, 385.  
Following an injury, Bergmann glia and cerebellar astrocytes both develop 
hypertrophic processes within 10 days of a lesion, overexpress the intermediate 
filaments GFAP and vimentin, and deposit NG2 – a CSPG that inhibits axon outgrowth 
– into the ECM386, 387. This response has been defined as characteristic reactive gliosis 
because of the strong similarities response to injury in cortical astrocytes. Nonetheless, 
cerebellar astrocytes and Bergmann glia also overexpress the intermediate filament 
nestin384 and a subset of cerebellar astrocytes express the embryonic neural cell 
adhesion molecule PSA-NCAM388, which is a permissive substrate for neurite 
outgrowth, together suggesting that these cells also retain characteristics of immaturity 
associated with radial glia. Early studies that did not distinguish between sub-layers 
within the cerebellum reported a glial scar induced by injury389, and biopsies from two 
case reports in human patients suggests evidence that implanted electrodes induce a 
gliotic response after 3 months390. However, subsequent research suggests that 
Bergmann glia do not reorganize and form a glial scar in the molecular layer92, 384; 
moreover, while cerebellar astrocytes do form a glial scar in the granular layer, their 
induction of PSA-NCAM expression beginning 3 months after axotomy corresponds to 
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the initiation of outgrowth from axotomized Purkinje cell axons, and up to 75% of axons 
sprouting past the glial scar are ensheathed by these reactive astrocytes388, 391. 
Together, this suggests that cerebellar astrocytes and Bergmann glia may facilitate a 
regenerative response to injury in the cerebellum because they represent an 
intermediate astrocytic phenotype between that of regenerative radial glia in non-
mammalian vertebrates and of non-regenerative cortical astrocytes in mammals. 
In chapter one, we established that endogenous electric fields regulate wound 
repair and determine regenerative outcomes after injury by directly influencing the 
cellular response to injury. In chapter two, we showed that physiologic EFs regulate 
behaviors from cortical astrocytes associated with their injury response, and that 
elevated EFs modify this response towards a more regenerative phenotype. Based on 
these observations, we hypothesized that physiologic EFs also regulate the astrocytic 
response to injury in the mammalian cerebellum. Moreover, we hypothesized that the 
greater regenerative potential in the cerebellum is associated with a more robust 
regenerative response among cerebellar astrocytes to physiologic EFs. In the 
experiments described in the current chapter, we exposed rat cerebellar astrocytes to 
EFs following the same experimental design that we used in chapter two. Our findings 
from these studies suggest that cerebellar astrocytes demonstrate a robust response to 
EFs that is greater in its intensity and duration the response we have observed among 
cortical astrocytes. This suggests that cerebellar astrocytes maintain a greater 
regenerative potential because they are more intrinsically responsive to physiologic EFs 
present in the injury environment. 
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Methods 
Cell source and culture methods 
Rat cerebellar astrocytes harvested from P2 cerebellum were purchased from 
ScienCell (cat # R1800). Cultures have greater than 99% purity as determined with 
GFAP immunolabeling by ScienCell. The company makes no distinction among 
astrocytic sub-populations from the molecular and granular layers, and GFAP staining 
cannot differentiate between these cell types. Consequently, the astrocytes used in 
these experiments represent a heterogenous population, similar to the mixed population 
present in an injury site in vivo. All of the astrocytes used for these experiments came 
from the first five passages after the initial thaw. Astrocyte cultures were maintained 
according to the protocol recommended by ScienCell. Briefly, astrocytes were thawed 
into poly-L- lysine (ScienCell # 0413) coated T75 culture flasks containing astrocyte 
media (pH 7.4; ScienCell AM-a 1831) supplemented with 2% fetal bovine serum 
(ScienCell # 0010) and 1% penicillin/streptomycin (ScienCell # 0503). Cultures were 
maintained in a humidified 37°C incubator with a 5% CO2 atmosphere, and culture 
media was changed every 2-3 days. Once the cultures reached confluence, 
approximately 5,000 astrocytes were sub-cultured into each EF chamber (see 
description below) for experiments. Methods used to design the EF chamber were 
identical to the methods described in chapter two (page 80).  
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Experimental design and statistical analysis 
For the experiments described in this chapter, we exposed cerebellar astrocytes 
to EFs of 0, 4, 40, or 400 mV/mm and repeated many of the analyses that we 
completed with cortical astrocytes in chapter two. We initially characterized the 
population of cerebellar astrocytes with immunolabeling for GFAP, vimentin, and nestin. 
We then assessed effects on migrational speed and direction, orientation of 
proliferation, and morphology. The methods and analyses used in these experiments 
are identical to those methods describe in chapter two (beginning on page 82), with the 
exceptions that cerebellar astrocytes used for immunocytochemistry studies were only 
exposed to EFs for 12 hours. 
Results 
Characterizing the cerebellar astrocyte population 
We used cultured rat cerebellar astrocytes to test whether the EFs that are 
associated with intact and injured mammalian tissues may affect cerebellar astrocyte 
behaviors in vitro. The cerebellar astrocytes used in these experiments were purchased 
as purified populations from ScienCell (a company that specializes in preparing purified 
primary cell cultures), who verified population purity with GFAP staining. We also 
characterized the astrocytic population prior to conducting each experiment. We used 
immunofluorescence labeling against GFAP, vimentin, and nestin, as well as 
morphological characteristics in DIC, to evaluate the purity and maturation of these 
astrocytes (Figure 3.2). These astrocytes consistently expressed high levels of GFAP 
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and vimentin; in contrast, most of the cells did not express nestin, although certain sub-
populations were strongly nestin-positive. Cell morphologies seemed to be consistent 
with the cytoskeletal elements that they expressed: nestin-negative cells maintained a 
lamellipodial morphology consistent with cerebellar astrocytes, while nestin-positive 
cells tended to have a more bipolar, process-bearing morphology similar to that 
characteristic of Bergmann glia. This suggests that this population contains a mixture of 
cerebellar astrocytes and Bergmann glia. 
Electric fields affect the speed of cerebellar astrocyte migration 
To test our overall hypothesis that EFs direct the astrocytic response to injury, we 
explored how EF exposure affects each of the behaviors that astrocytes 
characteristically display after injury in both mammalian and non-mammalian 
vertebrates. The first of these behaviors is migration, as astrocytes must move towards 
the lesion as they are recruited to restore BBB integrity and isolate the lesion 
environment from the surrounding healthy tissue. We tested the ability of EFs to 
influence astrocyte migration by using time-lapse DIC live cell microscopy to record how 
primary rat cerebellar astrocytes respond to dcEFs over a 12-15 hour period. We 
compared how EF intensities associated with intact (4 mV/mm), injured mammalian (40 
mV/mm), and injured non-mammalian vertebrate tissues (400 mV/mm) affect migration 
relative to an untreated control (0 mV/mm). We observed no evidence of cell death 
during these experiments as a function of either EF exposure or of phototoxicity from 
repeated exposure to light. We measured migration by tracking cells every 15 minutes, 
which was the frequency that provided the greatest temporal resolution for velocity 
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measurements without adding a significant component of error in selecting cell position 
(see page 95 for details). Each experiment was conducted at least 3 times using cells 
derived from different animals, and at least 30 cells were tracked at each time point 
from at least 5 fields of view for each experiment; results from each experiment were 
pooled and analyzed together (n ≥ 90 cells for each EF strength at each time point).  
Time-lapse videos show that, in the absence of any EF, astrocytes have a 
heterogeneous morphology and display non-directional movement. Cells exposed to 4 
mV/mm show similar morphologies and patterns of movement. In contrast to the cortical 
astrocyte response to 40 mV/mm, time-lapse videos show that 40 mV/mm does not 
induce directional migration or increased speed in cerebellar astrocytes. However, 
cerebellar astrocytes exposed to 400 mV/mm demonstrate a rapid response to the EF 
exposure, with the entire cell population migrating towards the anode of the EF within 
the first hour of the EF exposure. 
To qualitatively evaluate the EF-induced effect on migration, the paths of 
migration over the first six hours of EF exposure were plotted for individual astrocytes; 
the starting position was normalized to the origin of the graph (0, 0), and the direction 
was displayed relative to the orientation of the EF (Figure 3.3). The mean cell speed is 
plotted for each EF-exposure at 15-minute intervals over the 12-hour experiment 
(Figure 3.4A). Using a 1-factor ANOVA, we found no significant differences in the mean 
cell speed among the EF-exposure groups prior to the EF onset (0 minutes: F3, 360 = 
2.13, p = 0.096; mean speed ± SEM for 0 mV/mm: 16.64 ± 1.19 µm/hr; 4 mV/mm: 21.70 
± 2.62 µm/hr; 40 mV/mm: 17.89 ± 1.85 µm/hr; 400 mV/mm: 21.21 ± 1.52 µm/hr; Figure 
3.4B, left panel). 15 minutes after EF onset, there is a statistically significant difference 
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in mean astrocyte speeds among the different EF-exposure groups (F3, 357 = 17.1, p = 
2.12 x 10-10; mean speed ± SEM for 0 mV/mm: 16.26 ± 1.14 µm/hr; 4 mV/mm: 22.70 ± 
1.69 µm/hr; 40 mV/mm: 17.42 ± 1.48 µm/hr; 400 mV/mm: 30.55 ± 2.00 µm/hr; Figure 
3.4B, center panel). Using the Tukey-HSD post-hoc test, we found that cerebellar 
astrocytes exposed to 400 mV/mm have a greater cell speed than cells exposed to 0 
mV/mm (p = 1.761 x 10-9; estimated difference: 14.28 µm/hr, 95% CI: 8.60, 19.96), 4 
mV/mm (p = 3.826 x 10-3; estimated difference: 7.85 µm/hr, 95% CI: 1.93, 13.77), and 
40 mV/mm (p = 1.205 x 10-7; estimated difference: 13.12 µm/hr, 95% CI: 7.22, 19.02); 
we also found that cells exposed to 4 mV/mm had an increased speed relative to 0 
mV/mm (p = 2.717 x 10-2; estimated difference: 6.43.µm/hr, 95% CI: 0.51, 13.35), but 
that their speed was not different from astrocytes exposed to 40 mV/mm (p = 0.1197). 
Although this suggests that 4 mV/mm may transiently induce an increased migration 
speed, this more likely represents an aberration or artifact than a true effect as the 
difference between 0 and 4 mV/mm is relatively small, 4 mV/mm was not different from 
40 mV/mm, and 0 mV/mm was not different from 40 mV/mm; moreover, 4 mV/mm was 
different from neither 0 nor 40 mV/mm at 30, 45, or 60 minutes after EF onset, while the 
increased speed for astrocytes exposed to 400 mV/mm was sustained at each of these 
time points and throughout the rest of the 12 hour experiment. Cerebellar astrocytes 
exposed to 400 mV/mm sustained this increased speed (relative to 0 mV/mm) 
throughout the entire 12 hours of the experiment, while there were no differences in 
mean cell speed among the cells exposed to 0, 4, or 40 mV/mm at any subsequent time 
point. (Differences between cell speeds were compared between EF exposure groups 
at each time point using a 1-factor ANOVA with a Tukey-HSD post-hoc test; see Figure 
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3.4B for analyses at the start of the experiment, and 0, 15 minutes and 2 hours after the 
EF onset.) Thus, only EFs elevated at levels associated with regenerating non-
mammalian vertebrate tissues affect cerebellar astrocyte migration speed. 
Electric fields are a directional cue for cerebellar astrocyte migration 
Having demonstrated that EF exposure alters cell speed in an intensity- and 
time-dependent manner, we tested whether EFs also serve as an orientational cue by 
causing directional migration. Directionality was assessed for each EF intensity at each 
time point using Rayleigh’s test (which tests the hypothesis of a non-random direction 
about a circle against the null hypothesis of a random direction), using an overall p-
value = 0.05 with a Bonferroni correction for the total number of factor levels analyzed 
(196 comparisons: 4 EF levels at each of 49 time points). We found that there was no 
directional migration in the 0 mV/mm control group, and that neither 4 mV/mm nor 40 
mV/mm caused cerebellar astrocytes to move directionally. However, 400 mV/mm 
induced directional migration towards the anode within 15 minutes of EF exposure (i.e. 
the first time point measured after EF onset); the mean direction in which cells traveled 
was 93.29° ± 0.99°, κ = 1.56 ± 0.03, where 90° corresponds to the anode (circular mean 
direction ± circular standard deviation calculated for all cell directions at time points 
where there was statistically-significant directional migration) (Figure 3.5). As the lesion 
site within the CNS becomes the anode of the injury-induced EF (see discussion in 
Chapter 1, page 48), EFs may be contributing towards astrocyte migration towards the 
lesion site in vivo. Moreover, once directionality emerged, it continued throughout the 
entire recording period. We also found that, similarly to cortical astrocytes, cerebellar 
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astrocytes remain very sensitive to changes in the orientation in the extracellular EFs. 
We demonstrated this by exposing cerebellar astrocytes to 400 mV/mm for 6 hours and 
then reversing the polarity of the EF exposure for another 6 hours. We found that 
cerebellar astrocytes stop moving towards the original anode after 15 minutes of 
reversing the direction of the EF, and they orient themselves to the new anode after 30 
minutes of non-directional movement. From the time-lapse videos and the directionality 
double-plot, this period of “non-directional” movement appears to reflect the cells 
actually turning around as they reorient themselves to the new direction of the imposed 
EF, during which time half of the population turned clockwise and the other half turned 
counter-clockwise (as indicated by the phase-shifts in the directionality data, Figure 
3.5). This rate of reversal was much more rapid than the two-hours required for cortical 
astrocytes to reorient to a change in polarity of an applied EF, suggesting that cerebellar 
astrocytes may be more responsive to EFs than cortical astrocytes are. 
Electric fields align the axis of cell division 
While reviewing the time-lapse live cell videos, we observed that cells exposed to 
400 mV/mm tended to divide with an axis of division perpendicular to the EF vector. The 
orientation of division is known to influence cellular activity during mammalian 
embryogenesis107, and regeneration in non-mammalian vertebrates is known to 
recapitulate development, so we were interested in determining whether EF exposure 
aligns the axis of division in cerebellar astrocytes. Using the DIC time-lapse videos, we 
identified mitotic cells and measured the angle of the axis of division relative to the EF 
vector by drawing a line between the two daughter nuclei in the first frame where they 
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were distinctly visible (Figure 3.6A-D). The distribution of these axes relative to the EF 
vector are plotted for each EF strength (Figure 3.6E), with the axial data double-plotted 
on the x-axis relative to the anode (A) and cathode (C) to assist in visualizing the 
clustering of mitotic events perpendicularly to the EF vector. Using the Rayleigh test for 
alignment, we found that EF exposure aligned the axis of cell division for cells exposed 
to 400 mV/mm (n = 123, R = 0.1721, p = 2.61 x 10-2), with a mean direction µ ± SEM = 
98.21 ± 5.97°, κ = 1.35, and SD = 61.9° (the EF axis runs from 0° to 180°, with 90° 
being perpendicular to the EF vector). We found that there was no significant alignment 
for cells exposed to 0 mV/mm (n = 122, R = 0.1408, p = 0.089), 4 mV/mm (n = 99, R = 
0.0727, p = 0.5925), or 40 mV/mm (n = 55, R = 0.0533, p = 0.8553). Thus, only EFs 
associated with regenerating tissues align the axis of division in cerebellar astrocytes. 
Electric fields align cerebellar astrocytes 
Cerebellar astrocytes are a heterogeneous population, with a sub-population 
morphologically similar to mammalian cortical astrocytes and another sub-population 
(Bergmann glia) with long processes spanning the molecular layer resembling radial glia 
in non-mammalian vertebrates. These aligned processes help certain classes of 
neurons to migrate through the adult cerebellum, and aligned astrocytic processes also 
promote a regenerative phenotype in the mammalian and non-mammalian vertebrate 
CNS. In chapter 2, we demonstrated that elevated EFs at levels associated with 
regeneration promote cortical astrocytes to align their processes perpendicularly to the 
polarity of the applied EF. Our time-lapse videos from the cerebellar astrocyte migration 
studies suggested that EFs induce morphological changes in cerebellar astrocytes 
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similar those that we observed in cortical astrocytes and, given that these morphological 
changes are associated with a regenerative phenotype, we next set out to quantify 
these effects on morphology using FFTs on cells immunolabeled for DAPI, GFAP, 
vimentin, and nestin images (Figure 3.7). A qualitative review of these immunolabeled 
images showed that there was a relatively heterogeneous astrocytic population in the 
cells exposed to 0, 4, and 40 mV/mm, consisting of both lamellipodial and bipolar cells, 
while astrocytes exposed to 400 mV/mm appeared to assume a more process-bearing 
morphology. It also appears as though there is a relatively consistent expression of both 
GFAP and vimentin among these cells, with nestin-expressing cells intermittently 
present. We analyzed the vimentin-immunolabeled cells for alignment using an FFT 
analysis (Figure 3.8). These FFTs show that astrocytes exposed to 400 mV/mm align 
their processes perpendicularly to the applied EF; astrocytes exposed to 0, 4, and 40 
mV/mm also demonstrate some periodicity in the alignment of their processes, but this 
is much smaller in magnitude than the alignment induced by 400 mV/mm, it is focused 
at an arbitrary orientation, and it is consistent among the 0, 4, and 40 mV/mm groups, 
and it may represent some sort of artifact rather than an actual alignment effect. These 
results summarize data from only one experiment, so we are unable to determine 
whether the alignment demonstrated by astrocytes exposed to 4 and 40 mV/mm 
represents something real about these cells or if it instead is an artifact. 
Discussion 
Increasing evidence supports the notion that bioelectric fields interact with all 
cells, and that injury-induced EFs regulate the cellular response to injury215, 315, 392. This 
is evidenced by multiple studies demonstrating that elevated EFs induce the same 
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behaviors necessary for epimorphic regeneration among diverse cell types from many 
different tissues147, 315, 324, 392. We have previously described evidence that mammalian 
astrocytes, which are necessary for the cellular response to injury in the CNS, respond 
to elevated EFs through the same induced behaviors as are expressed by cells in other 
tissues upon EF exposure (chapter two). Our findings in the current study, that 
cerebellar astrocytes respond to elevated EFs, are consistent with the notion that EFs 
are a universal signal that regulates cellular activity and wound repair. We found that 
cerebellar astrocytes did not respond to EFs of 40 mV/mm; as 40 mV/mm induces 
behaviors in cortical astrocytes associated with glial scar formation, this suggests that 
cerebellar astrocytes may not form a glial scar because they do not respond to the 
injury-induced EFs within the cerebellum. In contrast, cerebellar astrocytes responded 
to EFs associated with regenerating tissues similarly to the response demonstrated by 
cortical astrocytes, demonstrating a rapid increase in cell speed and migrating towards 
the anode; we also found that only EFs associated with regeneration induced 
morphological changes in astrocytes that mirror those that facilitate regeneration in non-
mammalian vertebrates79. The difference between the EF intensities necessary to 
induce responses in cortical and cerebellar astrocytes also illustrates that the cellular 
response to EFs is an active one, whereby the cells are “choosing” to respond in certain 
nuanced ways; if instead cells were being forced to respond to gross electrochemical 
forces, both astrocytic sub-types should have had the same response. Assuming that 
the injury-induced EFs within the cerebellum are similar to those that are present in 
other injured mammalian tissues (and to the EFs within a hippocampal slice culture 
preparation290), this would suggest that physiologic EFs within the injury site do not 
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induce a robust reactive astrocytic response but that therapeutically elevated EFs may 
still induce regenerative behaviors in cerebellar astrocytes. 
This observed difference between the EF-induced response in cortical and 
cerebellar astrocytes is consistent with differences in their response to injury in vivo. 
Specifically, cortical astrocytes rapidly respond to an injury by restoring the BBB, but 
this response evolves into the formation of a glial scar33, 393; cerebellar astrocytes 
hypertrophy following an injury, but do not form a similarly robust glial scar92, 389, 391. 
However, it does not explain why the same injury-induced EF would have different 
effects on these astrocytic behaviors. One possibility is that 40 mV/mm may induce only 
a subset of the behaviors necessary for regeneration in cortical astrocytes, so they form 
a glial scar once they are stimulated to migrate to and proliferate at the lesion site, but 
EF-intensity does not reach the threshold necessary to induce neurogenesis or to 
promote axon sprouting; in contrast, the EF-induced threshold for each of the 
regenerative behaviors in cerebellar astrocytes remains within a close range of each 
other so that these behaviors are induced together in an all-or-none regenerative effort, 
and 40 mV/mm is not sufficiently intense to reach this threshold. Alternatively, it is 
possible that injury-induced EFs within the cerebellum are higher than they are in the 
cortex, so the lack of response among cerebellar astrocytes to 40 mV/mm could reflect 
the fact that these EFs are not within the range necessary to induce injury-associated 
behaviors. In either case, the underlying axiom of these experiments is that injury-
induced EFs determine the regenerative potential of the injured tissue. As the 
regenerative potential in the cerebellum is different from that in the cortex, and the 
astrocytic response to injury largely determines the regenerative potential of the injured 
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CNS, it is reasonable to assume either that the same injury-induced EFs are present in 
the cortex and cerebellum but that they have different effects on the resident astrocytes, 
or that different injury-induced EFs are present in these tissues which explains why the 
resident astrocytes respond differently to injury in each of these tissues. However, there 
is very little information as to the actual EF intensities within the intact and injured 
cerebral cortex, and there is no information about EFs within the cerebellum. Therefore, 
additional research is needed to explore the EFs throughout the mammalian CNS as we 
try to understand how physiologic EFs regulate the regenerative potential in the CNS. 
 153 
 
Figure 3.1: Heterogeneity of cerebellar astrocytes 
(A) Parasagittal section of the rat brain, Nissl stain. Astrocytes used in the 
experiments described in chapter two came from the cortex (black arrows), which is the 
phylogenetically newest region of the mammalian CNS. However, the resolution of CNS 
injury demonstrates regional variability throughout the CNS. The cerebellum (white 
arrowheads) is one of the phylogenetically oldest regions of the mammalian CNS and is 
thought to most closely resemble the CNS of non-mammalian vertebrates. (B) The rat 
cerebellum immunolabeled for GFAP, demonstrating the regional heterogeneity of the 
resident astrocyte populations. Bergmann glia have highly aligned processes spanning 
the molecular layer (white arrowhead) and resemble the radial glia found throughout the 
CNS of adult non-mammalian vertebrates; cerebellar astrocytes in the granular layer 
(white arrow with rounded base) have a stellate morphology more closely resembling 
that of cortical astrocytes in the adult mammalian CNS. (These images come from 
unpublished observations in the Colello lab.) 
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Figure 3.1: Heterogeneity of cerebellar astrocytes 
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Figure 3.2: Characterizing the cerebellar astrocyte population 
Representative confocal images used to characterize the astrocyte population 
based on immunolabeling. (A) GFAP, (B) vimentin, (C) nestin, and (D) an overlay 
shows that the population is morphologically heterogeneous, consisting of both 
lamellipodial and process-bearing cells. These astrocytes consistently expressed high 
levels of GFAP and vimentin; in contrast, most of the cells did not express nestin, 
although certain sub-populations were strongly nestin-positive. Cell morphologies 
seemed to be consistent with the cytoskeletal elements that they expressed: nestin-
negative cells maintained a lamellipodial morphology consistent with cerebellar 
astrocytes, while nestin-positive cells tended to have a more bipolar, process-bearing 
morphology similar to that characteristic of Bergmann glia. This suggests that this 
population contains a mixture of cerebellar astrocytes and Bergmann glia. 
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Figure 3.2: Characterizing the cerebellar astrocyte population 
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Figure 3.3: Cerebellar astrocyte migration paths in an EF 
To qualitatively evaluate the EF-induced effect on migration, the paths of 
migration over the first six hours of EF exposure were plotted for individual astrocytes; 
the starting position was normalized to the origin of the graph (0, 0), and the direction 
was displayed relative to the orientation of the EF with the cathode (+) at the top of the 
graph and the anode (-) at the bottom of the graph. 30 cells from each EF strength were 
randomly selected to be included in this plot (including more than 30 cells makes it 
difficult to discern individual tracks). X- and Y-units for the graph are in micrometers. 
These graphs demonstrate the different effects that each EF strength have on 
directional migration. 
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Figure 3.3: Cerebellar astrocyte migration paths in an EF 
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Figure 3.4: EFs affect cerebellar astrocyte migration speed 
(A) Astrocyte migration speed is plotted every 15 minutes for 12 hours. Within 15 
minutes of EF onset, cells exposed to 400 mV/mm show a rapid increase in mean 
speed, which is sustained throughout the entire 12-hour observation period of the 
experiment. (B) Effects of EF exposure on speed were assessed at each time point and 
3 representative time points are shown corresponding to the start of the experiment (0 
Hours), and 15 minutes and 2 hours after EF onset. Mean speed was compared 
between EF strengths at each time point with a 1-factor ANOVA followed by a Tukey-
HSD post hoc comparison. There was no difference in mean speed between groups at 
the start of the experiment (F3, 360 = 2.13, p = 0.096). There was a significant effect of 
EF exposure at both 15 minutes (F3, 357 = 17.1, p = 2.12 x 10-10) and 2 hours (F3, 363 = 
7.08, p = 2.30 x 10-6). The mean speed of cells exposed to 4 or 40 mV/mm did not 
significantly change over time compared to 0 mV/mm. All data are expressed as mean ± 
SEM. *p < 0.05; **p < 0.01; ***p < 0.001. 
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Figure 3.4: EFs affect cerebellar astrocyte migration speed 
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Figure 3.5: EFs affect cerebellar astrocyte direction of migration 
Astrocytes preferentially migrate towards the anode of an applied electric field of 
400 mV/mm. The direction of migration was measured for each cell every 15 minutes 
over 12 hours relative to the anode (A, indicated in red) and cathode (C, indicated in 
blue) of the applied EF and plotted, with each dot representing the direction of migration 
of a single cell at each time point. The x-axis is double-plotted for each field strength to 
help visualize the directionality. The random direction of cell movement in 0, 4, and 40 
mV/mm is visually displayed by the even distribution of data points along the x-axis. 
Directional migration towards the anode emerges in cells exposed to 400 mV/mm after 
15 minutes. If the polarity of the 400 mV/mm EF is reversed after 6 hours (panel labeled 
400(R) mV/mm, time when current was reversed is indicated with the dashed gold line), 
cells reorient to the new EF vector over the following 0.5 hours. 
  
 162 
 
 
Figure 3.5: EFs affect cerebellar astrocyte direction of migration 
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Figure 3.6: EFs affect orientation of cerebellar astrocyte mitotic axis 
Frequency histograms representing the relative number of nuclei counted at each 
orientation relative to the anode (A) and cathode (C) (histogram bin width of 15°), with a 
density curve super-imposed on each graph. Nuclear alignment is double-plotted along 
the x-axis to aid in observing the alignment of these data. Each EF strength was 
evaluated for alignment with Rayleigh’s test. Only 400 mV/mm induced alignment (n = 
123, R = 0.1712, p = 2.61 x 10-2), with a mean direction µ ± SEM = 98.21 ± 5.97°, κ = 
1.35, and SD = 61.9° (the EF axis runs from 0° to 180°, with 90° being perpendicular to 
the EF vector). There was no significant alignment for cells exposed to 0 mV/mm (n = 
122, R = 0.1408, p = 0.0890), 4 mV/mm (n = 99, R = 0.0727, p = 0.5925), or 40 mV/mm 
(n = 55, R = 0.0533, p = 0.8553). (Note, R is the test statistic for the Rayleigh test.) 
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Figure 3.6: EFs affect orientation of cerebellar astrocyte mitotic axis 
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Figure 3.7: Cytoskeletal elements in cerebellar astrocytes after EF exposure 
Representative confocal images showing cerebellar astrocytes after 12 hours’ 
exposure to 0, 4, 40, or 400 mV/mm. Each EF-exposure is listed on its own row, with 
the EF intensity indicated in the left-most panel. Column (A): DAPI-labeled nuclei, with 
an overlay indicating the orientation of the electric field vector (+) and (-), corresponding 
to the anode and cathode, respectively. Immunolabeling for GFAP (column B), vimentin 
(column C), nestin (column D), and an overlay of all of these elements (column E); the 
same acquisition and display settings were used for each of these images. 400 mV/mm 
produced a dramatic effect on cell morphology and cytoskeletal element expression, 
with all of the astrocytes demonstrating elongated, bipolar morphologies with their 
processes perpendicular to the orientation of the applied EF. Furthermore, the merged 
images indicate that cells exposed to 400 mV/mm had a greater ratio of vimentin to 
GFAP expression relative to those cells exposed to 0, 4, or 40 mV/mm. These images 
also show that there is a heterogeneous population of cerebellar astrocytes upon 
exposure to 0, 4, and 40 mV/mm for 12 hours: the majority of these cells expressed 
GFAP and vimentin; while GFAP was seemingly constant, vimentin appears to vary with 
greater expression in bipolar cells and lower expression in lamellipodial cells. In 
contrast, nestin expression was sporadic. Scale bar: 50 µm. 
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Figure 3.7: Cytoskeletal elements in cerebellar astrocytes after EF exposure 
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Figure 3.8: EFs align cerebellar astrocyte processes 
FFT analysis of normalized pixel intensity from vimentin-labeled images 
(averaged over 4-5 images); relative orientation is plotted in arbitrary units on the y-axis 
for each angle relative to the anode and cathode (in 1° increments; alignment is an axial 
unit, i.e. 0° = 180°, which is represented in the double-plotting of these graphs), and the 
same scale is used for the y-axis in each of the four graphs. These FFTs show that 
astrocytes exposed to 400 mV/mm align their processes perpendicularly to the applied 
EF; astrocytes exposed to 0, 4, and 40 mV/mm also demonstrate some periodicity in 
the alignment of their processes, but this is much smaller in magnitude than the 
alignment induced by 400 mV/mm, it is focused at an arbitrary orientation, it is 
consistent among the 0, 4, and 40 mV/mm groups, and it may represent some sort of 
artifact rather than an actual alignment effect. 
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Figure 3.8: EFs align cerebellar astrocyte processes 
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Chapter 4:  In Vivo Experiments 
Chapter Overview 
In the first chapter, we discussed the physiologic EFs reported in biological 
systems. Intact tissues generally produce dcEFs ≤ 10 mV/mm, injured mammalian 
tissues (i.e. non-regenerating tissues) sustain an 8-15 fold EF increase, and 
regenerating tissues produce a 50-100 fold EF increase. This suggests that the 
magnitude of injury-induced EFs, which varies between regenerating and non-
regenerating tissues, determines the regenerative outcome. In chapters two and three, 
we tested the hypotheses that physiologic EFs contribute to the astrocytic response to 
injury, and that a regenerative phenotype is favored by increasing the EF intensity 
towards levels found in regenerating tissues. The EFs used in these experiments were 
chosen based on previously published studies, but the existing literature also suggests 
the actual range of injury-induced EFs is broad. Moreover, certain types of equipment 
used to measure EFs is inherently biased, and the studies measuring EFs in the 
mammalian CNS are entirely based on ex vivo recordings. In previous chapters, we 
found that EFs induce intensity-dependent behaviors in mammalian astrocytes, and that 
the highest EF strength tested promoting a regenerative response. This suggests that 
physiologic injury-induced EFs may be therapeutically targeted to activate the 
physiologic mechanisms necessary for spontaneous regeneration. However, technical 
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challenges have prevented a thorough exploration of the strength, intensity, and 
duration of ionic currents produced by CNS injury. In this chapter, we discuss these 
limitations and our efforts to address them. 
Introduction 
Physiologic electric fields (EFs) drive the cellular response to injury and 
determine the regenerative potential in many vertebrate tissues. As we described in 
chapter one, EFs above a certain threshold are both necessary and sufficient to 
reactivate developmental physiology and induce complete regeneration of tissues and 
organs following injury or amputation. Injury-induced EFs are lower in tissues that do 
not regenerate, and regeneration can be stimulated by experimentally increasing these 
EFs towards levels found in highly regenerative tissues. Endogenous EFs have also 
been measured ex vivo in the mammalian CNS where they are similar in magnitude to 
the EFs that have been measured in other intact and injured mammalian tissues269. 
Similarly to how injury-induced EFs drive the cellular response to injury in peripheral 
tissues, we found that EFs within the ranges reported in the injured mammalian CNS290 
induce a series of behaviors in cortical and cerebellar rat astrocytes consistent with their 
physiologic response to injury (chapters two and three, respectively). Moreover, we 
found that EFs associated with highly regenerative tissues modify the astrocytic 
response, inducing changes that are associated with a more regenerative phenotype. 
Together, these observations suggest that the therapeutic manipulation of injury-
induced EFs may be sufficient to stimulate regeneration in the mammalian CNS. 
Endogenous EFs are sustained in intact tissues through an ionic current that is 
relatively constant in its magnitude and orientation over time, while injury-induced EFs 
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change in both magnitude and direction throughout the reparative process270. In 
regenerating newts, EFs increase immediately upon injury, and they continue to rise 
until they peak several days after the injury270. Moreover, the orientation of the injury 
current changes throughout limb regeneration in Urodele amphibians and tail 
regeneration in Anuran tadpoles: the initial outward current reverses direction after 
several days, and then gradually decreases in magnitude throughout regeneration, 
returning to its baseline value only once regeneration is complete270, 274, 276. Although 
the differences between the injury-induced EFs produced in regenerating and non-
regenerating tissues are often stated as function of the EF magnitude, this is a 
simplified version of reality. Following amputation, axolotl limbs regenerate while adult 
Xenopus do not, but the initial magnitude of the injury-induced current is very similar: 
10-100 µA/cm2 in salamanders270, 20-40 µA/cm2 in frogs278. Instead, differences in the 
injury-induced currents emerge only after several days when the current reverses 
direction in salamanders but not in frogs270, 274, 278 (Figure 4.1). The importance of the 
injury current’s orientation is further illustrated through studies in which Xenopus limb 
regeneration was induced by an implanted electrode when the applied EF was oriented 
with the cathode at the lesion site, while anodal stimulation caused the amputated limb 
stump to degenerate proximal to the original plane of the injury277, 282. These same 
studies have been replicated in rats283, 284, suggesting that these EF-induced effects on 
regeneration are externally generalizable, and that they reflect neither an artifact nor a 
feature unique among amphibians. Together, these observations clearly demonstrate 
that the magnitude and orientation of the EFs within the injury site together play a 
nuanced and highly choreographed role in regulating tissue regeneration in vertebrates. 
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Recordings of EFs that have been made in the mammalian CNS rely on an ex 
vivo model, which is prone to two obvious sources of bias. Endogenous EFs are a 
physiologic product of active ion transporters, which are highly metabolically 
demanding; removing the tissue from the body for an ex vivo preparation deprives it of 
vascular perfusion through which it receives the oxygen and glucose necessary to 
produce the ATP that drives the active transporters. While these nutrients are provided 
in artificial cerebrospinal fluid (aCSF) bathing the tissue, they rely on simple diffusion to 
permeate the tissue and the rate of diffusion is too low to satisfy the metabolic demands 
of cells. Thus, without vascular perfusion, the explanted tissue becomes ischemic, so 
the measured EFs may be less than their true value in vivo. Additionally, the ex vivo 
preparation involves dissecting the CNS out of the skull, a process that causes obvious 
trauma to the surrounding tissue and, if not performed correctly, to the CNS 
parenchyma itself. Moreover, the process of recording EFs within the CNS parenchyma 
using implanted electrodes causes damage to the tissue, which may further bias these 
recordings. As the preparation itself represents a considerable injury, any recording of 
current density or EF magnitude made from an ex vivo sample may actually reflect the 
bioelectric phenomena within the injured CNS or an artifact of the preparation and not a 
baseline recording from intact tissue. Interestingly, a previous study from the Borgens 
lab, which published recordings of injury-induced currents over the first hour after SCI 
ex vivo, demonstrated that the spinal cord is electrophysiologically “unstable” for the first 
hour after the ex vivo preparation, thus emphasizing the potential artifact in these ex 
vivo current density recordings394. This is most clearly illustrated in an experiment done 
by Cao and colleagues (2015), where they created a hippocampal slice culture 
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preparation that was 300-500 µm thick, measured an EF within the hippocampus of 
31.8 ± 4.5 mV/mm, and declared this to be the EF within the “intact” parenchyma290. 
However, current density measurements from in vivo cornea265, 268, 326 and skin256, 257, 
265, 279, 357, 362, 365, and from ex vivo spinal cord291, suggest that there are injury-induced 
changes in bioelectric phenomena that extend at least up to 1 mm from the lesion site, 
so the entire thickness of this slice culture preparation more likely reflects an injured 
rather than an intact environment. 
We found that 40 mV/mm EFs, which are comparable to the EF intensity 
measured in an “injured” hippocampal slice culture290, induce behaviors in mammalian 
astrocytes in vitro that are characteristic of their injury response in vivo. However, our 
studies, and those from other labs, explore EF effects in vitro by applying a constant EF 
throughout the duration of the experiment. Instead, in vivo evidence from non-
mammalian vertebrates suggests that injury-induced EFs that drive regeneration have a 
precise magnitude and direction, both of which change along a distinct temporal 
profile274. Moreover, while EFs can stimulate robust regeneration in frogs and rats, 
applying them with incorrect polarity can actually exacerbate the wound277, 282, 283. In the 
mammalian CNS, the only current observations measure injury-induced EFs over the 
first hour after an injury291. This is far shorter than the multiple days after the initial injury 
over which EFs reach their apex and then reverse during axolotl limb regeneration. 
While the injured mammalian CNS may indeed produce EFs that change upon injury, 
the temporal profile of the magnitude and orientation of endogenous EFs has yet to be 
characterized. Thus, while existing experimental data suggest that the injury-induced 
EFs drive the cellular response to injury and that therapeutic EFs might be able to 
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enhance regeneration, any such therapy aimed at enhancing regeneration through 
stimulating physiologic mechanisms of development would be purely speculative 
because the temporal and spatial dynamics of injury-induced EFs in the mammalian 
CNS are unknown. These parameters must be better understood before an EF-based 
therapy to promote regeneration can be developed, as certain elements of these 
bioelectric signals are fundamental to the success of any such approach. 
Considerations when measuring bioelectricity 
Electric fields strengths can be calculated either from the ratio of an electrostatic 
force to a known point charge (𝐸 = 𝐹 𝑞 where E is the electric field, F is the force 
experienced by a charged particle in the presence of the electric field, and q is the 
charge of the second point charge), or from the difference in electrical potentials (V) 
measured at two electrodes that are a known distance apart (𝐸 = 𝑑𝑉 𝑑𝑥 where E is the 
electric field, dV is the difference in voltage (i.e. dV = Vsource – Vreference), and dx is the 
distance between the electrodes). (These equations are algebraically equivalent. 
Coulomb’s Law defines electrostatic force as 𝐹 = 𝑘𝑞!𝑞! 𝑟! where r represents the 
distance between the two charges, q1 and q2, and 𝐸 = 𝑘𝑞! 𝑟!; electrical potential is 
calculated as 𝑉 = 𝑘𝑞! 𝑟 so 
𝐸 = 𝑘𝑞! 𝑟𝑟 = ∆𝑉𝑟 = 𝑑𝑉𝑑𝑥   
as r = dx). Since it is impractical to measure an electrostatic force on a point charge in a 
biological system, EF strengths are instead calculated using electrodes to measure the 
electrical potential V at different points separated by a known distance. Although this 
system is more practical to calculate EF strengths in biological systems because the 
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distance between the two electrodes can be measured with great precision, it is still 
prone to inaccuracy. The electrodes detect the voltage in the sample through an 
electrochemical redox reaction at the interface between electrons in the metal electrode 
and ions in the surrounding solution, but this reaction, which causes ions to aggregate 
around the electrode, creates a hydration shell around the electrode that physically and 
chemically impedes the very reaction that the electrode is designed to measure395. This 
hydration shell, known as an “electric double layer,” insulates the recording electrode 
because the EF induces the water molecules to become aligned such that their 
molecular dipoles oppose the EF, causing the effective EF within the hydration shell – at 
the surface of the electrode – to be less than the actual EF within the tissue. This 
voltage artifact at the boundary between the electrode and the solution, which is termed 
the half-cell potential, can range from 1 mV to well over 200 mV395. The half-cell 
potential is dependent both upon the type of metal in the electrode and upon the ionic 
composition of the aqueous environment. As the electrolyte composition of the aqueous 
environment within each tissue is usually not well defined, the half-cell potential 
represents a significant source of measurement error that is very difficult to predict. 
Technical challenges can prevent the accurate measurement of EFs by using 
electrodes. However, EFs can be calculated indirectly through measuring the ionic 
currents that they induce within the solution as a result of electrostatic force created 
between ions and the external EF. Jaffe and Nuccitelli first developed an ultra-sensitive 
probe that can accurately measure these ionic currents and endogenous electric 
potentials around biological specimens265, 396-398. Briefly, a highly-conductive platinum-
plated metal electrode is vibrated over a known amplitude (typically 20-30 µm). The 
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electrode acts as a capacitor, so an external EF induces a voltage in the electrode as a 
function of the electrode’s capacitance and the EF intensity; this voltage is continuously 
measured as the probe vibrates, and the EF is calculated from the difference between 
the measured voltages and the distance that the probe travels as it oscillates 
(depending on the set-up of the system and the specific way in which the probe is 
calibrated, some vibrating probe set-ups measure the ionic current density instead of 
the EF) 397. A half-cell potential cannot occur because the oscillating probe prevents a 
hydration shell from forming around the electrode, so EFs can be measured directly with 
minimal interference. 
The vibrating probe method cannot be used to make recordings within a tissue 
because this technique requires the probe to move continuously. Instead, the vibrating 
probe technique is used to measure the ionic current density outside of the tissue. 
Although the extraparenchymal EF induced by the ionic current can be calculated 
(𝐸 = 𝜌𝐼 𝐴 where ρ is the resistivity of the conducting media, and I/A is the ionic current 
density), the EF within the tissue cannot be calculated from this measurement because 
the tissue resistivity is often unknown and the current density within the tissue is not 
uniformly distributed. Nonetheless, the total ionic current within the tissue is the same 
as the amount of current outside of the tissue (Kirchoff’s Current Law states that the net 
current in the circuit is 0, see Chapter 1: Physics of electric fields, page 31), so the EF 
within the parenchyma is fundamentally proportional to the current density measured by 
the vibrating probe outside of the tissue and can thus be used as a measure of 
physiologic activity within the tissue362. 
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Experimental goals 
Although the vibrating probe can only measure current density outside of a 
tissue, these measurements are often used to make inferences about the physiologic 
activity and structural integrity within the tissue362. Using an ion-sensitive vibrating 
probe, it was found that the physiologic ionic currents an the cornea and the limb are 
principally composed of Na+ ions; and experiments with different ion-channel and 
transporter blockers demonstrated that this current is sustained by constitutive activity 
of the Na+/K+-ATPase147, 268, 280. Moreover, longitudinal current density measurements 
have also demonstrated that the current density is correlated to wound healing215, 274, 
329. Nonetheless, while measurements of external bioelectric phenomena provide insight 
into tissue physiology, they still cannot be used to calculate intraparenchymal EFs. One 
method to measure these intraparenchymal EFs is described by Cao and colleagues 
(2013): they implanted 4 electrodes into the brain, with the electrodes arranged in series 
throughout the fiber tract; they injected a known current through the outer two 
electrodes and measured the voltage drop between the inner two electrodes as a 
calibration, and then turned off their current source so that they could measure the 
endogenous EF269. However, even if this method adequately controls for the half-cell 
reaction at the electrodes, it still does not account for the potential artifact caused by the 
fact that the electrodes themselves damage the parenchyma as evidenced by studies 
demonstrating glial scar formation around implanted electrodes in vivo. 
In order to develop a therapeutic strategy to promote regeneration in the 
mammalian CNS by manipulating EFs, we first need to establish how these 
endogenous bioelectric phenomena change in magnitude and orientation throughout 
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the duration of wound healing. This exploration requires that a method be developed to 
measure ionic currents and EFs in the CNS in vivo for two reasons: first, wound repair is 
a prolonged process and longitudinal observations will be necessary to monitor how 
physiologic EFs change over time; second, in vivo recordings will obviate measurement 
artifacts resulting either from ischemia or from injury occurring during the ex vivo 
preparation. In this chapter, we describe our initial efforts to develop a method to record 
current density in an in vivo model of CNS injury. 
Methods 
Animals and surgical protocol 
Adult female Long-Evans rats (at least 6 months of age; n = 5) were used in 
these experiments (Harlan Laboratories). All animal protocols used in these studies 
were preapproved by the Virginia Commonwealth University IACUC. Rats were 
anesthetized with isoflurane and placed in a stereotaxic apparatus (see illustration, 
Figure 4.2); depth of anesthesia was monitored by respiratory rate and depth, and by 
regular assessment of reflexes. A 10 mm diameter area of skull was exposed with a 
midline scalp incision and the periosteum was removed. A plastic funnel (fabricated 
from the conical base of a 50 mL conical tube, Genesee Scientific #21-106; dimensions: 
approximately 15 mm tall, bottom diameter of 8-10 mm where the funnel was attached 
to the skull, upper diameter of 28 mm) was affixed to the skull with superglue to 
maintain a bathing solution of artificial cerebral spinal fluid (aCSF; 126.0 mM NaCl, 3.0 
mM KCl, 1.25 mM NaH2PO4, 2.0 mM MgCl2, 2.0 mM CaCl2, 10.0 mM glucose, and 26.0 
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mM NaHCO3) at least 7 mm deep over the recording area. The cortex was exposed by 
using a Dremmel tool to remove a portion of the parietal plate approximately 2 mm wide 
(ML) x 4 mm long (AP) in size; aCSF was frequently washed over the skull to prevent 
overheating of the bone and thermal injury to the underlying brain. The meninges were 
carefully removed to expose the intact cortex and surface vasculature was used to 
identify a landmark for the scan area and target for the injury. 
Measuring current with the Scanning Vibrating Electrode Technique 
Measurements of current density were obtained using the Scanning Vibrating 
Electrode Technique (SVET) apparatus (Applicable Electronics, New Haven, CT), 
based on the technique originally described by Jaffe396, 397. Briefly, Parylene-C insulated 
Platinum/Iridium electrodes attached to a gold connector and electrically arced to 
expose several micrometers of bare metal at the tip are used for these recordings 
(MicroProbes PI(2.5cm)0036.0A10). The electrode tips are platinum-coated by 
electroplating them in a solution of 1% Platinum Chloride, H2PtCl6) and 0.01% Lead II 
Acetate until they have at least a capacitance of 2.0 nanofarads (nF). The Electrode is 
inserted into a gold connector pin attached to the vibrator assembly, which is connected 
to a piezoelectric drive that vibrates in the X and Z planes. The probe vibration 
frequency is set at around 110 hertz (Hz) in the X plane and 70 Hz in the Z plane 
(optimal frequencies are at least ±10 Hz from 60 Hz to minimize electrical noise, and ±5 
Hz from the resonance frequency of the probe), with an amplitude in each plane that is 
approximately twice the diameter of the electrode tip. The electrode position is 
controlled with a motorized 3-dimensional micromanipulator. An Optem Zoom 70 micro-
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inspection videoscope lens system equipped with a 0.75x lens, a modular 1:7x zoom 
lens, and a 2x auxiliary lens system (total magnification range of 1.5 – 10.5x; Qioptiq), 
as well as a color uEyeLE camera (model UI-164xLE, CMOS sensor, 1280x1024 
resolution, manufacturer: IDS) is used to visualize the probe and scan area. A computer 
running the ASET-LV4 software package (version 3.1.0.0; Science Wares, INC, 
Falmouth, MA) is connected to the SVET apparatus and is used to drive the 
micromanipulator and collect the data. The probe is calibrated per the protocol from the 
manufacturer, under 10.5x magnification using a 60 nanoampere (nA) current source 
delivered through a glass micropipette. Calibration is performed prior to the start of each 
experiment and every time a new probe is used. A region of interest is specified under 
4x magnification, and the probe scans the current density approximately 50 µm above 
the surface of this region by moving in a grid-pattern to scan points every 40 µm in the 
x- and y-axes; a reference reading 5 mm above the brain surface is taken at the start 
and end of each scan to calibrate the measurements. An insect pin (approximately 150 
µm diameter) attached to a 3D-micromanipulator is used to make a 2 mm deep stab 
wound in the center of the scan area. Current densities are measured immediately 
before and after the stab wound. At the end of the experiment, animals were euthanized 
with a single intraperitoneal injection of euthasol (350 mg/kg sodium pentobarbital, 45 
mg/kg phenytoin sodium). 
Analysis 
Current density measurements and corresponding images were obtained for the 
z-axis (perpendicular to the surface of the tissue) over the surface of the cortex, both 
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before and after the injury. Data were analyzed and surface plots were generated using 
the JMP v. 11.2.1 statistical software package; bar-plots were generated using the 
statistical software R341. The dataset for each scan was reviewed for artifact from the 
vibrating probe contacting the surface of the brain by comparing readings from the 
Quadrature and In-phase channels of the recording (for a thorough discussion of how 
measurements are taken by the SVET apparatus, see Scheffey, 1986399). Per the 
recommendation from the company from which the SVET apparatus was purchased, 
data points where the signal in the quadrature channel was >10% of the signal in the In-
Phase channel were deemed suspect and excluded from analysis. Images of the scan 
area are automatically recorded before and after each scan, and the coordinates of 
each scan location are superimposed onto these images. Using these images, we 
labeled each scan location as being over intact cortex, surface vasculature (we were 
unable to differentiate between arterial and venous circulation), or the lesion site; we 
excluded scan locations for each animal that were on the border between two such 
classifications, defined as approximately 75-100 µm from the edge of a vessel or an 
injury site. We estimated the mean current density over the intact cortex and surface 
vasculatures separately, using a mixed-effects linear regression model 𝑌!" = 𝛽! +𝒩 0,𝜎!! + 𝜖!"   
where Yij is the estimated mean current density at each scan location, βj is the mean 
current density for each factor level (i.e. intact or injured cortex, or surface vasculature), 
and σb2 is the variance of the mean current density between animals. As our sample 
size for these pilot studies was relatively small and the only difference in mean current 
density with which we were interested was between the intact and injured cortex, we ran 
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separate models for the measurements over intact cortex and surface vasculature taken 
before the injury; we evaluated the hypothesis that there intact cortex and surface 
vasculature each sustain a current density across themselves against the null 
hypothesis that there was no such current density sustained by these tissues. We then 
ran a model with measurements over intact and injured cortex after the lesion 
(measurements over vasculature were excluded), and evaluated the estimated mean for 
each factor level as well as the difference between these groups. We used α = 0.05 as 
an overall threshold for significance, and also for each of the post-hoc comparisons. We 
report the mean ± SEM for each of our parameter estimates, and we report the test-
statistics with the degrees of freedom adjusted for the partial dependency of the 
observations made from each animal. 
Results 
Current density measurements 
The goal of this pilot study is to develop a protocol by which we can make 
recordings of current density over a lesion site in the injured brain over time, with 
multiple measurements taken from the same animal at regular intervals (e.g. daily) 
throughout the recovery of the animal. To accurately identify the same scan area 
between measurements, especially at later time-points as the injury location becomes 
less visually distinct, we needed to identify a landmark that would be constant over time. 
Because the rodent brain is lissencephalic, we decided to use the surface vasculature, 
which forms distinct patterns that were visible at both low and high magnification (Figure 
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4.2). From pilot studies, we settled on a scan resolution (distance between adjacent 
scan positions) of 40-50 µm because we found that this allowed us to detect subtle 
variations in cortical current density and to distinguish between the current density 
measurements over the cortex and surface vasculature. We made grid-scans over 
regions of interest over the intact brain, estimating the scan to be approximately 50-75 
µm above the cortical surface; however, the brain surface is not perfectly smooth so the 
exact distance from the cortical surface likely varies among the scan locations. 
Consistent with previously-reported results269, we found that the intact rat cortex 
sustains an outward current, while the large blood vessels have an inward current over 
them. This pattern of current density over scan areas of both intact cortex and 
vasculature clearly reveals this pattern (Figure 4.3). We used images of the scan area 
to visually categorize each scan position as either surface vasculature or intact cortex; 
locations that appeared to be at the border between these two features were excluded 
from the analysis. We estimated the mean current density and standard error of the 
mean (SEM) over both the cortical surface and the vasculature using a mixed-effects 
linear regression model, with the location (i.e. cortex or vasculature) treated as a fixed 
effect and the animal treated as a random effect; we ran separate models for each 
location because we were not interested in estimating the difference between them (this 
is equivalent to running a 1-sample t-Test, controlling for the nested dataset). We found 
that the current density over the intact cortex was 33.04 ± 10.86 µA/cm2 (mean ± SEM), 
which was statistically different from 0 µA/cm2 (t4.005 = 3.04, p = 0.0383; N = 5 animals, n 
= 591). We also found that there was an inward current over surface vasculature, which 
we estimated at 29.21 ± 20.24 µA/cm2; however, the model did not find that this was 
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significantly different from 0 µA/cm2 (t1.989 = 1.44, p = 0.2865, N = 3 animals, n = 100 
observations total), likely because there were far fewer points in the sample because 
the vasculature covers a small proportion of the scan area and we could not always find 
large enough vessels over which we could make distinct recordings. 
We next set out to determine the how current density changes upon injury to the 
cortex. We used images of the scan area to categorize scan locations as either over 
intact or injured cortex, excluding locations on the border between the lesion and the 
surrounding intact tissue. We evaluated how the current density at the injury site 
changes compared to the surrounding healthy tissue using a mixed-effects linear 
regression model. Specifically, we estimated the fixed effect of the injury while 
controlling for the variability in average current density among the animals by treating 
the animal as a random effect. We found that there was an overall effect of injury on the 
current density (F1, 667.8 = 479.22, p < 0.0001). We found that the mean current density 
over the intact cortex was estimated at 13.35 ± 4.394 µA/cm2, which was significantly 
different from 0 (t4.414 = 3.04, p = 0.0339); the mean current density over the injured 
cortex was estimated at -34.85 ± 4.500 µA/cm2 (the negative indicates that the current 
had the opposite direction as that over the intact cortex), and there was a statistically 
significant difference in current between the intact and injured cortex, which was 
estimated at 48.20 ± 2.162 µA/cm2 (t667.8 = 22.30, p < 0.0001). (Note, JMP v. 11.2.1 was 
used for these analyses, and JMP does not provide specific p-values if they are smaller 
than 0.0001.) These results demonstrate that the rodent cortex sustains a physiologic 
ionic current across itself, and that the current density changes direction over sites of 
injury. Together, these observations are consistent with the hypothesis that the injured 
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mammalian brain produces physiologic EFs, and that these EFs change immediately 
upon injury. Moreover, our methodology suggests that the surface vasculature can 
provide an easily-identifiable landmark to make recordings from the same location at 
regular intervals over time. 
Limitations of current density measurements: artifacts 
While measuring the current density over both the intact and injured cortex, we 
noticed considerable variability in the current density estimates among different animals 
(i.e. the estimated current density over the intact cortex for each of the five animals from 
which we obtained good measurements were: 6.30 ± 1.655 µA/cm2; 39.44 ± 1.952 
µA/cm2; 9.82 ± 0.560 µA/cm2; 47.66 ± 1.073 µA/cm2; and 61.97 ± 1.091 µA/cm2). While 
the pattern of current densities that we measured was consistent among each animal 
we used (e.g. outward current over intact cortex, inward current over intact vasculature 
and injured cortex), we were concerned about this variability. Specifically, as current 
density decays logarithmically as a function of the distance from the source, this 
variability could reflect differences in the distance between the probe and the brain 
surface due to topographical variations across the brain surface, small errors in 
estimating the height above the cortical surface, or the pulsatile nature of the brain due 
to the heart rate of the animal; however, it could just as easily reflect a methodological 
error. Moreover, the mean current densities that we estimated were over 10-fold greater 
than those over the intact cortex that have been previously published269, although they 
are within the range of current density measured upon limb amputation in both 
salamanders270, 274 and frogs278. To try and determine whether artifact may have 
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affected the validity of our measurements, we set out to confirm that the SVET 
apparatus was measuring current density accurately by rigorously testing its calibration 
settings. 
The protocol to calibrate the SVET apparatus specifies that the probe should be 
calibrated in the x- and z-axes separately. Specifically, the point-source of current for 
the calibration is defined as location (0, 0, 0) (x, y, z) in a 3-dimensional coordinate 
system; the probe is brought to (-150, 0, 0) to calibrate the x-axis, and to (0, 0, 150) to 
calibrate the z-axis (units are in µm). At each of these locations, the probe records a 
reference reading while vibrating to establish the background noise, and then it records 
while the point source passes a 60 nanoampere (nA) current. In physiologic saline, the 
real current density 150 µm from a 60 nA point current source is 21.2 µA/cm2 (per the 
protocol provided by Applicable Electronics, which is the company that manufactured 
the SVET apparatus). This measurement is compared to the recordings made by the 
probe, and is used to calibrate the phase-offset and the resistivity of the media. We 
assessed the accuracy of the probe calibration by making line scans around the point 
current source while it was passing 60 nA. We assessed the x-axis using a line-scan 
from (-100, 100, 0) to (-100, -100, 0) (i.e. a straight line traveling only through the y-
axis), and we assessed the accuracy of the z-axis by recording a line-scan from (0, 100, 
100) to (0, -100, 100); we chose to have our line scan pass through the y-axis because 
the probe only vibrates in the x- and z- axes and thus cannot record current in the y-
axis, so these line scans isolated the current recorded in the x- and z- axis channels, 
respectively. We also ran a line-scan through the y-axis to confirm that the SVET does 
not have cross-talk between detectors that would cause artifact. When we ran a line-
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scan from (-100, 100, 0) to (100, 100, 0), we found that the SVET recorded a change in 
current in the z-axis channel. We were unable to determine whether this signal is a real 
measurement due to aberrant vibration in the y-axis, or if it represents an artifact due to 
cross-talk between the channels. Thus, the specific current density values that we 
estimated over the intact and injured cortex may be suspect and additional experiments 
are required to identify the source of the artifact in the SVET and to confirm the values 
of current density that we measured. 
Considerations for improving experimental design 
We assume that these potential artifacts can be addressed given sufficient 
resources and further discussion with the company producing the system, so it is worth 
discussing how this methodology might be optimized for these in vivo recordings. There 
are two principal considerations for further improving this approach. First, the current 
density produced over the cortex decreases as a function of the square of the distance 
from the surface; it is difficult to measure the exact distance of the probe above the 
surface, and the brain is highly contoured so this distance varies over space. Second, 
the grid scans we used in these studies take over 12 minutes to complete, which limits 
the temporal resolution over any individual point; these grid scans are very helpful in 
identifying changes in current density between areas of vasculature and cortex, and 
they help to identify the borders between intact and injured tissues. However, once 
these regions are identified, the 12 minute scan over the entire area does not afford 
sufficient temporal resolution to make consecutive current measurements after the 
injury to assess how these currents change over time immediately after the lesion. 
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Instead of one large grid scan at a single plane in the z-axis, we propose either smaller 
individual grid scans (e.g. 3x3 x, y) over regions of intact and injured cortex, or a single 
line scan covering the distance between the intact and injured tissue which can reveal 
how the current density changes over distance from the lesion margin. We also propose 
that future experiments employ scans with a step-back protocol whereby the same (x, y) 
scan pattern is repeated in multiple (at least 3) steps in the z-axis; this will allow the fall-
off of the current density to be measured, which can be used to better determine 
distance between the measurement and the surface of the brain. (An additional 
technical note is that the surface vasculature is elevated above the level of the cortex; in 
several of our experiments, the vibrating probe hit a blood vessel during a scan, causing 
the vessel to rupture and making it impossible to take subsequent measurements from 
that scan area. By specifying smaller scans instead of relying on one large scan area, it 
would be much easier to avoid this type of hemorrhage.) 
Discussion  
These studies demonstrate that it is practical to take in vivo measurements of 
ionic current density with an SVET apparatus over the surface of the mammalian cortex, 
obviating concerns about bias in these measurements due to damage sustained during 
tissue dissection for ex vivo preparations or due to ischemia resulting from the fact that 
the ex vivo preparation does not have a functional vascular supply. We found that the 
intact rat cortex sustains a steady outward current while the surface vasculature 
sustains an inward current, which suggests that there may be a net ionic transport 
between the two tissues; we also found that the current over the cortex rapidly reverses 
direction upon injury. Importantly, we found that the current density over a cortical injury 
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reverses direction more rapidly than we were able to measure (less than 2-3 minutes), 
which is consistent with measurements from other studies showing that injury-induced 
changes in bioelectricity are immediate; as current density outside the tissue is 
fundamentally related to electric fields within the tissue, these results strongly support 
the notion that the mammalian cortex creates injury-induced electric fields within the 
lesion site and surrounding parenchyma. These results are consistent with the outwards 
orientation of current density that has been previously reported over mouse olfactory 
bulb269, and with the rapid change in direction upon injury matches the rate of change 
reported over the spinal cord, skin, and cornea265, 268, 291. 
It is worth noting that the outward current density over the intact cortex that has 
been measured both by us and by other groups has an orientation that is opposite that 
reported in many other tissues (for a further discussion, see chapter 1, page 48). In the 
intact skin and cornea, which have been much more thoroughly studied than the CNS, 
there is a steady inward current that is sustained by an asymmetric distribution of 
Na+/K+-ATPases in the basolateral membrane of the epithelial cells lining the tissues147, 
268, 270, 280, 281, 326. In contrast, Cao and colleagues found that the astrocyte end feet in 
the glia limitans  lining the cortical surface expressed Na+/K+-ATPase within the apical 
portion of their membranes; moreover, they measured an inward ionic current over the 
wall of the lateral ventricle, and they found that ependymal cells lining the lateral 
ventricles express Na+/K+-ATPases within their basolateral membranes269. While this 
suggests that the discrepancies in the direction of ionic current between the intact 
mammalian cortex and other tissues may be a function of the localization of these ionic 
transporters, it does not address the reason for which these differences may arise. 
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Borgens and Shi found that the axolotl embryo produces ionic currents at least as early 
as embryonic stage 16, and they measured an inward ionic current across the entire 
ectodermal surface215, 249. The ectoderm is still a laminar structure at this stage and the 
neural groove has not yet invaginated to form the neural tube, so the current across the 
neural groove has the same orientation as that over the rest of the ectoderm. The 
neural tube develops into the ventricular system and central canal of the spinal cord, 
and the lateral ectoderm develops into the skin and cornea. Thus, these two structures 
are topologically equivalent and ontogenetically derived from the same from the same 
structure, so it makes sense that the distribution of ion transporters and the orientation 
of the ionic current would be conserved across the skin and cornea, and the ependymal 
cells lining the ventricular system. As the neural tube starts out only several cells thick, 
the inward current over its apical face would be matched by an outward current across 
its basolateral face; as the outer cortical surface develops from the basolateral face of 
the presumptive neural tube, it is reasonable to assume that the current density across 
it would have an opposite polarity. 
The consistencies in our measurements in the context of previous literature, and 
the consistent variations we found in current density between the intact cortex and 
surface vasculature, strongly support the notion that our measurements reflect the 
physiologic activity of the tissue. However, the magnitude of the current densities that 
we measured over the intact cortex were approximately 10-fold greater than those 
previously reported269; this could reflect the fact that our observations were made in 
vivo, and the continued vascular perfusion allowed the brain to maintain a greater 
metabolic rate and, consequently, more activity in the ion transporters that drive the 
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ionic current. Alternatively, these differences could be methodological and reflect 
differences in the distance between the probe measurement position and the cortical 
surface. However, these measurements could also reflect an artifact due to a hitherto 
undetermined flaw in the setup of our SVET apparatus. Thus, while we are confident 
that the polarity of the current we measured reflects the true current density polarity, we 
are concerned about the potential contribution of artifact to our measurements and are 
therefore not confident about the accuracy of the magnitude of these measurements. 
Nonetheless, our results demonstrate that in vivo recordings of ionic current density are 
practical, and that this approach can be used to make repeated measurements from the 
same animal throughout the recovery period. 
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Figure 4.1: Injury currents in regenerating and non-regenerating vertebrates 
A graph illustrating the evolution of the injury current at the site of an amputated 
limb in frogs and salamanders; these are summary data based on several studies. The 
initial injury currents measured within the tissues are very similar initially, but they begin 
to diverge after 2-3 days and remain different throughout the duration of regeneration. 
(This image was modified from The Body Electric144 and is reprinted here under the “fair 
use” limitation in title 107 of the U.S. copyright law.) 
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Figure 4.1: Injury currents in regenerating and non-
regenerating vertebrates 
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Figure 4.2: Scanning vibrating electrode technique 
(A-D) Procedure for calibrating the vibrating probe, showing (A) the probe off, (B) 
the probe vibrating only in the x-axis, (C) the probe vibrating only in the z-axis, and (D) 
the probe vibrating in both the x- and z- axes. (Note, the probe cannot vibrate in the y-
axis.) (E) Illustration showing where the skull was drilled, relative to bregma and 
lambda, to access the cortex for SVET recordings; a piece of bone approximately 3 mm 
wide and 5 mm long was removed. (F) Illustration showing the in vivo recording 
configuration (courtesy of Christina Delli Santi). (G) A low-magnification view of the 
exposed cortex, demonstrating the vascular landmarks that we used; the inset (H) 
demonstrates the size of the scan area relative to what we expose. 
  
 195 
 
 Figure 4.2: Scanning vibrating electrode technique 
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Figure 4.3: In vivo current density measurements 
(A) An image showing the scan area prior to the injury, which was chosen 
because of the distinct landmarks made by the surface vasculature (indicated by the 
arrow and double-ended arrow), with the double-image of the vibrating probe visible 
(notched red arrowhead). (B) The same region, immediately after a 150 µm diameter 
insect pin was used to make a stab wound (arrowhead). Surface-plots of the intact (C) 
and injured (D) cortex, showing projections of the z-axis current density (µA/cm2) for 
each scan position in the x- and y-axes; the grid on each surface plot indicates 0 
µA/cm2 z-axis current, positive values correspond to outward current, and negative 
values correspond to inward current. Arrows in these surface plots correspond to the 
same areas indicated in the images of the scan area in (A, B). (Note, the surface plot in 
(C) was from a 5x5 (x, y) grid scan, while the plot in (D) was from a 20x20 (x, y) grid 
scan.) (E) graphical depiction of the mean current density over the intact (13.35 ± 4.394 
µA/cm2) and injured (-34.85 ± 4.50 µA/cm2) cortex; the random-effects model that we 
used for this analysis demonstrated that these two measurements were significantly 
different (p < 0.0001). 
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Figure 4.3: In vivo current density measurements 
 198 
 
Chapter 5:  Discussion 
The research project described herein was undertaken to test the hypothesis that 
endogenous electric fields regulate the injury response in the mammalian CNS in an 
intensity-dependent manner. Specifically, we hypothesized that physiologic injury-
induced EF intensities stimulate the characteristic cellular response to injury, while EF 
intensities associated with regenerating tissues modify this response towards one 
associated with regeneration. We were particularly interested in the effect of EFs on 
astrocytes because differences in particular injury-induced astrocytic behaviors have 
been attributed to the highly-regenerative response in non-mammalian vertebrates and 
the failure of regeneration in mammals. Through the experiments described in chapters 
two and three, we found evidence that EFs associated with injured mammalian tissues 
(including in the mammalian CNS) induce behaviors in cortical astrocytes associated 
with their response to injury (directional migration and increased proliferation), while no 
such responses were found in cerebellar astrocytes; these differences are consistent 
with the heterogeneous astrocytic response in vivo, where migration and proliferation of 
cortical astrocytes are associated with glial scar formation, whereas cerebellar 
astrocytes hypertrophy but do not form a demarcated glial scar. Most excitingly, EFs 
associated with regenerating tissues modified the response in cortical astrocytes and 
induced a robust response in cerebellar astrocytes, and the particular behaviors 
induced were consistent with a regenerative astrocytic phenotype. Our results indicate 
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that physiologic EFs regulate wound repair in the mammalian CNS, and that these EFs 
may be a viable therapeutic target to promote regeneration after injury. Thus, the role of 
EFs in peripheral tissues is likely conserved in the CNS, suggesting that bioelectric 
fields may represent a single unifying force that regulates tissue morphogenesis during 
embryogenesis and epimorphic regeneration within all vertebrate tissues. 
Electric field: a unifying stimulus of embryogenesis and regeneration 
The results described throughout this dissertation fit into a broader argument that 
physiologic EFs regulate morphogenesis in embryonic and injured tissues. Evidence 
that EFs function as morphogens during embryogenesis and regeneration is obvious: 
EFs are necessary for both embryogenesis250, 261 and regeneration275, 280, and they are 
sufficient for regeneration277, 284 (similarly thorough evidence that they are sufficient for 
embryogenesis is currently being explored400, 401). Moreover, EFs induce the same 
behavioral effects on diverse cell types in vitro as are necessary for both 
embryogenesis and regeneration in vivo. However, the notion that EFs have such a 
widely important role as the master regulator of both embryogenesis and regeneration 
in vertebrates – and, more broadly, all metazoans – is a hypothesis of causality and, 
while numerous experiments that we have described herein support this hypothesis, it is 
necessary to formally address this hypothesis. 
Sir Austin Bradford Hill enumerated nine criteria to establish a causal relationship 
in a publication in 1965402, and these criteria have become the benchmark against 
which causality has been evaluated in medicine, epidemiology, and basic science 
research over the subsequent 50 years. His nine criteria are listed below, along with a 
description and interpretation of each criterion that we have paraphrased from this work: 
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1. Strength: the putative causal variable must have a robust effect. 
2. Consistency: the association is replicated in studies in different settings 
using different methods. 
3. Specificity: a single putative cause produces a specific effect; as Hill 
describes, this is the weakest of the criteria and is not necessary to 
establish causality (he cites as an example that the diseases attributed to 
cigarette smoking do not meet this criterion). 
4. Temporality: the causal stimulus must necessarily always precede the 
observed effect; this is the only essential criterion. 
5. “Biological gradient” (i.e. dose-dependency): greater exposure to the 
putative causal agent should cause a greater effect. 
6. Plausibility: the association should biologically plausible, although – as Hill 
points out – what is biological plausible depends on current scientific 
knowledge, which can change over time. 
7. Coherence: the association should not conflict with the current scientific 
knowledge and theory, although occasional paradigm shifts serve as 
notable exceptions to this rule. 
8. Experiment: altering the causal conditions can alter the effect. 
9. Analogy: the proposed causal relationship is similar to other previously-
established causal relationships, and alternative explanations have been 
considered and, if possible, ruled out. 
Importantly, establishing causality is independent of establishing an underlying 
mechanism. Moreover, Hill states that there are no formal tests of significance that can 
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be used to quantitatively evaluate these criteria. Inferential statistical tests are 
quantitative tools that help the researcher evaluate a hypothesis objectively and answer 
the question of significance with a “yes” or a “no.” In contrast, Hill’s criteria are 
qualitative and are used to interpret the validity of the hypothesis in question. 
Many groups have quantitatively demonstrated that EFs have a physiologic effect 
on tissues and on cells, during embryogenesis and during regeneration. However, the 
inference that the groups exposed to EFs are different in some characteristic from the 
groups without similar exposure does not necessarily imply that EFs are causing the 
effect in these experiments, nor that EFs are physiologically relevant stimuli in vivo. 
Thus, It is worth comparing the current understanding of electric fields in regulating 
development and regeneration against Hill’s criteria to establish whether existing 
knowledge is concordant with a causal relationship and, if not, to determine which 
aspects of the causal relationship are yet to be determined. 
Evaluation of EFs as a causal stimulus 
We have already provided evidence that EFs conform to a number of Hill’s 
criteria for causality. (We refer the reader to the section in chapter one entitled 
“Physiologic electric fields regulate embryogenesis and regeneration”, beginning on 
page 29, for a thorough discussion of this literature.) EFs are produced by all cells and 
in all tissues as a function of their normal physiologic activity, and all cells are affected 
by EFs through electrostatic interactions. EFs are increased during embryogenesis, and 
their elevation precedes limb bud outgrowth; EFs are also elevated upon injury and 
remain elevated throughout regeneration. The intensity of injury-induced EFs is 
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associated with the success of regeneration, such that tissues with lower EFs heal by 
scar formation while those with higher EFs regenerate. Multiple different groups have 
independently demonstrated this correlation between EF intensity and both 
embryogenesis and regeneration; moreover, multiple groups have shown that blocking 
EFs interferes with embryogenesis and with regeneration. In vivo, EFs have been 
manipulated physically by directly applying electrical current to the tissue, manipulated 
pharmacologically through multiple different ion transporters and channels, and 
manipulated chemically through changing ionic content of tissues; in all of these 
examples, similar effects of the manipulation have been reported. At a cellular level, 
EFs have similar effects on inducing the same set of behaviors in cells from multiple 
different tissues, and the behaviors that EFs induce are the same cellular behaviors that 
are necessary for both embryogenesis and for regeneration. Moreover, EFs have been 
shown to regulate cellular activity through the some of the same physiologic 
mechanisms by which cells have previously been shown to respond to chemotaxic, 
mitogenic, and fate-determining stimuli. 
Cumulatively, this evidence is consistent with 7 of Hill’s criteria: strength, 
consistency, temporality, dose-dependency, plausibility, coherence, and experiment. It 
is worth noting that the two criteria not met, those of specificity and analogy, are actually 
consistent with the hypothesized role of EFs. EFs do not demonstrate specificity of 
effect on tissues or cells as master regulatory genes can stimulate the same cellular 
behaviors, developmental pathways, and regenerative effects; however, EFs are 
hypothesized to act upstream of the master regulatory genes, so this lack of specificity 
is necessary for the putative causal relationship. EFs also do not demonstrate a causal 
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relationship that is analogous to any other currently known relationship, but this lack of 
analogy is justified because EFs as a stimulus are hypothesized to be unique in their 
role as a trigger for morphogenesis. Of course, we could argue that EFs during 
embryogenesis are analogous to EFs during regeneration, but that is a 
mischaracterization of our hypothesis, which is that elevated EFs regulate the same set 
of cellular behaviors independent of the cell type, the tissue, or the species, in order to 
drive morphogenesis: in the embryo, morphogenesis is synonymous with embryonic 
development; after injury, morphogenesis is synonymous with epimorphic regeneration.  
This qualitative review is consistent with our over-arching grand hypothesis: that 
EFs have a conserved effect on all cells in all tissues from all metazoans during both 
embryogenesis and regeneration. The plausibility of this hypothesis as described thus 
far is purely circumstantial: it is based on the fact that all cells produce electrogenic 
activity and can detect external electrical cues. However, to be truly plausible, there 
must be an evolutionary reason for which EFs would have developed a universal effect 
on morphogenesis. Furthermore, while causality does not require an understanding of 
the mechanisms underlying the effect, the plausibility of this hypothesis will be strongly 
supported if potential physiologic mechanisms can be identified. Thus, we will turn our 
attention now to exploring potential physiologic mechanisms and evolutionary origins of 
the hypothesized universal role of bioelectric fields. 
Injury-induced EFs stimulate regenerative physiology in astrocytes 
The plausibility of EFs as a stimulus for development and regeneration relies 
upon physiologic mechanisms through which EFs may be transduced, although it is not 
necessary for these mechanisms to be elucidated for the hypothesized causal 
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relationship to be valid. Nonetheless, we will turn our attention now to exploring 
potential transduction mechanisms, with an emphasis on how each of the EF-induced 
behaviors on astrocytes that we explored in chapters two and three may be regulated. 
CNS regeneration in non-mammalian vertebrates is facilitated by radial glia, 
which restore the BBB, guide regenerating axons past the lesion site, and replace the 
damaged cell population by functioning as neural progenitor cells. These behaviors are 
mediated by a conserved set of cellular behaviors, including migration, proliferation, 
changes in differentiation, and morphological changes. Radial glia, which are the 
resident GFAP+ cell in the non-mammalian vertebrate CNS, are orthologous to 
astrocytes in mammals; the absence of regeneration in the mammalian CNS has been 
attributed to the fact that, while astrocytes also migrate and proliferate upon injury, they 
do no not undergo changes in differentiation or morphology that allow them to function 
as NPCs or to promote axon sprouting. Nonetheless, ample evidence demonstrates that 
astrocytes retain a latent regenerative potential as they can be induced both to function 
as NPCs and to promote axon outgrowth. 
Although we found that EFs stimulate multiple astrocytic behaviors associated 
with wound repair and regeneration, we did not explore the mechanisms by which these 
behaviors are induced. Ultimately, these transduction pathways are an ancillary 
curiosity: the entire idea of exploring EF-based therapies is that EFs will activate 
regeneration by regulating each of the necessary physiologic mechanisms, thus 
obviating the need to individually target each of the contributing signal transduction 
pathways. Nonetheless, in order to establish the causal relationship between 
endogenous EFs and regeneration, they must have a plausible way of interacting with 
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the known mechanisms by which each of these cellular behaviors is transduced. For the 
purpose of exploring the biological significance of EF-mediated astrocytic regeneration, 
we will discuss pathways by which migration, proliferation, differentiation, and 
morphology are regulated in mammalian astrocytes, and explore potential ways by 
which EFs may be transduced by each of these pathways. 
Migration 
Astrocyte migration requires the directional extension of cellular processes, 
which is driven by the assembly of actin and microtubules beneath the leading ends of 
these protrusions, and the breakdown of these cytoskeletal elements at the trailing end 
of the cell. We observed this same type of membrane protrusion at the leading edge of 
migrating astrocytes upon EF exposure, suggesting that the cytoskeletal assembly 
drives astrocytes electrotaxis. Directional migration in astrocytes requires polarization of 
the Golgi apparatus and the microtubule organizing center (MTOC) within the cytosol; 
asymmetric activation of Rho-GTPases then drive microtubule assembly and the 
stabilization of polymerized microtubules towards the leading edge403, 404. Consequently, 
anything causing MTOC polarization can drive directional migration405. One such 
pathway is driven by the Ca2+-mediated activation of Protein Kinase C zeta (PKCζ) at 
the leading edge of the cell, which can be induced by the activation of either integrins 
(through the GTPase Cdc42) 406 or transient receptor potential vanlloid-1 (TRPV1) 
channels, both of which are expressed in astrocytes407-409. Integrins are heterodimeric 
membrane proteins that exist in an equilibrium between an active and inactive state 
and, when in their active state, an inside-out transduction pathway allows them to be 
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activated even without the presence of an external ligand410; because these receptors 
demonstrate constitutive activity, the concentration of integrin receptors at the leading 
edge of the cell may create sufficient activation at the leading edge to drive directional 
migration. TRPV1 channels have a high Ca2+ permeability411, and they have voltage-
sensitive S1-S4 domains similar to those on NaV-channels that may become activated 
due to EF-induced depolarization of the cell membrane412. As both integrins and TRPV1 
channels are transmembrane proteins, an external EF may cause their redistribution to 
the leading edge of the cell through electroosmosis, thus allowing the cell to transduce 
the EF221. 
While the role of integrin- or TRPV1-mediated electrotaxis through PKCζ 
activation has not been explored, Ca2+-sensing receptors and integrins have each been 
shown to modulate migration and differentiation in cerebellar granule cell precursors413. 
Moreover, a different second messenger system has been shown to contribute to the 
transduction of EFs in hippocampal neurons: upon exposure to external EFs, 
phosophoinositide-3-kinase (PI3K) becomes activated at the leading edge of the cell 
and its negative regulator, phosphatase and tensin homologue (PTEN), becomes 
activated at the opposite side of the cell (Figure 1.8 uses these receptors as an example 
of cellular EF transduction through electroosmosis); this activation of antagonistic 
second messengers at opposite ends of the cell causes the MTOC and Golgi apparatus 
to become polarized, which establishes directional neuronal migration229, 232. Together, 
this demonstrates that the polarized organization of cellular organelles necessary to 
stimulate directional migration in astrocytes can be induced by external EFs. 
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Proliferation 
Resting membrane potential (Vm) varies throughout the cell cycle, with a relative 
depolarization throughout G1/S and G2/M and a hyperpolarization in interphase216. Vm 
exerts a causal role in cell cycle regulation, as hyperpolarization induces a reversible 
mitotic block217, while depolarization induces DNA synthesis and mitosis in mature 
neurons218, 414. Cells transduce changes in Vm through voltage-gated ion channels, 
whose opening-probability, and thus conductivity to ions, changes as a function of Vm. 
However, this relationship is not linear as many of the channels that determine Vm are 
themselves affected by both pH and Vm, so small changes in Vm can have large 
changes on ion channel conductance and intracellular ion concentration392. Increased 
Na+ conductance through NaV1.5 channels has been shown to drive mammalian 
astrocyte proliferation following an in vitro scratch wound; subsequently, the passive 
Na+/Ca2+-exchanger (NCX) causes intracellular calcium levels to rise, which is 
necessary for astrocyte proliferation following injury375. Another voltage-gated Na+ 
channel, NaV1.2, is necessary for the injury response in Xenopus tadpoles, where 
increased intracellular Na+ stimulates Salt-Inducible Kinase (SIK), which induces 
regeneration following tail amputation in Xenopus tadpoles; regeneration can be 
rescued in those animals where NaV1.2 is missing by transfecting human NaV1.5 into 
these cells147. SIK, which is a serine/threonine protein kinase – also known as SNF1LK 
– that belongs to a family of AMP-activated protein kinases, does not directly transduce 
Na+; instead, increased Na+ causes increased intracellular Ca2+ through the NCX, which 
activates a calcium-calmodulin dependent kinase that, in turn, activates SIK233, 234, 415, 
416. The transcriptome of mammalian cortical astrocytes published in 2008 
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demonstrates that astrocytes express two isoforms of SIK236, and SIK has also been 
found in Müller glia417 (the resident astrocytes of the retina), suggesting that this same 
pathway may allow astrocytes to transduce EF-induced changes in Vm and regulate 
DNA synthesis and mitosis. 
Extracellular EFs induce changes in Vm that cause an increase in intracellular 
Na+418 that subsequently regulates Ca2+ entry into the cell392, 419, which suggests that 
EFs may be transduced through the SIK pathway. Assuming injury-induced EFs drive 
astrocyte proliferation after injury through a Ca2+-regulated second messenger system 
(e.g. SIK), intracellular Ca2+ and proliferation should be greatest at the lesion border 
where EFs are highest, and they should decline with distance to the lesion margin in 
parallel with the decay in EF-intensity over distance from through the penumbra (Figure 
1.7). Indeed, intracellular Ca2+ concentration increases in astrocytes upon injury, but 
this dissipates with distance from the lesion408; and astrocyte proliferation following SCI 
is confined to the immediate penumbra33, 420. Additionally, EFs should have a cell-type 
specific effect on proliferation as voltage-sensitive membrane protein expression varies 
among different sub-populations of cells, a supposition that is supported by 
observations that membrane depolarization in neurons stimulates DNA synthesis and 
mitosis218, 414 while 200 mV/mm EF application inhibits endothelial cell proliferation (50 
and 100 mV/mm had no effect) 421. The hypothesis that EFs modify the Vm to regulate 
cell cycle checkpoints that induce proliferation suggests that cells would only need to be 
exposed to EFs long enough to get past these cell cycle checkpoints. Consistent with 
this hypothetical mechanism, a single EF pulse stimulates the activation of members of 
the fos and jun gene families, as well as the persistent activation of multiple 
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transcription factors within one hour of exposure422. Moreover, astrocyte proliferation 24 
hours after a scratch wound requires a Na+ current through NaV1.5 only for the first 15 
minutes after injury375, and tail regeneration in Xenopus tadpoles requires only 1 hour of 
Na+ current to stimulate regeneration147. Together, these observations demonstrate that 
EFs regulate a signal transduction pathway that is known to stimulate astrocyte 
proliferation, thus supporting the hypothesis that EFs have a causal effect in regulating 
proliferation. 
Differentiation and neurogenesis 
In peripheral tissues, injury-induced EFs stimulate terminally differentiated cells 
to revert to an immature progenitor phenotype, and these proliferating progenitors 
respond to master regulatory genes that guide morphogenesis throughout regeneration. 
In order for injury-induced EFs to stimulate regeneration in the mammalian CNS through 
astrocytes, elevated EFs must effect changes in astrocyte gene expression, and 
astrocytes must be able to respond to master regulatory genes. In the previous sections 
on migration and proliferation, we discussed possible mechanisms by which astrocytes 
may transduce EFs through second messenger systems associated with Ca2+, PI3K, 
PKC, and SIK; these same pathways can also contribute to transcriptional modification 
of genes associated with changes in differentiation, such as regulation of Notch1 and 
BMP by SIK-signaling during Xenopus tadpole tail regeneration147. Moreover, we 
previously described how cells transduce EF-induced changes in Vm to regulate 
proliferation, and how Vm is also associated with differentiation: progenitor cells have 
relatively depolarized Vm that become increasingly hyperpolarized as they 
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differentiate423, changes in Vm have been shown to actively regulate differentiation of 
mesenchymal stem cells424, and elevated EFs increase neurogenesis from mammalian 
NPCs in vitro244. A comprehensive study of the transciptome of murine astrocytes 
demonstrated that mature astrocytes express multiple receptors and downstream 
mediators necessary to transduce each of the master regulatory genes associated with 
epimorphic regeneration, including those for BMP, FGF, RA, Shh (the Ptch1 receptor), 
TGF-β, Wnt (the Fzd receptor family, especially Fzd2); and an ingenuity pathway 
analysis specifically identified Notch, Wnt/β-catenin, TGF-β, and Shh signaling 
pathways as being particularly enriched in astrocytes as compared to other cell types 
within the CNS236. Moreover, mature astrocytes actually express the transcripts for 
BMPs, FGFs, Shh, TGF-β, Wnt, suggesting that they may be a source of these 
morphogens in regenerating tissues236. It is well-established that astrocytes in the adult 
mammalian CNS have an ability to function as NPCs, but that this neurogenic potential 
is constitutively inhibited through Notch signaling103, 104; as astrocytes express SIK, and 
SIK signaling promotes regeneration in other tissues through regulating Notch, EFs may 
be able to induce regeneration in astrocytes by inhibiting Notch-mediated repression of 
neurogenesis through SIK signaling. 
Biophysics of EF transduction 
Heretofore we have framed our discussion under the assumption that cells detect 
purely the vector components of the EF: their magnitude and their orientation. However, 
this is a gross oversimplification of the information encoded by EF vectors. We have 
already described the fundamental relationship between EFs and ionic currents, which 
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themselves may regulate cellular physiology through magnetic interactions induced by 
the moving charge and thus may have effects that are completely independent of EFs. 
(These potential magnetic interactions are beyond the scope of this already expansive 
disquisition and thus will not be further considered here.) Within the scope of EFs, we 
have already suggested that EFs may also respond to the magnitude of the change in 
EFs, and to the duration of EF exposure. In the context of our overarching hypothesis – 
that EFs have an intensity-dependent effect on wound repair – we must consider that 
cells are exposed to EFs both in the intact tissue prior to the injury, and in the injured 
tissue immediately thereafter. Thus, cells may respond to the absolute value of the 
injury-induced EF, the absolute value of the change in EF intensity induced by the 
injury, the relative increase in EF-intensity upon injury, or the rate of change in EF 
intensity upon injury. Moreover, as some EF-induced cellular responses only require the 
initial activation of certain second messenger cascades, the duration of EF exposure 
also may also be an important signal: cells may respond to the total duration of the 
applied EF, or they may only require a certain EF flux (e.g. a higher EF over a shorter 
duration is equivalent to a lower EF over a longer duration). Each of these signals may 
be relevant in certain circumstances, and multiple properties of EF signaling may be 
involved in regulating different behaviors within the same cell; for example, the initiation 
of a cardiac action potential requires the myocyte to depolarize to an absolute value (i.e. 
the threshold potential), but the rate of this electrical conduction through the 
myocardium is dependent on the rate of cell depolarization once the action potential is 
triggered. Thus, while our exploration of the relationship between EFs and regeneration 
may be facilitated by this simplification, the biophysics underlying this relationship is far 
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more complex. Moreover, this suggests that our experimental approach of manipulating 
the absolute value of EF intensities to assess EF-induced effects on cells in vitro that 
we employed in chapters two and three, and that have been employed by many other 
labs, may not detect the full effect that physiologic EFs have on cellular behavior if cells 
transduce components of the EF other than their absolute value. 
The evolutionary relevance of electric fields 
In the previous section, we established that EFs can plausibly interact with the 
physiologic mechanisms regulating each of the astrocytic behaviors necessary for 
epimorphic regeneration and, by extension, embryonic development. Now we turn our 
attention to exploring reasons for which cells would have evolved an ability to respond 
to EFs, and why EFs may play such an important role in regulating development and 
regeneration. The evolution of the important role that EFs play in development and 
regeneration presents a considerable conundrum given that EFs only encode bivariate 
information (i.e. magnitude and direction), while the complex tissues within vertebrates 
seem to require interactions among the myriad families of signaling pathways whose 
necessity for morphogenesis we have already established. However, this teleological 
understanding of EFs is not consistent with their evolutionary origins. 
Ubiquity of EFs explains their evolutionary significance 
As ontogeny recapitulates phylogeny, an understanding of when EFs begin to be 
involved in embryogenesis will inform our understanding of their evolutionary origins. 
The earliest endogenous bioelectric activity that has been measured in embryonic 
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vertebrates is immediately prior to limb bud formation248, 250, 252, but this late 
measurement reflects technical difficulties in measuring EFs at earlier embryonic time 
points and is not an indication that they are absent at the start of development. Indeed, 
studies have found that asymmetric electrical activity precedes polarization of the 
fertilized egg from the alga Pelvetia, demonstrating that bioelectric signals are 
associated with the earliest stages of eukaryotic development. Moreover, the role that 
EFs play in establishing cell polarity in Pelvetia embryos246, 425 is similar to the role of 
EFs in defining body axes and guiding limb development in vertebrates252, 315, 400, 
suggesting that EFs played a similar developmental role in the common ancestor to 
these two species – which existed before the division of the ancestral eukaryote into the 
Unikonta and Bikonta supergroups that is estimated at 1100 – 2300 million years ago160, 
426. As bioelectric signaling was already involved in developmental processes in the 
primordial eukaryote, it is likely that the interaction between EFs and physiology has 
evolutionary origins that are far older. 
According to the theory of common descent, all extant life evolved through 
speciation from a universal protocellular ancestor. This protocell developed from the 
aggregation of a replicating genome containing hereditable information within a 
membranous vesicle that compartmentalized it from the surrounding environment427. 
Consequently, these basic elements of cellular physiology – a semipermeable 
membrane and a self-replicating genome – would have had the opportunity to be 
conserved among all life. In turn, each of these elements originally developed from the 
spontaneous formation of organic molecules from inorganic ions, and the polymerization 
of these molecules into structures capable of catalyzing their own replication. These 
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chemical processes developed in an acellular environment and thus they would have 
been directly affected by the physical properties within the environment, including solute 
concentration, heat, and electrostatic forces. Evolution has had billions of years to shed 
the mechanisms by which life detects these fundamental properties of the environment, 
but the fact that there are species among extant archaea, bacteria, and eukarya that still 
respond to each these cues underscores the importance of these physical properties to 
life. 
Electric fields are the most important of the physical properties of the 
environment to molecular interactions because, while temperature and solute 
concentration may affect the rate of metabolic reactions (and may even affect the 
stability of the tertiary and quaternary structures of larger macromolecules), the actual 
interactions between different molecules are mediated through their electric fields. The 
arrangement of polar and charged residues on the surface of molecules creates EFs 
that propagate through the surrounding area; electrostatic interactions between the EFs 
from different molecules mediate their formation into molecular complexes428, and EFs 
within the active site of enzymes are necessary for their catalytic activity429. Moreover, 
certain electrostatic properties appear to be evolutionarily selected in proteins to 
maintain specific functions428, 429. Indeed, the earliest organic molecules may have 
reacted with each other exclusively through electrostatic interactions as more elaborate 
molecular signals and enzymes had yet to originate. These same charged residues 
mediating intermolecular interactions also allow biological macromolecules align their 
dipoles parallel to the orientation of environmental EFs. It follows that cells should also 
be able to detect and respond to environmental EFs, as cells are merely aggregates of 
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ions and biological macromolecules. As these basic molecules of heredity developed 
prior to the origin of the protocell, interactions between external EFs and biological 
molecules must predate the origin of cellular life. 
Models of the membrane in primitive cells suggest that these original membranes 
were composed of simple fatty acids that allowed for the passage of polar solutes 
without the aid of specific transport machinery; such transport mechanisms gradually 
emerged as protocells developed nutrient requirements that exceeded those available 
through passive diffusion, and as the increasing complexity of membrane lipids caused 
membrane permeability to decrease430. These transport mechanisms include selective 
ion channels and transporters whose very activity is electrogenic because they result in 
a net movement of specific ions. Consequently, not only did protocellular physiology 
develop in an environment in which they were constantly exposed to EFs, but cells also 
began to produce their own electrogenic signals early in evolutionary history. Moreover, 
EFs have a universal effect on charged molecules, so physiologic EFs would have 
allowed early cells to interact with each other prior to the evolution of specific signaling 
molecules. 
EFs retained their physiologic relevance in intercellular communication 
throughout the evolution of multicellularity, which explains their integral role in 
morphogenesis during development and regeneration. In multicellular organisms, each 
tissue may have evolved a characteristic EF in parallel to the evolution of the tissue 
itself: each tissue has a characteristic structure that defines its electrical properties431, 
and each tissue is composed of characteristic sub-populations of cells that each may 
have unique electrogenic activity212. Epithelial cells lining the embryo sustaining the 
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same electrogenic activity as they do in adults but, because the undeveloped embryonic 
tissue is much thinner than the mature tissue, this electrogenic activity results in EFs 
that are elevated within the embryo (i.e. embryonic EFs are elevated in part because 
the same voltages created by epithelial cells are spread over a much shorter distance). 
Nascent tissues thicken throughout embryonic development due to EF-induced 
progenitor cell proliferation, which causes EFs to gradually diminish, which 
consequently drives the progressive differentiation of stem cells into increasingly-mature 
populations423, 424. In the developing limb, epithelial cells in the apical ectodermal cap 
(AEC) produce a high EF that may sustain progenitor cell proliferation in the underlying 
blastema; these EFs dissipate with distance from the AEC, allowing more proximally 
located progenitors to differentiate, and this voltage gradient may contribute to planar 
cell polarity that helps pattern the proximodistal axis of the developing limb248, 252, 401. 
Characteristic physical properties of tissues may have also led to the evolution of 
EFs as a key signaling mechanism in the injury response. Injury changes the physical 
properties of tissues, causing a passive increase in the EF intensity that is immediate 
and is based purely on the physiologic electrogenic activity in the tissue prior to injury. 
In contrast to the immediacy of changes in bioelectric signaling following injury, 
molecular signals associated with the injury response are relatively slow as they are 
actively released only upon exposure to specific triggers, and certain signaling 
molecules first need to be synthesized. Moreover, molecular signaling is limited by the 
relatively slow process of diffusion through the lesion site, whereas bioelectricity 
propagates instantly through the tissue surrounding the lesion and dissipates only as a 
function of distance. Furthermore, these elevated EFs, which have been shown to drive 
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the dedifferentiation of cells into pleuripotent progenitors245, 424, may drive epimorphic 
regeneration because they are the same signal that drives morphogenesis during 
development. Thus, the proposed importance of EFs in regulating molecular 
interactions within and between cells, and in tissue morphogenesis during development 
and regeneration, is compatible with the current understanding of the origins of life and 
subsequent metazoan evolution. 
Evolutionary loss of EF-induced regeneration 
Given the ubiquity of EFs in biological systems and their conserved role in 
regulating both embryonic development and regeneration, it is particularly curious that 
mammals have generally lost the ability to spontaneously regenerate. Having described 
in the previous section multiple reasons for which EFs evolved to be integrally important 
to development and regeneration, we must now consider how mammals have evolved 
the loss of EF-induced regeneration. The form of regeneration with which we are 
concerned is that which recapitulates embryogenesis so, as we described in chapter 
one (page 18), these mechanisms must be conserved in mammals as they are identical 
to those underlying their original embryonic development. We have also described 
evidence that these pathways are expressed in mammals in a functional state, and the 
experiments that we described in chapters two and three demonstrated that EFs can 
induce each of the astrocytic behaviors necessary for regeneration. Furthermore, we 
have discussed evidence that injury induces an increase in EFs in multiple mammalian 
tissues, so the putative stimulus initiating regeneration is also clearly conserved. 
Therefore, the absence of regeneration must be due to a divergence between the 
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robustness of the injury-induced EFs in mammals and the sensitivity of the signal 
transduction pathway through which cellular regeneration is initiated. Injury-induced EFs 
may have declined in intensity due to evolutionary changes in the physical properties of 
mammalian tissues – either to a changing composition of the ECM altering the dielectric 
properties of the parenchyma431, or to the development of the sub-dermal lymphatic 
system that electrically grounds the EF278 – or to an evolutionary diminution in the 
electrogenic capacity of epithelial cells. We have already described myriad pathways 
through which cells may transduce EFs; decreased efficiency of any of these pathways 
– due to a necessary molecule having reduced sensitivity, expression, or activity – could 
attenuate the cellular response to injury-induced EFs. 
Loss of regeneration as an evolutionary adaptation 
We have established that physiologic EFs regulate morphogenesis during 
embryonic development and regeneration, and that the physiology by which EFs are 
produced and transduced by cells is universally conserved. Therefore, the fact that 
regenerative potential exhibits variable expressivity among different vertebrate clades 
(Figure 5.1), and among different species within each clade, raises the question of why 
regeneration is not universal given that the underlying physiologic mechanisms are. 
This question is particularly pertinent in establishing the causality of endogenous 
electric fields as a universal regulator of embryogenesis and regeneration: in the 
previous section we posit that EFs evolved a loss-of-function mutation in certain 
vertebrates such that they continue to regulate embryogenesis but are insufficient to 
stimulate regeneration; for this hypothesis to be valid, we have to demonstrate that the 
loss of regeneration is evolutionarily plausible and coherent with preexisting theory. 
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Regeneration was a feature of the original metazoan 
Two competing theories account for the observed variability in regenerative 
potential (Figure 5.2): regeneration may have evolved from a common non-regenerative 
ancestor independently in each lineage where it is expressed, or regeneration may have 
been evolutionarily lost from a common regenerative ancestor. Under the hypothesis 
that regeneration in extant vertebrates is expressed only in those species where it arose 
as a gain-of-function adaptation from a non-regenerative ancestor, the underlying 
physiology would be expected to vary widely among different species. Instead, the 
physiologic mechanisms underlying epimorphic regeneration involve the conserved role 
of endogenous EFs and master regulatory genes, which has been demonstrated in 10 
extant vertebrate clades and absent only two – mammals and birds (Figure 5.1) 123, 125, 
133, 136, 188. Thus, the principal of parsimony summarized eponymously as Occam’s 
Razor suggests that the common ancestor among vertebrates expressed regeneration 
and that loss-of-function adaptations independently arose in separate clades (theory 
posited in Figure 5.2A). However, this conclusion merely displaces the original 
quandary: mammals evolved the loss of regeneration from a highly-regenerative 
common ancestor, but it does not address the question of whether regeneration 
originated as a gain-of-function adaptation in this common ancestor or if regeneration is 
a more universal trait. 
In addition to phylum Chordata61, 124, 125, 133, 142, 143, 154, 432, 433, of which Vertebrata 
is a subphylum, epimorphic regeneration has also been demonstrated in phylum 
Arthropoda434-436, and total body regeneration has been demonstrated in phyla 
Cnidaria437-439, Platyhelminthes440, 441, and Porifera442. As regeneration has been 
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conserved across these diverse phyla, it is likely that regeneration is a feature present 
in the original metazoan – a multicellular organism resembling the modern sea-sponge 
– and that it was preserved through speciation to the common vertebrate ancestor after 
which it was subsequently lost within the mammalian clade subsequent to its 
evolutionary divergence from other vertebrates in which regeneration was retained. 
It may be counter-intuitive to think that the loss of regeneration may confer an 
adaptive advantage to a species. However, evolution is not progressive: it is the result 
of cumulative selection pressures from immediate environmental factors acting on 
individuals, the culmination of which favors the emergence of a specific trait over 
multiple generations. Evolution requires that these traits are heritable characteristics 
with variable expression among different individuals within the population, and that 
environmental pressures acting on individuals at discrete points in time favor the spread 
of a subset of those characteristics over the expense of others. Not all traits are 
adaptive, and those traits that are beneficial in one generation may lead to a series of 
adaptations over subsequent generations that are ultimately maladaptive443, 444. 
It is posited that colonies of unicellular organisms resembling choanoflagellates 
gradually developed codependence, resulting in the original metazoan that is the 
progenitor of all multicellular life134, 445-448; this organism likely resembled modern sea-
sponges that are composed of individual choanocytes that are cytologically similar to 
the unicellular life forms from which they descended446. These original metazoans 
represent the advent of regeneration and demonstrate its fundamental importance to 
multicellularity: codependence creates a situation in which the loss of an individual cell 
does not equate death of the entire organism, and thus those individual cells lost to 
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injury need to be replaced by the remaining cells within the animal. Similarly to colonies 
of unicellular organisms, these original multicellular organisms may survive after the 
death of a subset of their cellular composition, and new organisms may be regenerated 
from a small number of isolated individual cells. Sea-sponges – representing the origin 
of multicellularity and cellular codependence – are able to regenerate in much the same 
way: loss of a portion of the sponge is replaced by regeneration while isolating small 
numbers of dissociated cells results in the re-aggregation of these cells into a functional 
organism442. 
Selection pressures favoring cellular codependence resulted in the development 
of a simple organism resembling the modern sea sponge and continued to encourage 
the speciation of this metazoan into increasingly diverse phyla446. The original 
regenerative capacity of sea sponges is preserved in modern hydra437, 438 and 
planaria441, 449 as demonstrated by their capacity to regenerate complete organisms 
from only a small number of isolated cells, and this suggests that regeneration was an 
important feature worth preserving over the hundreds of millions of years of evolutionary 
history since the origin of multicellularity. Deuterostomes share a common ancestor with 
planaria and hydra134, 160, 426, 446 but the totipotent regenerative phenomena expressed in 
planaria and hydra are lost in subset of deuterostomes from which vertebrates 
emerged. Within the phylum Chordata, Urodele amphibians and Teleost fish represent 
two examples of numerous non-mammalian vertebrates capable of completely 
regenerating their hearts, spinal cords, limbs/fins, and other organs after significant 
damage105, 122, 124, 450, 451; mammals do not exhibit these robust regenerative 
properties452-454 in spite of the fact that all vertebrates share a common ancestor134. 
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Because regeneration is a process found among most multicellular organisms, the 
principle of parsimony suggests that these regenerative mechanisms developed once 
and that its subsequent loss represents relatively unique evolutionary adaptations. 
Thus, the loss of regeneration in higher vertebrates in spite of the proficiency with which 
Urodeles and Teleosts recover from injury suggests a strong selection pressure against 
the ability to repair certain damaged tissues. 
Mammals may have evolved an inability to regenerate, but many other 
organisms retained this feature over an equally long evolutionary opportunity to lose it. It 
is a fallacy to think that these early-branching organisms split from the vertebrate 
lineage and became evolutionarily stagnant; they have had as much time to evolve as 
have mammals. Although there has been an incredibly long time for the mechanisms 
underlying regeneration in these distantly-related organisms to evolve different 
mechanisms, the conservation of orthologous regenerative genes across multiple phyla 
indicates that there has been a constant selection pressure favoring the preservation of 
regenerative physiology. Mammals do not typically express epimorphic regeneration as 
adults, but the functional preservation of the underlying genes and pathways 
demonstrates that the potential to induce regeneration is retained136, 437, 455-461. 
Conservation of the pathways underlying regeneration throughout hundreds of 
millions of years of evolution indicates their fundamental importance. Given the extent to 
which regeneration can occur in other lineages, the loss of these phenomena in 
mammals is, when considered as an independent variable, likely a cause of increased 
mortality in these organisms following injury. That these pathways are present but 
unexpressed in mammals indicates that there must be a greater benefit afforded 
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elsewhere by suppressing regeneration than is gained by completely resolving organ 
damage through regeneration after injury. Understanding the selection pressures 
favoring the loss of regeneration is necessary to inform the development of a 
therapeutic strategy to stimulate a regenerative phenotype while compensating for 
those evolutionarily adaptive traits through which it is suppressed. 
Inclusive fitness: lost regeneration as an adaptive advantage 
Developing a multicellular lifestyle requires a shift in fitness strategy favoring 
inclusive fitness over a direct reproductive approach. The metazoan concestor likely 
resembled a simplistic sea sponge that, as already discussed, was capable of 
regenerating its entire body plan from small aggregates of individual cells445-448. This 
totipotent regenerative capacity was conserved past this point and is still expressed 
among different modern phyla including Porifera442, Cnidaria437, 438, and 
Platyhelminthes441, 449. Organisms from each of these phyla show evidence of 
immortality: Porifera re-aggregate upon being dissociated into individual cells442; Hydra 
reproduce when offspring bud from the parent while the parent remains capable of 
surviving and reproducing over the course of at least four years (the longest published 
example of hydra reproduction being studied) 462; Planaria reproduce by binary fission 
producing two offspring from the original parent, and injury resulting in one Planaria 
being torn in two results in the regeneration of two independent organisms463, 464. This 
same type of immortality is seen in many unicellular organisms447, 465 that reproduce 
symmetrically to form two identical and indistinguishable daughter cells and suggests 
either that immortality results from convergent evolution that returned to metazoans 
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after the advent of multicellularity, or that the original metazoan concestor was a 
conglomerate of immortal codependent cells. The preponderance of evolutionary 
evidence and the simplicity required by Occam’s razor suggest that the totipotent 
regenerative capacity in sea sponges, and the immortality of Porifera, Planaria, and 
Hydra, are the result of immortality within the original metazoan. 
Multicellular life most likely began with an immortal organism, so the 
deuterostome clade in which modern mortal organisms must have evolved the trait of 
mortality at some subsequent point in its speciation134, 137. Common ancestry between 
mortal and immortal organisms implies that the concestor population from which the trait 
of mortality arose contained coexisting mortal and immortal members. That this clade 
survives and has undergone wildly successful speciation events over hundreds of 
millions of years, and that examples of convergent evolution of mortality is seen in 
examples of asymmetrically dividing prokarya in which the parent cell ages and dies466, 
467 is a clear indication that mortality must offer a significant benefit to the survival of a 
species. 
Mortality’s survival benefit is assumed because of the evolutionary success of 
organisms in which this trait exists, but a net benefit is not required for its persistence in 
a population. What is necessary for the continued existence of mortality is that its 
development does not yield a net loss in fitness468, 469. While numerous other phyla 
developed during this era of evolutionary history, widespread extinction of entire phyla 
suggests that selection pressures are extremely effective at eliminating maladaptive 
traits from the evolutionary gene pool. Modern computer models of the spread of 
adaptive traits that benefit decreased individual reproduction support this and show that 
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novel phenotypic traits may spread rapidly through a population (within 500 
generations) accompanied by the equally quick loss of the maladaptive version468. 
Therefore, while the magnitude of the direct benefit offered by its evolution may be 
controversial, it is established that mortality is at least not maladaptive. 
The development and success of mortality, together with the loss of totipotent 
regenerative potential in higher vertebrates, suggests that there must be an adaptive 
advantage to eliminating individual organisms for the benefit of the entire species. 
However, the adaptive benefit of death directly conflicts with the evolutionary axiom that 
the organism with the greatest fitness is the one producing the most offspring. Imagining 
the concestor in which mortal and immortal organisms coexisted, it is intuitively obvious 
that the infinite reproductive capacity of immortal variants must have a fitness 
advantage over the mortal variant that eliminates itself from the reproductive population. 
This hypothetical situation, while informative, is incomplete. Interpreting the best 
adaptation as the one leading to the greatest number of direct offspring is a 
conceptually-simple fallacy that obfuscates the reality that, although natural selection is 
based on unequal inheritance of phenotypes, the heritable unit of a phenotype is the 
genotype on which it is based. Thus, although inheritance of traits is easy to 
conceptualize, selection pressures favor the particular alleles that are best able to reach 
the next generation regardless of the method by which they are propagated. While 
individual reproduction creates immediate genetic transmission that increases the direct 
fitness of an organism, the ubiquitous evolutionary loss of directly-reproducing life within 
metazoans due to the distinction between somatic and germ cell lines indicates that 
selection pressures beyond direct fitness must also participate in evolution. 
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Following the evolution of mortality, further traits developed in which tissues lost 
their totipotent regenerative route of reproduction in favor of a distinct germ cell line 
from which all of that organism’s descendants arose. This development created a 
situation in which a subset of cells became completely incapable of directly reproducing, 
instead relegating reproduction to a specialized germ cell lineage. The remaining 
somatic cells sacrifice their direct inter-generational reproductive potential in favor of 
increasing the fitness of the specialized germ cells. Multicellular organisms represent an 
enormous conglomerate of clonal cells that, although differentiated into different 
phenotypes, are (for the most part) genetically identical. While non-germ cells forego 
direct reproduction in favor of assisting the germ cells, the genetic homogeneity means 
that each cell has the same reproductive fitness regardless of whether it is the direct 
progenitor of the reproducing germ cell. Thus, the somatic cell population can forego 
direct reproduction because it has the same fitness afforded to it by germ cell success 
that it would if it was directly responsible for reproduction. 
More recent examples in evolution recapitulate the same axiom: that there are 
situations in which a greater reproductive benefit exists by foregoing opportunities to 
reproduce directly in favor of offering a benefit to other closely-related members of the 
population468, 470. Numerous examples within phylum Arthropoda illustrate the adaptive 
advantage of survival strategies that employ a helper caste whose primary fitness 
benefit is through assisting their close kin rather than by directly reproducing471-473. 
Paper wasps employ an altruistic strategy by which fertile females forego direct 
reproduction in favor of assisting the reproductive efforts of their colony’s founding 
queen471; gene expression changes when females become the foundress queen of a 
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new colony, which corresponds to a dramatic increase in reproductive behavior473. 
Eusocial behavior is an alternative indirect fitness strategy exemplified by the honeybee 
in which a morphologically distinct worker caste of sterile female functions to maintain 
their closely-related hive: workers deter invaders with the kamikaze delivery of venom 
through a barbed stinger, which is left embedded in the victim along with the bee’s 
venom sac and abdominal viscera474, 475. 
Altruism and eusocial behavior pose an evolutionary paradox first solved by 
Hamilton in the 1960s. He predicted that indirect fitness would become a predominant 
fitness strategy in any species in which the allelic benefit from indirect fitness 
outweighed the cost of lost direct reproduction469; specifically, he predicted that indirect 
fitness strategies would emerge in a population whenever rb – c > 0 (where c is the 
fitness cost to the altruist, b is the benefit to the beneficiary, and r is their genetic 
relatedness) 468. The extent to which evolutionary altruism is advantageous is illustrated 
by multiple examples of convergent evolution towards this phenotype among different 
arthropod species, of which the altruistic paper wasp and the eusocial honeybee serve 
as two examples. The high degree of genetic relatedness among members of the paper 
wasp471, 473, 476 and honeybee hives472, 474, 475 and the prolific reproduction of the colony 
queens results in an incredibly high allelic benefit afforded by indirect fitness methods. 
Kin selection also occurs within mammals, as is illustrated by the altruistic alarm 
call behavior seen in Belding’s ground squirrels477. Ground squirrels selectively alert 
their close kin to the presence of predators so that they will have an increased 
opportunity to protect themselves, but this calling behavior significantly increases their 
risk of death through predation. The benefit of increased kin survival outweighs the 
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direct cost of increased predation. Similarly to the altruistic insects that forego direct 
fitness to benefit their hive, ground squirrels are much more likely to give alarm calls 
when they have closely related kin that stand to benefit from this behavior. However, 
squirrel populations are not as genetically homogenous as those of insects: while 
females stay close to their place of birth and are typically surrounded by kin, males 
travel to new territories and do remain to help raise their offspring. Females, therefore, 
are much more likely to have close kin that stand to benefit from altruistic behavior than 
males do, and they are also much more likely to emit alarm calls than are males477. 
Although a less dramatic example than the suicidal behavior in insects, this still 
illustrates the benefit of foregoing individual reproductive opportunities to benefit close 
relatives. 
Inclusive fitness helps resolve the paradox created by the evolutionary success 
of mortality and the potential benefit of an individual foregoing direct reproduction. 
Initially proposed by Hamilton, the overall benefit of an individual’s fitness – described 
as the sum of direct and indirect fitness – illustrates the idea that natural selection 
responds to the interaction between phenotype and environment by favoring the 
transmission of the responsible genes468, 469. An individual organism may increase its 
genetic impact on subsequent generations through direct reproduction, or through 
supporting other organisms that are genetically similar. In this context, the success of 
both mortality and altruism as adaptations implies that each trait must increase the 
overall inclusive fitness of the organism expressing it. 
Complex organs evolved at the cost of direct fitness to the somatic tissue, which 
is evolutionarily understandable in the context that the cost of lost intergenerational 
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reproduction by the cells in each organ is outweighed by the benefit from a net fitness 
gain through inclusive fitness. To achieve this gain, each organ must have developed in 
a way that supported increasingly advantageous functions of the entire organism. 
Therefore, loss of organ function following injury is understood to be detrimental to the 
overall function of that organism. In non-mammalian vertebrates, and elsewhere 
throughout metazoans, totipotent regeneration permits complete recovery after tissue 
damage124, 125, 134, 438, 441, 449, 463. Regeneration is a feature without which an organ 
cannot recover from injury, ergo the loss of regeneration in mammals must reflect an 
adaptation that is ultimately beneficial to the species’ fitness. 
Establishing that the loss of regeneration is associated with a survival advantage 
in mammals implies that novel selection pressures, which would have arisen at the point 
when this clade diverged from a regenerative concestor, must have favored this 
development. It is likely that two distinct pressures drove this development in parallel to 
each other: one favoring the evolution of increasingly complex organs whose 
maintenance following injury required rapid recovery of function, and a second through 
which injured individuals somehow compromised the fitness of the entire group. 
Regeneration is energetically costly and time consuming, and the increasing importance 
of each organ likely favored a reparative response to rapidly restore functional integrity 
while inadvertently antagonizing the regenerative pathways. The decreased survival 
(and direct fitness) of the individual created by this failure to regenerate is insignificant 
when juxtaposed with the benefit to the surviving group members that no longer need to 
care for those infirm injured individuals that have decreased capacity to gather food, 
defend the group, or otherwise move. 
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Lost regeneration is not an epiphenomenon of evolution 
The CNS and the heart are two examples of organs whose obstreperous 
response to injury does not support regeneration even though the pathways through 
which regeneration could be facilitated are preserved in a latent state. The benefit to 
inclusive fitness is only a partial explanation for why regeneration is not expressed: the 
loss of regeneration may not be directly advantageous to either the clade or the 
individual, but the fitness benefit resulting from regeneration was less than the fitness 
provided by the reparative processes of astrogliosis and cardiac fibrosis. As the 
physiology of regeneration and fibrosis directly conflict with each other, wound repair 
through fibrosis out-competed regeneration. Although not expressed, the preservation 
of latent regenerative physiology in mammalian tissues suggests that these 
mechanisms are still important for the normal function of the species and that there has 
been an active selection pressure to maintain it. 
Traits may be eliminated by different mechanisms, each of which is informative 
about the reason for which it was lost. Convergent evolution of atrophied organs and 
genes illustrates the frequency with which obsolete functions accumulate loss-of-
function mutations once the selection pressure to maintain them is removed: organs 
persist as vestigial remnants (e.g. the appendix and coccyx in humans478, 479, and the 
recurrent convergent atrophy of eyes in blind cave fish480), while genes become 
nonfunctional pseudogenes (e.g. hundreds of human odorant receptors became 
pseudogenes as they became increasingly visual animals, compared to the 1200-1500 
functional receptors that remain in other olfactory vertebrates) 481. Obsolete genes and 
tissues persist in vestigial or pseudogene states because, while the pressure to 
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maintain them is removed, there is no selection favoring their loss. Alternatively, 
maladaptive phenotypes are actively selected against and, as in the case of the Irish Elk 
in which the initially adaptive enlargement of the male’s horns ultimately became too 
heavy for the males to lift their heads444, may lead to the extinction of the entire species. 
Together, this supports the notion that regeneration is not expressed in mammals 
because it is subrogated by the gain-of-function of new physiology with which 
regeneration is mutually exclusive. 
Although atrophy and negative selection are common mechanisms driving 
evolutionary change, neither of these mechanisms is responsible for the loss of 
regeneration in mammals. Instead of being selected against or being lost to evolutionary 
atrophy, regenerative physiology is maintained in a potentially functional state that may 
be actively suppressed during injury42-44, 450, 482. Multiple mechanisms exist by which a 
trait may be lost as a species evolves, and each pathway reflects the emergence of a 
different selection pressure. While maladaptive traits often result in extinction and 
obsolete traits become vestigial, unexpressed pathways are preserved when the 
function they serve remains a strong benefit under specific circumstances. For 
regeneration, the functional preservation of the underlying physiology is likely due to the 
conserved use of these pathways during embryogenesis142, 437, 441. 
Mammals do not commonly regenerate following significant damage to their 
heart, CNS, or limbs, but the functional orthologous pathways promoting regeneration in 
other vertebrates are conserved in mammals. This implies that tissue regeneration in 
mammals was once adaptive and, while the preservation of these pathways may be due 
to their involvement in embryogenesis, that they persist in adulthood suggests that a 
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therapeutic program has the potential to stimulate regeneration if the physiologic 
mechanism through which spontaneous regeneration is activated in other organisms 
can be identified in mammals. Given the health care burden of caring for patients 
suffering from long-term sequelae of CNS injury16, 21, 483, 484 and the inability to find a 
substantial therapeutic intervention to promote functional recovery485-487, a strategy to 
promote regeneration based on these physiologic mechanisms should be a research 
priority. 
Immune system and the effect on regeneration 
The complex immune system in mammals responds to tissue damage with an 
initial neutrophilic, and delayed macrophage, infiltrate to remove damaged tissue by 
phagocytosis; a concomitant proliferation of fibroblasts is responsible for generating 
scar tissue, which restores tensile strength to the injured tissue. (An exception to this is 
the CNS, which lacks fibroblasts; instead, astrocytes react to injury by isolating the 
lesion cavity488, 489, but there is no CNS equivalent of the fibroblast to fill the resulting 
cystic cavity with any cellular or collagen-based substrate35.) Immune cells are recruited 
by cytokines released from damaged tissue and they function to expedite recovery by 
rapidly clear damaged tissue to make way for proliferating fibroblasts490. These 
fibroblasts initially accumulate in the granulation tissue surrounding the necrotic injury 
focus and gradually deposit collagen into the area cleared by the immune response490. 
Neutrophils and macrophages create free radicals and other molecules that can 
be directly toxic to healthy cells as part of their natural response to injury491, 492. In 
addition to serving as the source of fibroblasts, the granulation tissue surrounding the 
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injury site also functions to prevent the toxic compounds produced by the inflammatory 
process from spreading into the adjacent healthy tissue as shown by experimental 
paradigms in which attenuating the granulation tissue barrier results in a larger lesion 
cavity490. Although lacking granulation tissue, the CNS exhibits a similar response to 
injury by which astrocytes isolate the lesion cavity from the adjacent healthy 
parenchyma to prevent the lesion from expanding due to secondary injury from toxic 
metabolites31, 32, 35, 493. 
Inflammation in response to injury is an incredibly important mechanism by which 
injured tissue is cleared, but it also appears to have maladaptive aspects in both the 
acute and chronic phases of recovery; the therapeutic efficacy of steroids in improving 
outcomes by attenuating inflammation is a clear indication of this491, 492. Although 
methylprednisolone was the only approved pharmacologic intervention for CNS injury 
beginning on the 1990s, the therapeutic effect was small and the side effects were 
numerous485-487, 494; thus, although inflammation is an important component of the injury 
response, it is clearly not the only factor in the associated pathophysiology. 
Within the CNS, inflammatory mediators are toxic to neurons and are contained 
by a barrier of reactive astrocytes35, 50. As previously mentioned, this barrier is incredibly 
important for preserving the integrity of the adjacent parenchyma and for restoring the 
blood brain barrier that is disrupted by the injury. The astrocytic barrier anatomically 
isolates the lesion site, allowing a cystic cavity of liquefactive necrosis to form as the 
immune system removes the necrotic tissue through phagocytosis. Reactive astrocytes 
also respond to injury by modifying the extracellular matrix with the addition of CSPGs, 
which prevent axons from accidentally sprouting into the lesion cavity by serving as a 
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repulsive cue to the growth cones49, 50. Thus, the astrocytic reaction provides an 
immediate advantage by isolating a hostile lesion cavity35, 51, 495, but ultimately creates 
an anatomical and functional barrier to axon regeneration. 
Cardiac evolution illustrates the benefit of size over regeneration 
As evolution favored the emergence of increasingly large and complex 
organisms, passive diffusion ceased to be an efficient means of distributing nutrients 
throughout the body. Diffusion’s failure across significant distances is apparent in the 
extent to which cells expend energy on actively transporting substances through 
themselves using molecular motors such as kinesins and dyneins496-498. Extracellular 
transport permits nutrient and waste exchange using a circulatory system that must be 
increasingly self contained and pressurized as organism size and complexity increases; 
the open circulatory system in arthropods is replaced by an increasingly efficient closed 
system in chordates134 that has developed the potential to generate high pressures that 
is necessary to support the larger body size within the vertebrate clade142, 441. Vascular 
damage can compromise myocardial integrity, and physiologic pressures increase the 
risk of aneurysm formation and rupture499. 
Ischemic injury in the cardiovascular system results in coagulative necrosis29. 
Disruption to the muscular layer reduces vessel integrity500, 501 and recruits the immune 
system to remove the necrotic tissue490-492. Granulation tissue forming at the lesion 
border gradually replaces the necrotic vascular wall with fibrosis490. Cardiac fibrosis 
begins within 48 hours after ischemic injury and continues over a period of 5-7 days; 
during this time, cardiac integrity is compromised and there is a significantly increased 
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risk of physiologic systolic pressure causing ventricular aneurysm rupture resulting in 
cardiac tamponade500, 501. Fibrosis quickly restores myocardial integrity, and risk of 
rupture decreases dramatically once it is completed. However, the scar tissue has 
decreased structural and functional integrity relative to the healthy myocardium. The 
fibrotic reparative response is necessary to obviate the morbidity associated with 
ventricular aneurysm formation and rupture, but it blocks endogenous stem cell 
proliferation and cardiac regeneration in the process. Because the scar tissue cannot be 
replaced with intact cardiomyocytes under physiologic conditions in mammals, the 
remaining myocardium undergoes compensatory hypertrophy to compensate for the 
decreased contractility of the fibrotic tissue. This beneficial compensatory response can 
become maladaptive and cause a progression to heart failure if it proceeds unchecked, 
which is reflected in the ~65% congestive heart failure complication rate over 5 years in 
patients recovering from a myocardial infarction499. 
Adult hearts in Urodele amphibians and Teleost fish are capable of complete 
regeneration following ventricular amputation by a combined proliferation of 
endogenous cardiac stem cells and by the dedifferentiation of mature cardiomyocytes 
into pleuripotent stem cells135, 143, 183; mature cardiomyocytes themselves may be 
capable of undergoing karyokinesis and cytokinesis without first dedifferentiating, even 
if they are multinucleated482, 502, 503. Division requires a partial disassembly of the 
contractile apparatus within these cells from metaphase through cytokinesis that leaves 
the cell temporarily incapable of contracting482. Thus, regeneration in these lower 
vertebrates results in a transient decrease in cardiac function while the cardiomyocytes 
return to the cell cycle, but this is ultimately permissive to the complete restoration of 
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cardiac function. Interestingly, a major model for cardiac regeneration involves 
amputation of the ventricular apex in newts142, 504 and zebrafish135, 142, an injury that 
would be rapidly fatal in mammals142, 143, 450, 504. Inducing ischemic injury in newt and 
zebrafish myocardium is extremely difficult because the thin tissue permits sufficient 
diffusion with ventricular blood such that coronary vasculature is unnecessary. The 
increased efficacy of nutrient transport by passive diffusion – rather than on active 
cardiovascular circulation – is recapitulated throughout their bodies such that the 
demand on the circulatory system for adequate perfusion is much less than that placed 
on the mammalian circulatory system. Smaller body size and decreased circulatory 
demand do not require the perfusion pressures seen in mammals, so the incision 
initiating clotting in a newt or zebrafish heart would cause rapid exsanguination and 
death in a mammal. 
Within the hearts of lower vertebrates, cardiomyocytes and stem cells are vital 
components of regeneration142. Although mammalian hearts contain both cell types, the 
granulation tissue is thought to inhibit or kill the cardiac stem cells, while the fibrotic 
response is thought to inhibit proliferation of cardiomyocytes490. The fibrotic and 
regenerative responses are thought to be balanced such that the dominance of one 
process impedes the progress of the other482, 505. The dramatically higher number of 
fibroblasts in mammalian hearts likely results in the fibrotic response easily out-
competing the regenerative response, while the lower fibroblast content in non-
mammalian vertebrate hearts is the reason for their successful regeneration. Studies 
endorsing this theory have shown that blocking regeneration in newts results in fibrosis 
and scarring instead of regeneration143, while blocking fibroblast activation in mice has 
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resulted in essentially complete cardiac regeneration with function and structural 
capacity reaching that of uninjured animals over a six month recovery period482. 
Significantly, mouse cardiac regeneration occurred over six months, during which time 
the lack of fibrosis likely compromised the cardiac integrity of these animals (although 
mortality rates in these mice were not reported); the accelerated rate of restoring 
structural cardiac integrity by fibrosis may result in a significant decreased human 
mortality following MI than the six-month regenerative period seen in mice would afford. 
Assuming a relatively constant rate of ventricular aneurysm formation and rupture 
throughout the six month regenerative process comparable to that seen during the 
fibrotic process in humans 0.2-0.3%, increasing the period of compromised structural 
integrity to a six month window of regeneration would significantly increase the 
complication rate506, 507. 
In summary, the increased perfusion pressure that evolved in mammals to permit 
a larger body size created a selection pressure favoring the rapid restoration of 
structural integrity following an ischemic injury. Although the fibrotic process that 
developed in response to this stress is inhibitory to the endogenous regenerative 
physiology, blocking fibrosis can still stimulate this pathway. However, fibrosis is highly 
adaptive and any treatment aimed at blocking it must compensate for the substantially 
prolonged regenerative period and its concomitant decreased structural integrity. 
Conclusions and implications 
Throughout this dissertation we have put forth evidence supporting two 
interrelated hypotheses. First we explored the hypothesis that physiologic bioelectric 
fields regulate the injury response and determine regeneration in the mammalian CNS, 
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in chapters two, three, and four. The validity of this hypothesis is predicated upon, and 
nested within, the larger hypothesis that endogenous EFs are a universal stimulus that 
regulate morphogenesis underlying embryogenesis and epimorphic regeneration in all 
metazoans, the causal justification for which we explored throughout chapter five. 
The implications for these findings are vast and important. First, EFs are a 
promising therapeutic option to promote CNS regeneration. Specifically, as EFs 
stimulate morphogenesis through endogenous physiologic pathways, therapeutic EFs 
could likely change the cellular response and facilitate regeneration by releasing these 
latent pathways from inhibition. Upon appropriate EF-based treatment, the tissue 
contains sufficient physiologic information to completely regenerate, obviating the need 
for supplemental drugs or combinatorial treatments. Beyond the CNS, the single 
unifying hypothesis of EFs as the stimulus underlying morphogenesis suggests that EF-
based therapies may be used to promote regeneration following injury in any tissue or 
organ, and to treat structural abnormalities that arise as a consequence of congenital 
defects. 
The successful application of EFs-based therapies relies upon a thorough 
understanding of three specific variables: the specific component of the EF that cells 
transduce, the parameters of physiologic EFs produced upon injury in the target tissue, 
and the parameters of EFs associated with tissues where successful regeneration 
occurs. Understanding these parameters is a necessary prerequisite to developing an 
EF-based therapy for stimulating regeneration. Before EFs should be therapeutically 
applied, it is necessary to fully elucidate how injury-induced EFs in non-regenerating 
tissues differ from those in regenerating tissues so that injury-induced EFs can 
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appropriately altered. Moreover, understanding how each physical component of the EF 
contributes to morphogenesis will inform the development of the most efficient 
application of therapeutic EFs. Multiple options for EF-based therapies have been 
explored in basic science, some of which have even been applied clinically; however, 
the optimal EF-based therapy cannot be designed and applied without fully 
understanding the underlying endogenous EFs. 
We are left, then, with the conclusions that our research, especially when taken 
in the context of previous research by countless others, supports our hypotheses that 
EFs regulate wound repair in the mammalian CNS, and that this is an example of the 
universally conserved role of EFs in regulating morphogenesis throughout all 
metazoans. Based on these conclusions, further research is needed to identify 
differences in injury-induced EFs that correspond to differences in regenerative 
potential. Future projects are also needed to explore the physiologic mechanisms 
through which EFs are transduced, as this will provide insight into the specific physical 
attributes of bioelectricity to which cells respond. Once identified, differences in the 
expression of these physiologic pathways among species can be used to develop 
insight into the mechanisms underlying how certain species lost evolved the loss of 
spontaneous EF-induced regeneration. A more detailed understanding of the 
evolutionary role of EFs in morphogenesis is essential to the development of an optimal 
EF-based therapy to promote regeneration and thus would the translation of this 
approach to a clinical application. 
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Figure 5.1: Distribution of epimorphic regeneration throughout phylum Vertebrata 
This figure illustrates the phylogenetic relationship among extant vertebrate 
clades. The expression of epimorphic regeneration among these groups based on 
published scientific literature is indicated by the colors to the left of each class: green 
indicates that there is at least one species within the group that demonstrates 
epimorphic regeneration, red indicates that epimorphic regeneration has been 
repeatedly shown to be absent, and black indicates an absence of evidence either way. 
(Note, mammals are listed as lacking epimorphic regeneration even though evidence 
discussed in chapter 1, page 22.) These data are based principally on a review by Bely 
and Nyberg, 2010133. 
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Figure 5.2: Evolutionary origins of epimorphic regeneration among vertebrates 
Phylogenetic tree illustrating two competing hypotheses about the origins of 
epimorphic regeneration in vertebrates based on the expression of epimorphic 
regeneration among extant vertebrate clades as illustrated in Figure 5.1. Green lines 
indicate a lineage capable of epimorphic regeneration, red lines indicates a lineage with 
evidence of absent epimorphic regeneration, and black lines indicate a lineage where 
no observations have been made. (A) Epimorphic regeneration was present within the 
common vertebrate ancestor and was retained throughout evolution except for two 
clades in which it was (mostly) lost. (B) Epimorphic regeneration was not present in the 
common vertebrate ancestor, so each vertebrate clade in which regeneration is 
observed evolved it independently. Assuming that epimorphic regeneration arose 
immediately upon the regenerative clade diverging from a common ancestor shared 
with either Mammalia or Aves, it would have had to have evolved convergently on at 
least seven separate occasions. The principle of parsimony as described by Occam’s 
razor suggests that the single evolutionary origin of epimorphic regeneration as posited 
in (A) is more probable than the convergent evolution of epimorphic regeneration 
through consistent molecular and cellular events that emerged through at least seven 
independent events as posited in (B). These data are based principally on a review by 
Bely and Nyberg, 2010133. 
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Appendix 1: Miscellaneous Protocols 
Solutions 
General solutions procedure 
Note: this protocol assumes 1L of final solution; adjust accordingly 
1. Fill a 1L beaker to 900 mL with deionized water (for solutions with 1L final 
volume) 
2. Add a stir bar and stir a 300 RPM (approximately) 
3. Weigh out solids with accuracy of ± 1% and add to the beaker of water 
4. Raise the fluid volume to 950-970 mL with deionized water and continue to stir 
until solution is clear 
5. Adjust to specified pH 
6. Transfer to a volumetric flask and fill to 1L line with deionized water 
7. Clearly label container with contents, date made, initials of the person that made 
it, and pH (only once it has been measured) 
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Using the pH meter 
Based on the instruction manual for the Accumet Basic AB15 pH meter and 
Accumet Gel-Filled Electrode 
 
General protocol for using the pH Meter 
• The pH meter should always be stored in electrolyte storage solution and must 
not dry out 
• Never wipe the glass bulb within the electrode; wiping the electrode may scratch 
the glass tip, which will render it useless 
• pH should be measured while the solution is being gently stirred on a stir plate 
 
1. Press “std” on the Accument pH meter to turn on the display 
2. Carefully remove the electrode from the electrolyte storage solution 
3. Rinse the electrode with deionized water, blot (do not wipe!) the bottom with a 
Kim wipe, and wipe the sides of the pH meter 
4. Immerse the electrode into the solution, being careful not to hit the electrode tip 
with the stir bar. 
• The pH meter will measure pH continuously. Measurements are complete 
when “STABLE” appears. 
• If calibrating the electrode, see instructions below for additional information at 
this point 
5. Add HCl or NaOH drop-wise until the pH adjusts to the desired range 
6. Rinse the electrode with deionized water (per step 3) after measuring each 
solution and before returning it to the electrolyte solution 
7. When finished using the pH meter, press “stdby” 
 
Calibration of the pH Meter 
• For accurate pH measurements, it is recommended that calibration be done with 
every use. 
• Calibration settings are saved between uses and must be cleared before 
beginning calibration 
 
1. To clear the previously-stored standards: 
• Press setup to view the %slope of the standard curve 
• Press setup again to bring up the clear BUFFER icon and press enter to 
clear all existing buffers 
2. Immerse the electrode into the buffer solution while stirring the solution 
moderately 
3. Press “std” on the pH meter; the display will show a group of buffers. 
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• If the wrong buffer series is displayed, return to the main screen and press 
setup until the correct buffer series appears, then press enter to select it. 
4. Press “std” a second time to initiate the standardization. The pH meter will 
recognize the buffer and return to the measure screen. 
• Repeat the calibration with each of the buffered pH standards (pH = 4.01, 
7, 10.01) 
• At least two buffers must be used to establish the pH standard curve 
5. The slope should be between 90-102% and a value in this range will return 
“Good Electrode” 
• A slope reading outside of this range will return “Electrode Error” 
• The electrode can still be used when “Electrode Error” is present 
• Clear buffer data cache (per step 1) to reset the electrode error and re-
calibrate the electrode 
• The most common cause of an electrode error is old buffer that needs to 
be replaced 
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Phosphate-buffered saline 
Note: this protocol was modified from Cold Spring Harbor Protocols 
Note: Sodium phosphate dibasic 
comes in many different hydrated 
forms; this recipe assumes that the salt 
is anhydrous; if hydrated salts are 
used, the amount of sodium phosphate 
added (by weight) will need to be 
increased in order to keep the resulting 
molarity the same. 
 
Autoclave the 10x Phosphate-Buffered Saline Solution (40 minutes) to sterilize it. 
The mixture of salts will prevent them from crystallizing. 
 
The following recipes are based on 10x Phosphate Buffer and 10x Normal Saline 
being prepared in separate containers. 10x phosphate buffer tends to crystallize out of 
solution, so the above recipe for 10x Phosphate Buffered Saline is preferable. 
 
10x Phosphate Buffer (0.1 M)  10x Normal Saline (9%) 
pH = 7.4 1L   1L 
Sodium Phosphate 
Monobasic 
31.2 g  Sodium Chloride 90g 
Sodium Phosphate Dibasic 113.5 g    
     
     
1x Phosphate-Buffered Saline (0.01 M)  1x PBS with 0.1% Triton X-100 
pH = 7.4 1L  pH = 7.4 1L 
10x Phosphate Buffer 100 mL  10x Phosphate Buffer 100 mL 
10x Normal Saline 100 mL  10x Normal Saline 100 mL 
   Triton X-100 1 mL 
  
10x Phosphate-Buffered Saline (0.1M) 
pH = 7.4 500 mL 1 L 
Na2HPO2 (MW: 141.96) 6.78g 13.56g 
NaCl 40g 80g 
KCl 1g 2g 
KH2PO4 1g 2g 
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4% paraformaldehyde 
Note: Only use glassware and equipment that is labeled as “Para”; this 
equipment is stored on a cart to the right of the chemical fume hood. Keep these 
segregated from general purpose lab-ware as trace fixatives have been known to cross-
contaminate and affect other experiments. 
 
For 100 mL made from paraformaldehyde powder 
1. Place a 250 mL beaker with a magnetic stir bar on the heater-mixer in the 
chemical fume hood. Add: 
a. 4 grams of paraformaldehyde (weighed in the hood) 
b. 90 mL deionized water 
2. Mix while heating the solution (heat setting approximately 5.5); stir until 
dissolved 
3. DO NOT heat above 60°C as this may result in the formation of formic acid 
4. Add 1M NaOH drop-wise to the solution to help the paraformaldehyde 
dissolve 
5. Add 10 mL 1.0M Phosphate Buffer while continuing to mix 
6. Filter entire solution through a paper funnel into a flask 
7. Adjust the pH to 7.4 
8. Refrigerate or chill to room temperature 
 
For 40 mL made from 16% paraformaldehyde ampules (specifically for fixation 
for electron microscopy) 
16% paraformaldehyde (formaldehyde) aqueous solution is ordered from 
Electron Microscopy Sciences (www.emsdiasum.com) order number RT-15710 
1. Add 1 ampule (10 mL) of 16% paraformaldehyde to a marked container. 
2. Rinse out the ampule with filtered 1x 0.1M PBS (to remove any crystals that may 
have formed) and add to the container with 16% paraformaldehyde. Add 30 mL 
total PBS for a total concentration of 4% paraformaldehyde. 
3. Mix thoroughly before use. 
 
• Paraformaldehyde solution is allegedly stable for a week once prepared and is 
ideally made fresh less than 24 hours prior to use. 
• Paraformaldehyde is a regulated waste; collect it in a marked waste container. 
DO NOT DISPOSE DOWN THE DRAIN. 
• Collect solid paraformaldehyde waste (e.g. weigh-boats, contaminated gloves) in 
a marked container that can be sealed (e.g. empty chemical bottle; sturdy plastic 
bag, but not one of the red biohazard bags) 
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Artificial cerebrospinal fluid 
10x aCSF stock 
MW mM Compound grams in 1 Liter (for 10x) 
58.44 126.0 NaCl 73.634 
74.55 3.0 KCl 2.236 
137.99 1.25 NaH2PO4  H2O 1.725 
203.30 2.0 MgCl2  6H2O 4.066 
147.02 2.0 CaCl2  2H2O 2.94 
180.20 10.0 Glucose 18.02 
 
 
10x Sodium Bicarbonate stock 
MW mM Compound grams in 1 Liter (for 10x) 
84.01 26.0 NaHCO3 21.842 
 
Note: The concentrations (mM) listed are those for the 1x working solution, not 
for the 10x stock. 
 
To make a working solution, dilute equal volumes of the two stock solutions 1:10 
(e.g. for 1 Liter of 1x solution, mix 100 mL 10x aCSF with 100 mL 10x sodium 
bicarbonate stock solution, and dilute with deionized water to a final volume of 1 Liter) 
 
Note: the solution tends to form a precipitate after several hours, so make it fresh 
daily. 
• The precipitate can be re-dissociated into solution by mixing the solution over 
gentle heat and bubbling oxygen 
 
Note: this protocol was given to us from the Jacobs lab; it does not specify a pH 
for the solution. 
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Borate buffer 
Used as part of the antigen retrieval protocol for BrdU immunostaining 
 
0.1M Borate Buffer: 
• 3.81 grams sodium tetraborate (Borax) per 100 mL deionized water 
 
Mix solution until Borate dissolves 
Adjust pH to 9.0 
 
Note: Sodium Tetraborate is not acutely toxic, but it can cause respiratory and 
skin irritation in large quantities. Accordingly, measure it out and dissolve it in a 
chemical fume hood. Collect waste and dispose of it through OEHS. 
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Cell culture protocols 
Coating culture flasks 
Powdered Poly-L-Lysine Hydrobromide (Sigma P1524-25mg) Store at -20°C 
• For astrocytes, recommended 2 µg / cm2 (per ScienCell) 
 
1. Dissolve 25 mg (entire contents of vial) in 41.6 mL of sterile de-ionized water to 
make 600 µg / mL (40x) stock solution. 
2. Thoroughly-vortex, then use a 60 mL syringe to sterile-filter the solution through 
a Millex-GP filter unit (Ref # SLGP033RS) into a sterile 50 mL plastic centrifuge 
tube 
3. Add 250 µL of 40x solution and 10 mL of sterile deionized water to a T-75 and 
gently tilt to evenly distribute 
4. Store remaining solution in 250 µL aliquots in sterile microcentrifuge tubes at -
20°C 
 
Liquid Poly-L-Lysine (10 mg / mL) (ScienCell 0413) Store at -20°C 
1. Add sterile water and poly-L-lysine to flask 
2. Gently tilt to evenly distribute 
 
 Water (mL) Poly-L-Lysine (µL) 
T-25 5 5 (10 mg / mL) 
T-75 10 15 (10 mg / mL) 
T-175 13 30 (10 mg / mL) 
 
1x working concentration of poly-L-Lysine for astrocytes: 15 µg / mL (per 
ScienCell) 
1. Once poly-L-Lysine has been added to the culture flask, return it to a 37°C 
incubator overnight (at least 1 hour) 
2. Rinse the poly-L-lysine coated flask with sterile water twice and allow it to dry 
before adding culture media and cells. 
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Thawing astrocytes 
• ScienCell estimates 7.5 x 105 cells in each vial, 90% (6.75 x 105) survive the 
thaw 
 
1. Remove cryogenic vial containing astrocytes from freezer, transfer it to a 37°C 
water bath to thaw 
• Gently mix vial as it thaws 
• Do not allow cap to be submerged in water; wrap in parafilm to protect cap 
if necessary 
2. Transfer the cells directly to a poly-L-Lysine coated culture flask containing 
astrocyte media 
• 20 mL for a T-75, 7 mL for a T-25 
• Poly-L-lysine provides helps astrocytes adhere to the dish 
• Do not disturb the dish for 16 hours 
• Thawed cells are fragile; do not re-suspend, centrifuge, or otherwise 
manipulate cells before adding them to the culture flask, as these actions 
are more harmful to the cells than the effect of DMSO residue in the 
culture. Return them to the culture as quickly as possible with minimal 
handling. 
3. Gently tilt flask to distribute cells evenly 
4. Place cap on the flask and return to the incubator 
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Set up Initial Culture after Receiving the Order 
Prepare poly-L-lysine coated flask (recommended 1 day before thawing cells) 
1. 2 µg/cm2, T-75 flask is recommended 
2. Add 10 mL of sterile water to a T-75 flask 
3. Add 15 µL of poly-L-lysine stock solution (10 mg/mL) 
4. Leave the flask in the incubator overnight (minimum one hour at 37°C) 
Prepare the Complete Medium 
1. Decontaminate the external surfaces of all containers with 70% Ethanol 
2. Transfer sterilized containers to sterile field 
3. Aseptically add each supplement to the basal medium with a pipette. 
4. Rinse each tube with medium to recover the entire volume 
Take the poly-L-lysine coated flasks: 
1. Rinse the poly-L-lysine coated flask with sterile water twice. 
2. Add 20 mL of complete medium to the flask. 
Seeding frozen cells (recommended density of 5,000 cells/cm2) 
1. Place vial in 37°C waterbath, hold and rotate the vial gently. 
2. Remove the vial from the waterbath as soon as they thaw completely. 
3. Wipe vial down with 70% Ethanol and place in sterile field. 
4. Remove cap, being careful not to touch the interior threads with fingers 
5. Resuspend the vial contents carefully using a 1 mL eppendorf pipette 
6. Dispense the contents into the equilibrated, poly-L-lysine coated flask 
7. Replace the cap or cover, and gently rock the vessel to distribute cells 
evenly.  Loosen cap if necessary to permit gas exchange. 
8. Return the culture vessels to the incubator (for best results, do not disturb 
for at least 16 hours) 
Maintenance of the Culture 
Frequency of Changing the culture Medium 
1. 1 day after seeding, change the medium to fresh supplemented medium 
to remove residual DMSO and unattached cells 
2. Until 70% Confluent: Change medium every 3 days 
3. Once 70% Confluent: Change medium every 2 days 
4. Once 90% Confluent: Split cells 
Characteristics of Healthy Cells: 
o Polygonally shaped sheets of contiguous cells 
o Cell number doubles after 2-3 days in culture 
Subculture (i.e. split cells) when 90% Confluent 
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Acid-washing slides & coverslips 
Purpose: Acid washing cleans glass to prepare it for cell culture; do not assume that 
it is ready for cell culture 
• Acid washing does not need to be completed in a sterile environment 
 
Protocol: 
1. Assemble glass on a rack that can hold  
2. Soak glassware in alconox for 15 minutes 
3. Rinse slides 3 times in dH2O 
4. Soak 20 minutes in 1N HCl 
5. Rinse 3 times in dH2O 
6. Soak 20 minutes in 70% ethanol 
7. Sterilize by either: 
• Place under UV light in sterile laminar flow hood until dry, at least 15 minutes 
• Autoclave 
 
If glassware was previously contaminated with a hydrophobic substance, e.g. 
vacuum grease or wax: 
• Clean slides by using a dehydration in ethanol (50%, 70%, 95%, 100%) 
• Soak 2-3 times in xylene 
• Rehydrate in ethanol (100%, 95%, 70%, 50%) then water 
• Continue with acid wash starting at alconox above 
Coating culture plates with fibronectin 
ScienCell Catalogue # 8248 (1 mg / mL) Store at -20°C 
1. Dilute Fibronectin in sterile 1x PBS 
• For astrocytes, 10 μL Fibronectin (1 mg / mL) per 1 mL PBS 
2. Coat the culture surface with a minimal volume 
3. Incubate at room temperature for 2 hours OR 2-8°C overnight. 
4. Aspirate remaining fibronectin solution and rinse with deionized water. The 
culture vessels are now ready to use. 
 
• We coat glass culture substrates in fibronectin for astrocytes 
• Store in aliquots to minimize number of freeze-thaw cycles to which the 
Fibronectin is subjected 
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Sub-culturing astrocytes 
Prepare Culture Dishes: 
• Company recommends adding 2 µg / cm2 poly-L-Lysine to culture flasks  
• Company recommends warming all media to room temperature (not to 37°C 
with a water bath) 
 
Necessary components of media (warmed to room temperature) 
• Trypsin/EDTA solution 
• HBSS (Hank’s Balanced Salt Solution) 
• FBS (Fetal Bovine Serum) 
• Trypsin Neutralization Solution (can be made from 10% FBS in HBSS) 
 
Items to prepare prior to beginning: 
• Coat new culture plates in appropriate substrate 
• Clearly-labeled cryogenic vial (if freezing cells) 
• Add 5 mL of fetal bovine serum (FBS) to a 50 mL conical tube (to receive the 
cells) 
• Ensure 10 mL of trypsin neutralization solution is prepared at room temperature 
o 1 mL FBS 
o 9 mL HBSS 
• Bring HBSS, Astrocyte media, FBS, Trypsin, and Trypsin-Neutralization Solution 
to room temperature 
• Add astrocyte media to all new culture plates and place in the incubator 
 
Dissociate astrocytes from a T-75 culture plate (adjust volumes for other plates) 
1. Remove media from culture plate 
2. Rinse cells in HBSS (remove serum-containing media) 
3. Add 8 mL HBSS to the flask, followed by 2 mL of 0.25% Trypsin/EDTA solution 
a. Gently rock flask to ensure that cells are covered 
b. Incubate the flask in a 37°C incubator for 2 minutes (or until cells are 
completely rounded up) 
4. Use 10 mL serological pipet to wash the plate with the Trypsin-containing media 
2-3 times to remove cells, then transfer the media to the 50 mL conical tube 
containing 5 mL FBS 
5. Return the culture plate to the incubator (no solution in the flask). After 1-2 
minutes, gently tap the flask to detach remaining cells from the plate 
6. Wash the plate twice with 5 mL of Trypsin Neutralization Solution (TNS) to 
harvest the residual cells and transfer the solution to the 50 mL conical tube 
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7. Examine the flask under the inverted microscope to make sure that the cell 
harvesting was successful; if not, wash with additional TNS or add additional 
Trypsin as necessary; fewer than 5% of the cells should remain. 
8. Centrifuge the 50 mL centrifuge tube at 1000 rpm for 5 minutes, remove the 
supernatant, and gently re-suspend the cells in 1 mL of astrocyte media. 
9. Determine the concentration of cells using a hemocytometer. Then, either: 
a. Pipet the appropriate number of cells into each new culture plate 
b. Dilute the cells to a constant volume (e.g. 1x105 cells per mL) 
 
NOTE: 
• Estimated number of cells on a 100% confluent T-75: 2 million (26,500 cells per 
cm2) 
• 5 x 105 cells will produce an estimated 25% confluence 
• Doubling time for astrocytes is estimated at 2-3 days (per ScienCell) 
 
Troubleshooting: Cells not detaching from plate: 
• Try new Trypsin; trypsin activity can decrease on repeated freeze-thaw cycles. 
Ideally, it should be stored in 1 or 2 use aliquots after initially thawed. 
• Forcefully re-wash / pipet liquid over cells to dislodge them 
• Pre-rinse cells with HBSS to remove serum-containing media prior to adding 
trypsin (serum competitively inhibits trypsin activity) 
• Do NOT expose cells to trypsin for too much time; 2 minutes is sufficient. 
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Hemocytometer 
Each square of a hemocytometer, with coverslip in place, represents a total 
volume of 0.1 mm3 (0.1 µL) 
 
1. Seat coverslip onto the hemocytometer 
using a small amount of water along the 
edges to hold the coverslip firmly down 
2. Make sure the cells are evenly distributed in 
the solution by gentle pipetting 
3. Place 10 µL of the cell suspension in the 
grooves of the hemocytometer (figure 1) 
4. Place the hemocytometer on the stage of a 
microscope 
5. Use a 10x objective with either phase contrast or DIC to focus on the central grid. 
6. Count cells in the central 1 x 1 mm grid of the hemocytometer (figure 2); to avoid 
repeat counting, count cells touching the top or right lines of the hemocytometer, 
but not those touching the bottom or left lines. 
7. Move backward and forward across the 5x5 grid of the hemocytometer to ensure 
that all cells are counted. 
• Depending on cell counts, either count the grids marked 1 – 5 (figure 2), or 
count all of the grids.  
• For accuracy, at least 100 cells should be counted. 
8. To calculate the cells per mL: 
• If only a subset of squares in the grid were counted:  
                   cell density = average cell count per square x 25 x 104 cells 
per mL 
• If all the squares in the grid were counted: 
                   cell density = cell count x 104 (per mL) 
Assembling the hemocytometer 
Hemocytometer layout Example of cell counting 
with a hemocytometer 
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Freezing astrocytes 
1. Suspend cells to be frozen in 800 µL of astrocyte media and transfer to a 
labeled cryogenic vial 
2. Add 100 µL FBS 
3. Add 100 µL of sterile DMSO 
4. Close cryogenic vial and freeze in liquid nitrogen as quickly as possible 
o If possible, transfer to -80°C for 24 hours prior to transferring to liquid 
nitrogen; this theoretically limits damage to cells on freezing 
 
Note: DMSO damages cells; minimize time between adding it to the cells and 
freezing the vial 
Fixing adherent cell cultures 
Preparation for Immunocytochemistry 
1. Wash culture 2-3 times with isotonic serum-free media 
• Washes should be gentle to minimize the risk of washing cells off of the 
culture plate 
• Goal of washes is to remove soluble proteins from the culture media, as 
these proteins can contribute to non-specific antibody binding. 
2. Add 4% paraformaldehyde in 0.1M PBS (pH = 7.4) for 15-30 minutes 
3. Wash off paraformaldehyde and replace with 0.1M PBS 
• Add 0.05% sodium azide to the PBS if cells will be stored for a prolonged 
period of time to minimize bacterial growth 
4. Tightly wrap the culture dish with parafilm and store at 4°C until ready to use 
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Immunostaining 
BrdU Cell Proliferation Assay 
BrdU Preparation:  
• From Solid BrdU (Sigma B5002): BrdU is difficult to dissolve; use 0.007N NaOH, 
place it into a heated sonicator, and vortex frequently. 
• From Liquid BrdU stock (Invitrogen 000103): Dilute 1:100 in culture media 
Note: BrdU solution will need to be sterile-filtered before use 
 
Protocol 
5. Change culture media and add media containing BrdU; wash a second time to 
ensure the appropriate concentration of BrdU is achieved 
6. Incubate cells for desired period of time 
7. Wash off BrdU-containing media and replace with fresh media 
8. Fix cells in 4% paraformaldehyde for at least 30 minutes 
9. Immunolabel 
Antigen retrieval for BrdU staining 
This protocol is used for both tissue sections and cell staining 
 
Solutions required: 
2N HCl   (Fisher SA-431) 
1N HCl   Dilute 2N HCL in deionized water (1:1) 
0.1M Borate Buffer dissolve 3.81 g sodium tetraborate (Borax) per 100 mL 
deionized water, adjust pH to 9.0 
• HCl and Borate Buffer are regulated wastes. Collect them in individual waste jars 
for disposal through OEHS. 
 
Procedure 
1. 1N HCl for 10 minutes on ice 
2. 2N HCl for 10 minutes at room temperature 
3. 2N HCl for 20 minutes at 37°C (place in an oven) 
4. 0.1M borate buffer for 10 minutes at room temperature 
5. Begin washes in PBs with 0.1% Triton X-100 per the beginning of normal 
immunostaining 
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Immunocytochemistry 
Solutions Required: 
0.1M PBS 
0.1M PBS + 1% Triton X-100 (10 µL Triton per mL PBS) 
 
Blocking Solution: 4% NGS, 0.5% BSA, 1% Triton-X100 in 0.1M PBS 
 1 mL 5 mL 10 mL 
Normal Goat Serum (NGS) 40 µL 200 µL 400 µL 
Bovine Serum Albumin (BSA) 5 mg 25 mg 50 mg 
Triton X-100 10 µL 50 µL 100 µL 
 
Primary Antibody Staining (Day 1) 
1. 0.1M PBS: 3 washes for 5 minutes each 
2. Blocking solution: 30 minutes 
3. Primary antibody (diluted in blocking solution) 
• Incubate either for 2 hours at room temperature, or overnight in the 
refrigerator 
• To avoid cells drying out if using a small volume of antibody solution, 
cover in a piece of parafilm 
• If using parafilm, float it off with media to remove 
 
Secondary Antibody Staining (Day 2) 
1. 0.1M PBS: 3 washes for 5 minutes each 
2. Secondary antibody (diluted 1:200 in PBS): 2 hours 
3. 0.1M PBS: 3 washes for 5 minutes each 
 
Nuclear Stain (if using) 
• DAPI (1:10,000 diluted from 1 mg/mL stock): 15 minutes 
Bis-Benzimide (1:10,000 from 10 mg/mL stock): 1 minute 
DAPI NucBlue (2 drops/mL; from Molecular Probes R37606): 5 minutes 
• 0.1M PBS: 3 washes for 5 minutes each after the nuclear stain 
 
Coverslip 
1. Deionized: 3 washes for 5 minutes each 
• This helps to remove the salt from the buffer and prevents the formation of 
salt crystals 
2. Use vectashield as a mounting media 
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Appendix 2: Record keeping and Checklists 
Cell culture experiments can generate extraordinary numbers of samples. 
Thorough records will facilitate identifying samples in the lab, confirm results, and locate 
information. Each sample should have a unique, unambiguous, understandable, and 
concise identifier associated with it that corresponds to a full set of records that is kept 
either in hard copy or, preferably, digitally where all of the details about the experimental 
conditions are recorded. For example, labeling specimens as E1, E2, E3, C1, C2, C3 for 
“experiment 1” (etc) is ambiguous: it only provides information about how the samples 
are related to each other without providing any other information. However, labeling 
each sample with its full set of records is absurdly onerous and unnecessary. A 
necessary compromise is a project name, an experiment number, the treatment group, 
the replicate number, the date, and the initials of the experimenter. This way, no two 
samples from a single experiment can be confused with each other, samples from each 
experiment can be readily identified, and there is sufficient information to look up the 
records associated with these experiments either by date or by project. 
Considerations in devising a method for record-keeping should include the 
human elements involved. Hand-written records may be considered traditional, but 
digital records do not suffer from being incomprehensible due to hand-writing and they 
can easily re-printed in the event a hard copy version is damaged. Digital records are 
more readily backed-up, and they can also be easily accessed from remote locations. 
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Moreover, digital records simplify and expedite duplicating lengthy information about 
records, such as protocols with minor changes. And, most importantly, computers can 
search through digital records for keywords far more expeditiously than an experimenter 
can leaf through hard copy records. 
Here, I will briefly describe my own record keeping system based on the 
previously-stated requirements. As my experiments were focused on cell culture, the 
following records are organized to reflect this. I devised standard forms for each level of 
record keeping, and arranged them heirarchically so that I could readily find the 
information I needed. Each cell line or genotype is referred to by a unique lot number, 
and the Cell Culture Record Sheet is used to keep track of each dish associated with 
that genotype; these records are used in real-time to help keep track of ongoing cell 
culture experiments, and they are also used as reference markers to try and recreate 
the history of certain cells if there are possible anomalies with analysis of experimental 
data. 
Each project is given a name, and each experiment (full set of treatment groups) 
is assigned a unique number. A single Project Record Sheet provides an overview of 
ongoing progress with each experiment, tracks experimenter participation in these 
projects for subsequent attribution of credit (i.e. determining authorship on publications). 
Each experiment listed in this log has a corresponding Experiment Record Sheet, in 
which details of the treatment groups, the protocol, and the history of the experiment are 
kept. For experiments with multiple replicates, each replicate is listed on its own line and 
has a corresponding In Vitro Staining Record (for ICC, other sheets can be composed 
for different types of studies); this staining record sheet includes the full staining 
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protocol and records of the procedure. Importantly, these record sheets include 
checklists for each experiments, allowing the experimenter to have access to the 
protocol in real time during the experiment and also providing a tangible record that 
each step of the procedure occurred; it also provides explicit instructions for each 
solution used within the experiment, minimizing experimental error due to mistakes in 
preparing solutions. 
The heirarchical organization of these records can (and should) also be used for 
storing these records, both digitally and in hard copy. For example each Project Record 
Sheet should be assigned its own folder; each experiment within a project should be 
assigned a sub-folder in which the staining records for each replicate are stored. This 
organization ensures that all records for a single project are stored in one place and 
thus that they are readily found. Digital images can be stored in folders on a computer, 
with a  heirarchical structure matching the organization of hard-copy records. (Another 
note on digital images: each folder and each image should be labeled according to the 
same strict guidelines established for samples. Do NOT label images as “image 1” 
because you will certainly forget everything about that particular image no matter how 
hard you try not to.) 
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In#Vitro#Experiment*Record* *
Project:*
!
!
Investigator(s):* ! Experiment*#:* ! Replicates:* 1! Dates:* !#! !
Cell*Type:* ! Media:* !
Cell*Lot*#:* ! SubDID*#:* * Time*Lapse:! ! !
Culture*Plate:* ! Coating:* Uncoated! * ! *!
Purpose:* !
Groups:* !
Design:* !
Analysis:* !
Other*Comments:*!!
Culture*Records*
Date* User* Manipulation* Comments*! ! ! !! ! ! !! ! ! !! ! ! !! ! ! !! ! ! !! ! ! !
*
Purpose*for*Each*Replicate*
ICC*/*Western*/*Other* Purpose* Stained* Imaged* Analyzed* Outcome*1.! ! ! ! ! ! !2.! ! ! ! ! ! !3.! ! ! ! ! ! !4.! ! ! ! ! ! !5.! ! ! ! ! ! !
Indicate)dates)of)staining,)imaging,)and)analysis)
Experiment*Comments:* Overall*Outcome:*! !
*
In#Vitro#Experiment*Record* Results*
Project:*
!
!
Investigator(s):* ! Experiment*#:* ! Replicate*#:* 1* !For!each!result,!indicate!date(s)!of!analysis,!methods!used!for!analysis,!outcome!of!any!statistical!tests,!interpretation,!and!plan!
*
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In#Vitro#Staining'Record' '
Project:'
!
!
Investigator(s):' ! Experiment'#:' ! Replicate'#' ! Dates:' !"! !!Antibody!Information!
Antigen' Host' Isotype' Dilution' ' Secondary' Label' Dilution' Host'
'
' ! ! ! ! ! ! ! !
' ! ! ! ! ! ! ! !
' ! ! ! ! ! ! ! !!Immunocytochemistry!Protocol!
BrdU' Secondary' Nuclear'Stain!Y!!/!!N!!(If!no,!skip!to!Primary)! 3x!PBS!washes!(5!min)! !None!!1N!HCl!x!10!min!(on!ice)! !!!!1.! !!!!2.! !!!!3.! ! !DAPI!NucBlue!(2!drops!per!mL,!Molec.!Probes!R37606)!!!!5!min!!2N!HCl!x!10!min!(25°C)! !Secondary!(2!hours)! !Bis"Benzimide!(1:10,000!from!10!mg/mL)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!1!min!!2N!HCl!x!20!min!(37°C)! 3x!PBS!washes!(5!min)! !DAPI!(1:10,000!from!1!mg/mL)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!15!min!!0.1M!Borate!Buffer!x!10!min!(25°C)! !!!!1.! !!!!2.! !!!!3.! ! Staining'Comments'
Primary' !Nuclear!Stain!(!Y!!/!!N!)! !3x!PBS!washes!(5!min)! !!!!!3x!PBS!washes!(5!min)!!!!!1.! !!!!2.! !!!!3.! ! !!!!!!!!!1.! !!!!2.! !!!!3.! !!Block!(30!min,!25°C)! 3x!dH2O!(5!min)!!!!!!Per!1!mL!0.1M!PBS:! !!!!1.! !!!!2.! !!!!3.! !!!!!!!!!!4%!NGS!(40!µL)! !Coverslip!!!!!!!!!!1%!Triton!(10!µL)! !Mounting!Media!!!!!!!!!!0.5%!BSA!(.005g)! Preliminary'Outcome'!Primary!(diluted!in!block)! Staining:!!!!Good!!!!Bad!!!!!!! !2!Hrs!(25°C)!/! !Overnight!(4°C)! Repeat:!!!!!!Yes!!!!!!!No!!Imaging!Microscope:! ! Objective:! ! Date:! !
Label'1' Label'2' Label'3' Label'4'Laser/Cube:! ! Laser/Cube:! ! Laser/Cube:! ! Laser/Cube:! !Notes:! ! Notes:! ! Notes:! ! Notes:! !General!Imaging!Comments:! !!Analysis!
Hypothesis'Test' Results'!!!!
!
Program'&'Method'!!!!!Outcome:! !
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Appendix 3: Data manipulation and analysis using R 
Overview of using scripts in R 
R is a powerful statistical language that is open source and widely supported. 
Data analysis in R involves writing scripts, which are algorithms involving step-by-step 
instructions that the software uses to analyze data and plot graphs. Accordingly, once a 
script is written to perform an analysis, new datasets can be analyzed (or old datasets 
can be re-analyzed) in exactly the same way by running the new data through the old 
script. This ensures that the same statistical tests are run in the same way on every 
dataset that you analyze. It also means that, after a script is initially developed, 
subsequent data analysis takes only as long as your computer takes to process the 
data. 
R does require data to be stored in particular ways in order for it to read files 
correctly. All of the data files used in the scripts that I have developed should be .csv 
files, and the first row of the dataset should be the titles of each column. The easiest 
way to compile .csv files is with Microsoft Excel or any other spreadsheet-based 
program; enter the data, and then choose file -> Save As and choose “.csv” from the 
menu. The .csv files also need to be structured in the same way, with the same names 
for each column; names are case sensitive. A brief description of how to compile data to 
used by each script is found at the start of that section. 
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R Scripts for Chapter 2 
Optimizing the measuring interval for tracking cell migration 
Scripts are organized in the same fashion as those for the migration analysis. 
See description found on page 305 for more information. 
library(ggplot2) 
library(reshape) 
library(multcomp) 
library(car) 
library(nlme) 
 
### Load and sort data ----------------------------------------- 
# as of 6-26-15, use data files labeled 
# Tracks.csv and Points(6-26-15).csv 
points1 <- read.csv(file.choose(), 
                    header = TRUE 
                    ) 
points1 <- points1[!is.na(points1$vel), 
                   c("EF", 
                     "Position", 
                     "FrameInterval", 
                     "TrackID", 
                     "PointID", 
                     "hours", 
                     "vel", 
                     "dir" 
                     ) 
                   ] 
points1$FrameInterval <- factor(points1$FrameInterval) 
 
points1$EF <- factor(points1$EF) 
levels(points1$EF) <- paste(levels(points1$EF), 
                            "mV/mm" 
                            ) 
 
tracks1 <- read.csv(file.choose(), 
                    header = TRUE 
                    ) 
tracks2 <- tracks1 
names(tracks2)[c(4:8)] <- c(3, 6, 15, 30, 60) 
 
tracks2 <- melt(tracks2, 
                id = c("EF", 
                       "Position", 
                       "TrackID" 
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                       ), 
                variable_name = "interval" 
                ) 
tracks2$interval <- factor(tracks2$interval, 
                           levels(tracks2$interval), 
                           ordered = TRUE 
                           ) 
 
tracks2$EF <- factor(tracks2$EF) 
levels(tracks2$EF) <- paste(levels(tracks2$EF), 
                            "mV/mm" 
                            ) 
 
# mixed effects model -------------------------- 
t2 <- s1h 
t2$id <- paste(t2[,1],t2[,2],t2[,4], sep=".") 
 
# random effects model and post-hoc test for 0 mV/mm 
lr0 <- lme(vel ~ FrameInterval, 
           random = ~ 1|id, 
           data = t2[t2$EF == levels(t2$EF)[1],], 
           method = "REML" 
           ) 
lr0 
lrs0 <- summary(lr0) 
lrs0 
lr0.anova <- anova(lr0) 
lr0.anova 
 
tuk.lr0 <- glht(lr0, 
                linfct = mcp(FrameInterval = "Tukey") 
                ) 
tuk.lrs0 <- summary(tuk.lr0) 
tuk.lr0 
tuk.lrs0 
 
# random effects model and post-hoc test for 400 mV/mm 
lr400 <- lme(vel ~ FrameInterval, 
             random = ~1|id, 
             data = t2[t2$EF == levels(t2$EF)[2],], 
             method = "REML" 
             ) 
lr400 
lrs400 <- summary(lr400) 
lrs400 
lr400.anova <- anova(lr400) 
lr400.anova 
 
tuk.lr400 <- glht(lr400, 
                  linfct = mcp(FrameInterval = "Tukey") 
                  ) 
tuk.lr400 
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tuk.lrs400 <- summary(tuk.lr400) 
tuk.lrs400 
 
# evaluate constant variance using residuals 
# i.e. Levene test for heteroscedasticity 
# 0 mV/mm 
leveneTest(y = residuals(lr0), 
           group = lr0$data$FrameInterval, 
           center = "mean" 
           ) 
# 400 mV/mm 
leveneTest(y = residuals(lr400),  
           group = lr400$data$FrameInterval, 
           center = "mean" 
           ) 
 
# plots of 0 & 400 mV/mm 
opar <- par(no.readonly = TRUE) 
par(mfrow = c(1,2), 
    mar = c(5, 4, 6, 2) 
    ) 
plot( 
  cld(tuk.lr0), 
  col = "lightgrey", 
  xlab = "Tracking Intervals", 
  ylab = expression(paste("Cell Speed (", mu, "m / hour)")), 
  sub = levels(t2$EF)[1] 
  ) 
plot( 
  cld(tuk.lr400), 
  col = "lightgrey", 
  xlab = "Tracking Intervals", 
  ylab = expression(paste("Cell Speed (", mu, "m / hour)")), 
  sub = levels(t2$EF)[2] 
  ) 
par <- opar 
rm(opar) 
Migration analysis 
Migration analysis (including “Optimizing the measuring interval for tracking cell 
migration”): track cells in time-lapse videos using the ImageJ plugin MTrackJ. (Make 
sure that the time interval and distance unit in the image properties is appropriate.) 
When tracking is finished, click “measure.” Two datasets will appear: one labeled 
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“points” with data corresponding to each position that was clicked during tracking, and 
one labeled “tracks” that has summary statistic for each track (i.e. cell). The migration 
scripts use the “points” datasets from MTrackJ, including the same column labels. In 
addition, 3 columns labeled “Experiment” “Position” and “EF” must be added at the start 
of the dataset. (For these analyses, I made separate datasets for cells tracked before 
and after the onset of the EF.) 
### Load Packages ---------------------------------------------------- 
library(circular) 
library(ggplot2) 
library(pastecs) 
library(reshape) 
library(multcomp) 
library(grid) 
 
options(digits = 3)         # prints 3 significant figures 
 
# Define Functions --------------------------------------------------- 
 
data.subsample <- function(dataset, 
                           size, 
                           group 
                           ) { 
  data1 <- dataset 
  data.subset <- data.frame() 
  data1$factor <- as.factor(group) 
   
  for (i in 1:length(names(table(data1$factor)))) { 
    sub1 <- sample(x = names(table(data1$id[data1$factor == 
                            names(table(data1$factor))[i]])), 
                   size = size 
                   ) 
    data.subset <- rbind(data.subset, 
                         data1[data1$id %in% sub1, -ncol(data1)] 
                         ) 
  } 
  data.subset 
} 
 
id.create <- function(dataset) { 
  paste(dataset[, "Experiment"], 
        dataset[, "Position"], 
        dataset[, "EF"], 
        dataset[, "TID"], 
        sep = "." 
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        ) 
} 
 
# n = number of points selected per time, per group 
# interval = how often the points are plotted 
points.subset <- function(dataset, 
                          n,  
                          t.start = 0, 
                          t.end = 12, 
                          interval = 0.25, 
                          group = "ef.factor" 
                          ) { 
  # sub-samples individual data points within each group 
  data1 <- dataset 
  levels1 <- names(table(data1[, group])) 
  times <- seq(from = t.start, 
               to = t.end, 
               by = interval 
               ) 
  output1 <- data.frame() 
   
  for (i in 1:length(levels1)) { 
    ef1 <- levels1[i] 
     
    for (j in 1:length(times)) { 
      t1 <- times[j] 
      dsub <- data1[data1[ , group] == ef1 & data1$time == t1, ] 
      id1 <- c(1:nrow(dsub)) 
      sub1 <- sample(x = id1, 
                     size = n, 
                     replace = FALSE 
                     ) 
      dsub <- dsub[sub1, ] 
      output1 <- rbind(output1, 
                       dsub 
                       ) 
    } 
  } 
  output1     
} 
 
position.normalize <- function(dataset, 
                               t.start, 
                               t.end 
                               ) { 
  data1 <- dataset 
  data1$id <- id.create(data1) 
  data1 <- t.subset(dataset = data1, 
                    t.start = t.start, 
                    t.end = t.end 
                    ) 
  data1$t.norm <- data1$time - t.start 
 308 
 
  data1$x.norm <- NA 
  data1$y.norm <- NA 
   
  for (i in 1:length(names(table(data1$id)))) { 
    cell.id <- names(table(data1$id))[i] 
     
    x0 <- data1$x..micron.[data1$id == cell.id &  
                               data1$time == t.start] 
    y0 <- data1$y..micron.[data1$id == cell.id &  
                               data1$time == t.start] 
     
    data1$x.norm[data1$id == cell.id] <-  
          data1$x..micron.[data1$id == cell.id] - x0 
    data1$y.norm[data1$id == cell.id] <-  
          y0 - data1$y..micron.[data1$id == cell.id] 
  } 
  data1 
} 
 
t.subset <- function(dataset, 
                     t.start, 
                     t.end 
                     ) { 
  data1 <- dataset[(dataset$time >= t.start) &  
                   (dataset$time <= t.end), 
                   ] 
  cell.id <- data.frame("cell" = names(table(data1$id))) 
   
  for (i in 1:nrow(cell.id)) { 
    cell.id$t.min[i] <-  
          min(data1$time[data1$id == cell.id$cell[i]]) == t.start 
    cell.id$t.max[i] <-  
          max(data1$time[data1$id == cell.id$cell[i]]) == t.end 
  } 
  cells.to.keep <- cell.id$cell[cell.id$t.min & cell.id$t.max ] 
  data.new <- data1[data1$id %in% cells.to.keep &  
                    data1$time >= t.start & data1$time <= t.end, 
                    ] 
} 
 
vel.sub <- function(dataset, 
                    t.start = 0, 
                    t.end = 12, 
                    ef = "ef.factor", 
                    time = "time", 
                    speed = "speed", 
                    dir = "dir" 
                    ) { 
  data1 <- dataset 
  data1 <- data1[!is.na(data1[, speed]) & data1[, time] <=  
          t.end & data1[, time] >= t.start & data1[, speed] != 0, 
                 c(ef, 
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                   time, 
                   speed, 
                   dir 
                   ) 
                 ] 
  data1[, dir][data1[, dir] < 0] <-  
          data1[, dir][data1[, dir] < 0] + 360 
  data1 
} 
 
# Load Data ---------------------------------------------------------- 
mig1 <- read.csv(file.choose(), 
                 header = TRUE 
                 ) 
# mig2 is the data set that will be used to plot cell tracks 
mig2 <- mig1 
mig1$time[mig1$EF == 0] <- mig1$time[mig1$EF == 0] - 0.5 
mig1.baseline <- read.csv(file.choose(), 
                          header = TRUE 
                          ) 
mig1 <- rbind(mig1.baseline, 
              mig1 
              ) 
 
mig1R <- read.csv(file.choose(), 
                  header = TRUE 
                  ) 
mig1R.baseline <- read.csv(file.choose(), 
                           header = TRUE 
                           ) 
mig1R$EF <- "400(R)" 
mig1R.baseline$EF <- "400(R)" 
mig1R <- rbind(mig1, 
               mig1R, 
               mig1R.baseline[mig1R.baseline$time == 0,] 
               ) 
rm(mig1.baseline, mig1R.baseline) 
 
# create a variable for EF strengths that serves as a labeled factor 
mig1$ef.factor <- as.factor(mig1$EF) 
mig2$ef.factor <- as.factor(mig2$EF) 
mig1R$ef.factor <- as.factor(mig1R$EF) 
 
### Create dataframe for velocity analysis --------------------------- 
# mig.vel stands for "migration data for analyzing velocity" 
# excludes any time points greater than 12 hours 
mig.vel <- vel.sub(mig1) 
 
# make separate database for directionality double-plot so that dir 
variable is not coerced into class circular 
mig.vel1 <- vel.sub(mig1R) 
levels(mig.vel1$ef.factor) <- paste(levels(mig.vel1$ef.factor), 
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                                    "mV/mm" 
                                    ) 
 
# coerce directional data into circular 
mig.vel$dir <- as.circular(mig.vel$dir, 
                           type = "angles", 
                           units = "degrees", 
                           template = "none", 
                           modulo = "2pi", 
                           zero = 0, 
                           rotation = "clock" 
                           ) 
 
### aggregate mig.vel into dataframe for summary statistics ---------- 
  # create dataset of factor levels (EF level x time) 
mig.vel.stats <- aggregate(mig.vel[, 3], 
                          by = list(ef.factor = mig.vel$ef.factor, 
                                    time = mig.vel$time 
                                    ), 
                          FUN = mean 
                          )[, c(1:2)] 
  # create dataset of summary statistics pertaining to migration 
mig.spd.stats <- as.data.frame( 
  aggregate(mig.vel[, 3], 
            by = list(ef.factor = mig.vel$ef.factor, 
                      time = mig.vel$time 
                      ), 
            FUN = function(x) c(n = length(x), 
                                mean.speed = mean(x), 
                                sd.speed = stats::sd(x), 
                                sem.speed = 
                                  as.numeric(stat.desc(x)["SE.mean"]), 
                                ci.95.speed = 
                             as.numeric(stat.desc(x)["CI.mean.0.95"]), 
                                med.speed = median(x), 
                                q25 = as.numeric(quantile(x, 0.25)), 
                                q75 = as.numeric(quantile(x, 0.75)) 
                                ) 
            )[,3] 
  ) 
 
# create dataset of summary statistics pertaining to direction 
mig.dir.stats <- as.data.frame( 
  aggregate(mig.vel[!is.na(mig.vel$dir), 4],                               
# !is.na(mig.vel$dir) omits any directionality data point 
# labeled NA from the analysis, which would otherwise cause 
# the entire function to return NA 
            by = list(ef.factor = 
mig.vel$ef.factor[!is.na(mig.vel$dir)], 
                      time = mig.vel$time[!is.na(mig.vel$dir)] 
                      ), 
            FUN = function(x) c(rayleigh.p =  
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                                 as.numeric(rayleigh.test(x)$p.value), 
                                mean.dir =  
                                 as.numeric(mle.vonmises(x)$mu), 
                                             # estimated mean 
                                             # direction 
                                sd.dir = deg(sd(x)), 
                                se.mu.dir = 
                                  as.numeric(mle.vonmises(x)$se.mu), 
                                            # standard error of the 
                                            # mean direction estimate 
                                kappa.dir = 
                                  as.numeric(mle.vonmises(x)$kappa), 
                                            # kappa parameter 
                                            # (concentration) 
                                se.kappa.dir = 
                                  as.numeric(mle.vonmises(x)$se.kappa) 
                                         # standard error of the kappa 
                                         # parameter (concentration) 
                                ) 
            )[, 3] 
  ) 
 
  # combine with statistics summary 
mig.vel.stats <- cbind(mig.vel.stats,  
                       mig.spd.stats, 
                       mig.dir.stats 
                       ) 
  # remove unnecessary datasets 
rm(mig.spd.stats, 
   mig.dir.stats 
   ) 
   
# store this original mig.vel dataset 
mig.vel.stats.original <- mig.vel.stats 
 
 
# create dataset of rayleigh results 
  # include a variable indicating whether the test is significant 
  # TRUE/FALSE depending on significance of test 
  # Bonferroni correction built into analysis  
  # (i.e. threshold for significance is divided by  
  # the number of factor levels) 
mig.vel.stats$r.is.signif <- mig.vel.stats$rayleigh <= 
    .05/(length(levels(mig.vel.stats$ef.factor)) * 4  # number of EF 
                                                      # strengths 
                                                                   
length(table(mig.vel.stats$time))    # number of time points 
                                                            ) 
# convert all circular statistical results to NA if  
# the rayleigh test reveals that the time point is non-significant 
mig.vel.stats[!mig.vel.stats$r.is.signif, c(12:16)] <- NA 
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# character string of statistical results 
mig.vel.stats$r.text <- paste("p =", signif(mig.vel.stats$rayleigh, 
digits = 3)) 
 
### Display Results of Summary Stats --------------------------------- 
# display the results of the rayleigh tests 
mig.vel.stats[, c(1, 2, 11, 17)] 
 
# display the results of the rayleigh tests for specific EF strengths 
mig.vel.stats[mig.vel.stats$ef.factor == 0, c(1, 2, 11, 17, 12)] 
 
# tabular output of rayleigh results 
xtabs(r.is.signif ~ ef.factor + time, 
      data = mig.vel.stats 
      ) 
 
# Plot mean speed by time with 95% CI ------------------------ 
mspeed.plot <- ggplot(data = mig.vel.stats, 
                      aes(x = time, 
                          y = mean.speed, 
                          fill = ef.factor, 
                          shape = ef.factor 
                          ) 
                      ) + 
  geom_line(size = 1.5) + 
  geom_point(size = 7) + 
  scale_shape_manual(values = c(21, 19, 15, 22)) + 
  scale_fill_manual(values = c("#FFBA00", 
                               "black", 
                               "black", 
                               "#FFBA00" 
                               ) 
                    ) + 
  coord_cartesian(xlim = c(0, 12.15), 
                  ylim = c(5, 30) 
                  ) + 
  scale_x_continuous(breaks = seq(0, 12, 
                                  by = 1 
                                  ) 
                     ) + 
  scale_y_continuous(breaks = seq(0, 30, 
                                  by = 5 
                                  ) 
                     ) + 
  theme_bw(base_size = 28) + 
  theme(legend.position = c(1, .95), 
        legend.justification = c(1, 1), 
        legend.direction = "horizontal", 
        panel.border = element_blank(), 
        panel.grid = element_blank(), 
        plot.title = element_blank(), 
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        axis.line = element_line(colour = "black", 
                                 lineend = "square" 
                                 ) 
        ) + 
  labs(y = expression(paste("Cell Speed (", mu, "m / hour)")), 
       x = "Duration of Electric Field Exposure (hours)", 
       title = "Electric Fields Affect  
                              Cortical Astrocyte Migration Speed", 
       shape = "EF (mV / mm)", 
       fill = "EF (mV / mm)" 
       ) + 
  geom_errorbar(aes(ymin = mean.speed - sem.speed, 
                    ymax = mean.speed + sem.speed 
                    ), 
                width = 0,                    # width of the bar-caps 
                size = 1,                     # line thickness 
                colour = "black" 
                ) + 
  geom_point(size = 7)  
mspeed.plot 
 
### Bar Plot of Mean Speed at Certain Times -------------------------- 
# specify time and subset the data 
time1 <- c(0, .5, 4) 
mig.vel.stats.sub <- mig.vel.stats[mig.vel.stats$time %in% time1, ] 
mig.vel.stats.sub$time <- paste(mig.vel.stats.sub$time, 
                          "Hours" 
                          ) 
# create bar plot 
speed.bar.plot <- ggplot(data = mig.vel.stats.sub, 
                         aes(x = ef.factor, 
                             y = mean.speed, 
                             fill = ef.factor 
                             ) 
                         ) +  
  geom_bar(stat = "identity") +  
  geom_errorbar(aes(ymin = mean.speed - sem.speed, 
                    ymax = mean.speed + sem.speed 
                    ), 
                width = 0.25, 
                size = 1 
                ) + 
  facet_grid(. ~ time) + 
  scale_y_continuous(breaks = seq(0, 50, 
                                  by = 5 
                                  ) 
                     ) + 
  coord_cartesian(ylim = c(5, max(mig.vel.stats.sub$mean.speed + 
                              mig.vel.stats.sub$sem.speed) + 6)) + 
  labs(y = expression(paste("Mean Speed (", mu, "m / hour)")), 
       x = "Electric Field Strength (mV/mm)" 
       ) + 
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  theme_bw(base_size = 28) + 
  theme(legend.position = "none", 
        strip.background = element_rect(size = 1.5, 
                                        fill = "white", 
                                        colour = "white" 
                                        ), 
        panel.grid = element_blank(),# Remove major & minor grid lines 
        panel.border = element_rect(size = 1.5, 
                                    colour = "black" 
                                    ) 
        ) + 
  scale_fill_grey() 
speed.bar.plot 
rm(time1, mig.vel.stats.sub) 
   
### Analysis of speed at a certain times ------------------------ 
# Statistical Analysis of differences between groups 
time1 <- 4 
mig.vel.sub <- mig.vel[mig.vel$time == time1, ] 
 
means1 <- aggregate(mig.vel.sub$speed, 
                    by = list(mig.vel.sub$ef.factor), 
                    FUN = mean 
                    ) 
means1 
fit1 <- aov(mig.vel.sub$speed ~ mig.vel.sub$ef.factor) 
summary(fit1) 
 
plot(TukeyHSD(fit1)) 
TukeyHSD(fit1) 
rm(mig.vel.sub, means1, fit1, time1) 
 
# Analyze change in speed over time within a given EF 
time1 <- c(0, .5, 4, 6) 
mig.vel.sub <- mig.vel[mig.vel$time %in% time1 & 
                            mig.vel$ef.factor == 400,] 
 
aggregate(mig.vel.sub$speed,                # Show means for each 
factor level 
          by = list(mig.vel.sub$time), 
          FUN = mean 
          ) 
fit <- aov(mig.vel.sub$speed ~ as.factor(mig.vel.sub$time)) 
summary(fit) 
 
TukeyHSD(fit) 
plot(TukeyHSD(fit)) 
rm(time1, mig.vel.sub, fit) 
 
### Plot Direction by time (repeated x-axis) ------------------------- 
# if you want to plot all data points (not a subset) 
mig.sub <- mig.vel1 
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# if you want to plot a subset of data points at each time 
mig.sub <- points.subset(dataset = mig.vel1, 
                         n = 45 
                         ) 
 
## Generate plot  
dir2.plot <- {ggplot(data = mig.sub, 
                    aes(x = c(dir, dir+360), 
                        y = c(time, time) 
                        ) 
                    ) + 
  # add  lines to indicate cathode and anode, respectively 
  geom_vline(xintercept = c(90, 270, 90+360, 270+360), 
             colour = rep(c("red", 
                            "blue" 
                            ), 
                          2 
                          ), 
             size = 1.5, 
             alpha = 0.5 
             ) + 
  # Add points 
  geom_point(size = 1.75, 
             alpha = 0.5 
             ) + 
  # Black-White theme elements 
  theme_bw(base_size = 28) + 
  ## facets by EF strength 
  facet_grid(. ~ ef.factor) + 
  coord_cartesian(xlim = c(0, 720), 
                  ylim = c(-.1, 12.1) 
                  ) + 
  scale_x_continuous(breaks = c(90, 270, 90+360, 270+360), 
                     labels = rep(c("A", 
                                    "C" 
                                    ), 
                                  2 
                                  ) 
                     ) + 
  scale_y_continuous(breaks = seq(0, 
                                  12, 
                                  by = 1 
                                  ) 
                     ) + 
  ## Modify axis titles 
  labs(x = "Direction of Astrocyte Migration Relative to the  
                                                  Electric Field", 
       y = "Duration of EF Exposure (hours)", 
       title = "Electric Field Effects on Direction of Cell Migration" 
       ) + 
  # Remove minor grid lines 
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  theme(panel.border = element_rect(colour = "black", 
                                    fill = NA, 
                                    size = 2 
                                    ), 
        panel.grid = element_blank(), 
        panel.margin = unit(1, 
                            "lines" 
                            ), 
        strip.background = element_rect(fill = "white", 
                                        colour = "white", 
                                        size = 1.5 
                                        ), 
        plot.title = element_blank(), 
        axis.title = element_text(size = rel(1)), 
        axis.text.x = element_text(colour = rep(c("red", "blue"), 
                                                2 
                                                ), 
                                   size = rel(1), 
                                   face = "bold" 
                                   ), 
        strip.text = element_text(face = "bold", # modify facet header 
                                  size = rel(1) 
                                  ) 
        ) + 
  # adds a horizontal line to the reverse-current plot to 
  # indicate when the current was changed 
  geom_segment(data = data.frame(xmin = 0, 
                                 xmax = 720, 
                                 ymin = 5.875, 
                                 ymax = 5.875, 
                                 ef.factor = 
levels(mig.sub$ef.factor)[length(levels(mig.sub$ef.factor))] 
                                 ), 
               aes(x    = xmin, 
                   xend = xmax, 
                   y    = ymin, 
                   yend = ymax 
                   ), 
               show_guide = FALSE, 
               colour = "#FFBA00", 
               size = 1.5, 
               linetype = 2 
               )} 
dir2.plot 
 
rm(mig.sub) 
 
# Plot each track, normalized ---------------------------------------- 
t.start <- 0 
t.end <- 6 
n = 30 
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mig2.sub <- position.normalize(dataset = mig2, 
                               t.start = t.start, 
                               t.end = t.end 
                               ) 
 
mig2.sub2 <- data.subsample(dataset = mig2.sub, 
                            size = n, 
                            group = mig2.sub$ef.factor 
                            ) 
levels(mig2.sub2$ef.factor) <-  
                paste(levels(mig2.sub2$ef.factor), " mV/mm") 
                          # change names of the levels  
                          # so the facet labels include "mV/mm" 
 
tracks.plot <- ggplot(data = mig2.sub2, 
                      aes(x = x.norm, 
                          y = y.norm, 
                          group = id 
                          ) 
                      ) + 
  geom_vline(xintercept = 0, 
             colour = "darkgrey" 
             ) + 
  geom_hline(yintercept = 0, 
             colour = "darkgrey" 
             )+ 
  geom_path() + 
  labs(y = expression(paste(mu, "m")), 
       x = expression(paste(mu, "m")) 
       ) +  
  annotate("text", 
           label = "+", 
           size = 15, 
           x = 0,  
           y = -180, 
           colour = "red" 
           ) +  
  annotate("text", 
           label = "-", 
           size = 15, 
           x = 0, 
           y = 180, 
           colour = "blue" 
           ) + 
  facet_grid(. ~ ef.factor) + 
  theme_bw(base_size = 28) + 
  theme(panel.grid = element_blank(), 
        panel.border = element_rect(colour = "black", 
                                    size = 1.5 
                                    ), 
        panel.margin = unit(1, "lines"), 
        strip.background = element_rect(colour = "white", 
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                                        fill = "white" 
                                        ), 
        axis.text = element_text(size = rel(0.75)) 
        ) + 
  coord_fixed(xlim = c(-201, 201), 
              ylim = c(-201, 201) 
              ) + 
  scale_x_continuous(breaks = c(-200, -100, 0, 100, 200), 
                     labels = c("    200", "100", 
                                           "0", "100", "200    ") 
                     ) + 
  scale_y_continuous(breaks = c(-200, -100, 0, 100, 200), 
                     labels = c(200, 100, 0, 100, 200) 
                     ) 
tracks.plot 
 
# Plot Total Displacement of each track ------------------------------ 
end.plot <- ggplot(data = mig2.sub[mig2.sub$time == t.end, ], 
                   aes(x = x.norm, 
                       y = y.norm 
                       ) 
                   ) +  
  facet_grid(. ~ ef.factor) + 
  coord_cartesian(xlim = c(-200, 200), 
                  ylim = c(-200, 200) 
                  ) + 
  theme_bw(base_size = 28) + 
  theme(panel.grid = element_blank(), 
        strip.background = element_rect(fill = "white", 
                                        colour = "white" 
                                        ) 
        ) + 
  geom_vline(xintercept = 0, 
             colour = "darkgrey" 
             ) + 
  geom_hline(yintercept = 0, 
             colour = "darkgrey" 
             ) + 
  labs(y = expression(paste(mu, "m")), 
       x = expression(paste(mu, "m")) 
       ) +  
  annotate("text", 
           label = "+", 
           size = 15, 
           x = 0,  
           y = -180 
           ) +  
  annotate("text", 
           label = "-", 
           size = 15, 
           x = 0, 
           y = 180 
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           ) + 
  scale_x_continuous(breaks = c(-200, -100, 0, 100, 200), 
                     labels = c("    200", "100", "0", 
                                           "100", "200    ") 
                     ) + 
  scale_y_continuous(breaks = c(-200, -100, 0, 100, 200), 
                     labels = c(200, 100, 0, 100, 200) 
                     ) + 
  geom_point() 
end.plot 
Migration following reversal of current 
Scripts are organized in the same fashion as those for the migration analysis. 
See description found on page 305 for more information. 
### Load Packages ---------------------------------------------------- 
library(circular) 
library(ggplot2) 
library(pastecs) 
library(reshape) 
library(multcomp) 
library(grid) 
 
options(digits = 3)         # prints 3 significant figures 
 
# Define functions --------------------------------------------------- 
 
t.subset <- function(dataset, 
                     t.start, 
                     t.end 
                     ) { 
  data1 <- dataset[(dataset$time >= t.start) &  
                        (dataset$time <= t.end),] 
  cell.id <- data.frame("cell" = names(table(data1$id))) 
  for (i in 1:nrow(cell.id)) { 
    cell.id$t.min[i] <- 
         min(data1$time[data1$id == cell.id$cell[i]]) == t.start 
    cell.id$t.max[i] <- 
         max(data1$time[data1$id == cell.id$cell[i]]) == t.end 
  } 
  cells.to.keep <- cell.id$cell[cell.id$t.min & cell.id$t.max ] 
   
  data.new <- data1[data1$id %in% cells.to.keep & 
         data1$time >= t.start & data1$time <= t.end, ] 
} 
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id.create <- function(dataset) { 
  paste(dataset[, "Experiment"], 
        dataset[, "Position"], 
        dataset[, "EF"], 
        dataset[, "TID"], 
        sep = ".") 
} 
 
position.normalize <- function(dataset, 
                               t.start, 
                               t.end 
                               ) { 
  data1 <- dataset 
  data1$id <- id.create(data1) 
  data1 <- t.subset(dataset = data1, 
                    t.start = t.start, 
                    t.end = t.end 
                    ) 
  data1$t.norm <- data1$time - t.start 
  data1$x.norm <- NA 
  data1$y.norm <- NA 
   
  for (i in 1:length(names(table(data1$id)))) { 
    cell.id <- names(table(data1$id))[i] 
     
    x0 <- data1$x..micron.[data1$id == cell.id & 
                                 data1$time == t.start] 
    y0 <- data1$y..micron.[data1$id == cell.id & 
                                 data1$time == t.start] 
     
    data1$x.norm[data1$id == cell.id] <-  
                    data1$x..micron.[data1$id == cell.id] - x0 
    data1$y.norm[data1$id == cell.id] <- 
                     y0 - data1$y..micron.[data1$id == cell.id] 
  } 
  data1 
} 
 
data.subsample <- function(dataset, 
                           size, 
                           group 
                           ) { 
  data1 <- dataset 
  data.subset <- data.frame() 
  data1$factor <- as.factor(group) 
   
  for (i in 1:length(names(table(data1$factor)))) { 
    sub1 <- sample(x = names(table(data1$id[data1$factor == 
                                names(table(data1$factor))[i]])), 
                   size = size 
                   ) 
    data.subset <- rbind(data.subset, 
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                         data1[data1$id %in% sub1, -ncol(data1)] 
                         ) 
  } 
  data.subset 
} 
 
# Load Data --------------------------------------------- 
 
# data set for directionality double-plots 
mig.rev <- read.csv(file.choose(), 
                    header = TRUE 
                    ) 
 
# data set for plotting individual tracks 
mig.rev.tracks <- read.csv(file.choose, 
                           header = TRUE 
                           ) 
 
### Plot Direction by time (repeated x-axis) ------------------------- 
# only copies data if there is a value for speed (i.e. not NA) 
mig.vel.rev1 <- mig.rev[!is.na(mig.rev$speed) & 
                     mig.rev$time <= 12 & mig.rev$time >= 0,  
                 c("EF", 
                   "time", 
                   "speed", 
                   "dir" 
                   ) 
                 ] 
 
# Convert range of angle measures for direction variable 
# new range: 0-360 (degrees) 
mig.vel.rev1$dir[mig.vel.rev1$dir < 0] <- 
                  mig.vel.rev1$dir[mig.vel.rev1$dir < 0] + 360 
 
# if speed == 0, MTrackJ records direction as 0 
# make dir == NA if(speed == 0) 
mig.vel.rev1$dir[mig.vel.rev1$speed == 0] <- NA 
 
## Generate plot 
dir.rev.plot <- 
       ggplot(data = mig.vel.rev1[is.na(mig.vel.rev1$dir) == FALSE,], 
                    aes(x = c(dir, dir+360), 
                        y = c(time, time) 
                        ) 
                    ) + 
  # Add points 
  geom_point(size = 2, 
             alpha = 0.3 
             ) + 
  # Black-White theme elements 
  theme_bw(base_size = 28) + 
  ## facets by EF strength 
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  facet_grid(. ~ EF) + 
  coord_cartesian(xlim = c(0, 720), 
                  ylim = c(-.1, 12.1) 
                  ) + 
  scale_x_continuous(breaks = c(90, 270, 90+360, 270+360), 
                     labels = rep(c("A", 
                                    "C" 
                                    ), 
                                  2 
                                  ) 
                     ) + 
  scale_y_continuous(breaks = seq(0, 
                                  12, 
                                  by = 1 
                                  ) 
                     ) + 
  ## Modify axis titles 
  labs(x = "Direction Relative to the EF", 
       y = "Duration of EF Exposure (hours)" 
       ) + 
  # Remove minor grid lines 
  theme(panel.border = element_rect(colour = "black", 
                                    fill = NA, 
                                    size = 2 
                                    ), 
        panel.grid.minor = element_blank(), 
        strip.background = element_rect(fill = "white", 
                                        colour = "black", 
                                        size = 1.5 
                                        ), 
        plot.title = element_text(size = rel(1.25), 
                                  face = "bold" 
                                  ), 
        axis.title = element_text(size = rel(1)), 
        axis.text.x = element_text(colour = rep(c("black", "black"), 
                                                2 
                                                ), 
                                   size = rel(1), 
                                   face = "bold" 
                                   ), 
        # modify facet header 
        strip.text = element_text(face = "bold", 
                                  size = rel(1) 
                                  ) 
        ) + 
  # remove legend 
  guides(colour = FALSE) + 
  # add colored lines to indicate cathode and anode, respectively 
  geom_vline(xintercept = c(90, 270, 90+360, 270+360), 
             colour = rep(c("black", 
                            "black" 
                            ), 
 323 
 
                          2 
                          ), 
             size = 1, 
             alpha = 0.5 
             ) + 
  # add horizontal line to indicate where the current was reversed 
  geom_hline(yintercept = 5.875, 
             colour = "black", 
             size = 1, 
             linetype = 2 
             ) 
dir.rev.plot 
rm(mig.vel.rev1) 
 
### Plot Direction by time (400-Reverse only) (repeated x-axis) ------ 
# only copies data if there is a value for speed (i.e. not NA) 
mig.vel.rev1 <- mig.rev[!is.na(mig.rev$speed) & 
                            mig.rev$time <= 12 & mig.rev$time >= 0, 
                        c("EF", 
                          "time", 
                          "speed", 
                          "dir" 
                          ) 
                        ] 
 
# Convert range of angle measures for direction variable 
# new range: 0-360 (degrees) 
mig.vel.rev1$dir[mig.vel.rev1$dir < 0] <- 
mig.vel.rev1$dir[mig.vel.rev1$dir < 0] + 360 
 
# if speed == 0, MTrackJ records direction as 0 
# make dir == NA if(speed == 0) 
mig.vel.rev1$dir[mig.vel.rev1$speed == 0] <- NA 
 
## Generate plot 
dir.rev2.plot <- ggplot(data = mig.vel.rev1[is.na(mig.vel.rev1$dir) == 
                           FALSE & mig.vel.rev1$EF == "400-Reverse",], 
                        aes(x = c(dir, dir+360), 
                            y = c(time, time) 
                            ) 
                        ) + 
  # Add points 
  geom_point(size = 2.5, 
             alpha = 0.4 
             ) + 
  # Black-White theme elements 
  theme_bw(base_size = 38) + 
  coord_cartesian(xlim = c(0, 720), 
                  ylim = c(-.1, 12.1) 
                  ) + 
  scale_x_continuous(breaks = c(90, 270, 90+360, 270+360), 
                     labels = rep(c("A", 
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                                    "C" 
                                    ), 
                                  2 
                                  ) 
                     ) + 
  scale_y_continuous(breaks = seq(0, 
                                  12, 
                                  by = 1 
                                  ) 
                     ) + 
  ## Modify axis titles 
  labs(x = "Direction Relative to the EF", 
       y = "Time (hours)" 
       ) + 
  # Remove minor grid lines 
  theme(panel.border = element_rect(colour = "black", 
                                    fill = NA, 
                                    size = 2 
                                    ), 
        panel.grid = element_blank(), 
        axis.text.x = element_text(colour = rep(c("black", "black"), 
                                                2 
                                                ), 
                                   size = rel(1), 
                                   face = "bold" 
                                   ), 
        axis.text.y = element_text(colour = "black", 
                                   size = rel(1)) 
        ) + 
  # remove legend 
  guides(colour = FALSE) + 
  # add colored lines to indicate cathode and anode, respectively 
  geom_vline(xintercept = c(90, 270, 90+360, 270+360), 
             colour = rep(c("black", 
                            "black" 
                            ), 
                          2 
                          ), 
             size = 1, 
             alpha = 0.5 
             ) + 
  # add horizontal line to indicate where the current was reversed 
  geom_hline(yintercept = 5.875, 
             colour = "black", 
             size = 1, 
             linetype = 2 
             ) 
dir.rev2.plot 
rm(mig.vel.rev1) 
 
# Plot Tracks for 400 mV/mm only ------------------------------------- 
t.start <- 3 
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t.end <- 12 
n = 15 
 
mig.rev.norm <- position.normalize(dataset = mig.rev.tracks,  
                                   t.start = t.start, 
                                   t.end = t.end 
                                   ) 
 
n = 10 
norm.sub <- data.subsample(dataset = mig.rev.norm, 
                           size = n, 
                           group = mig.rev.norm$EF 
                           ) 
 
tracks.plot <- ggplot(data = norm.sub, 
                      aes(x = x.norm, 
                          y = y.norm, 
                           
                          group = id 
                          ) 
                      ) +  
  geom_vline(xintercept = 0, 
             colour = "darkgrey" 
             ) + 
  geom_hline(yintercept = 0, 
             colour = "darkgrey" 
             )+ 
  geom_path() + 
  facet_grid(. ~ EF) + 
  theme_bw(base_size = 28) + 
  theme(panel.grid = element_blank(), 
        panel.border = element_rect(colour = "black", 
                                    size = 1.5 
                                    ), 
        panel.margin = unit(1, "lines"), 
        strip.background = element_rect(colour = "white", 
                                        fill = "white" 
                                        ), 
        axis.title = element_blank(), 
        axis.text = element_text(size = rel(0.75)) 
        ) + 
  coord_fixed(xlim = c(-201, 201), 
              ylim = c(-201, 201) 
              ) + 
  scale_x_continuous(breaks = c(-200, -100, 0, 100, 200), 
                     labels = c("    200", "100", "0", "100", "200    
") 
                     ) + 
  scale_y_continuous(breaks = c(-200, -100, 0, 100, 200), 
                     labels = c(200, 100, 0, 100, 200) 
                     ) 
tracks.plot 
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Orientation of proliferation 
Data are collected using ImageJ. Column names are: “Cell” [i.e. the cell type, e.g. 
cerebellar or cortical, in reference to astrocytes], “Experiment” “Position” “EF” 
“Measurement” “Angle” “Frame” and “Length”. 
The second part of this script includes a graph that plots the orientation of 
proliferation over time. This graph was used for data exploration, but was not included in 
the analysis presented in this dissertation. 
### Load Packages ---------------------------------------------------- 
library(circular)     # For circular stats (seems more thorough than 
CircStats) 
library(survival) 
library(ggplot2) 
library(grid) 
 
### Load Data -------------------------------------------------------- 
prolif1 <- read.csv(file.choose(), 
                    header = TRUE 
                    ) 
 
## limit prolif1 data range to 12 hours (241 frames) 
prolif1 <- prolif1[prolif1$Frame <= 241,] 
 
### Data Management -------------------------------------------------- 
# Create time variable (hours) 
prolif1$Time <- (prolif1$Frame - 1) / 20 
 
# Convert angle measurements into axial measurements 
# Range from 0 - 180 degrees (original range -180 to +180) 
prolif1$Axial[prolif1$Angle < 0] <- prolif1$Angle[prolif1$Angle < 0] + 
180 
prolif1$Axial[prolif1$Angle >= 0] <- prolif1$Angle[prolif1$Angle >= 0] 
prolif1$Axial[prolif1$Angle == 180] <- prolif1$Angle[prolif1$Angle == 
180] - 180 
head(prolif1) 
 
# Determine whether alignment exists --------------------------------- 
# note: change the number for the ef1 variable to 
# calculate the alignment for each EF strength 
# factor levels: 0, 4, 40, 400 
ef1 <- 4 
a1 <- circular(prolif1$Axial[prolif1$EF == ef1],  
               units = "degrees",  
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               modulo = "pi" 
               ) 
rayleigh.test(2 * a1)[[2]] 
rayleigh.test(sample(2 * a1, 
                     size = 30 
                     ) 
              )[[2]] 
length(a1) 
mle.vonmises(a1)         # numbers in parentheses of results are the 
standard error of those results 
mean.circular(a1) 
deg(sd.circular(a1)) 
 
# Distribution of Orientation of Mitotic Axis ------------------------ 
prolif1.dir <- ggplot(data = prolif1, 
                      aes(x = c(Axial, Axial + 180), 
                          y=..density.. 
                          ) 
                      ) +  
  geom_histogram(binwidth = 15, 
                 size = .75, 
                 fill = "grey" 
                 ) +  
  geom_line(stat = "density") + 
  coord_cartesian(xlim = c(0, 360), 
                  ylim = c(0, .007) 
                  ) + 
  facet_grid(. ~ EF) + 
  theme_bw(base_size = 28) + 
  scale_x_continuous(breaks = seq(0, 360, 
                                  by = 90 
                                  ), 
                     labels = c("C", "", "A", "", "C") 
                     ) + 
  theme(panel.border = element_rect(colour = "black", 
                                    size = 2 
                                    ), 
        panel.grid = element_blank(), 
        panel.margin = unit(1.25, 
                            "lines" 
                            ), 
        strip.background = element_rect(colour = "white", 
                                        size = 1.5, 
                                        fill = "white" 
                                        ), 
        axis.ticks.y = element_blank(), 
        axis.text.y = element_blank() 
        ) + 
  labs(x = "Orientation of the axis of cell division", 
       y = "Relative number of cells       " 
       ) 
prolif1.dir 
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# ggplot2 Orientation of Division over Time -------------------------- 
orient1 <- ggplot(data = prolif1, 
                  aes(x = c(Axial, Axial + 180), 
                      y = c(Time, Time) 
                      ) 
                  ) + 
  ## add points for each speed value 
  geom_point(data = prolif1, 
             size = 2, 
             alpha = 0.6 
             ) + 
  scale_x_continuous(limits = c(0, 360), 
                     breaks = seq(0, 
                                  360, 
                                  by = 90 
                                  ), 
                     labels = c("", 
                                "Cathode", 
                                "", 
                                "Anode", 
                                "" 
                                ) 
                     ) + 
  scale_y_continuous(limits = c(0, 12), 
                     breaks = seq(0, 
                                  12, 
                                  by = 2 
                                  ) 
                     ) + 
  ## Modify axis titles 
  labs(x = "Orientation of Axis of Cell Division", 
       y = "Duration of Electric Field Exposure\n(hours)", 
       title = "Electric Field Effects on the Orientation of Cell 
Division over Time\n(horizontal axis repeated)" 
       ) + 
  ## facets by EF strength 
  facet_grid(. ~ EF) + 
  # colour scheme is black and white 
  theme_bw() +  
  # Remove minor grid lines 
  theme(panel.grid.minor = element_blank()) + 
  # add colored lines to indicate cathode and anode, respectively 
  geom_vline(xintercept = c(90, 270), 
             colour = c("red", "blue") 
             ) 
orient1 
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Proliferation – BrdU experiments 
Only summary statistics are needed for this data file; these were calculated in the 
statistical software JMP v. 11.0.0. Column names are: “Time” “EF” “N Rows” 
“Mean(Percent)” “Median(Percent)” and “Std Err(Percent)”. 
library(ggplot2) 
 
brdu1 <- read.csv(file.choose(), 
                  header = T 
                  ) 
brdu2 <- brdu1 
brdu2$EF <- factor(brdu2$EF) 
brdu2$Time <- factor(brdu2$Time) 
levels(brdu2$Time) <- paste(levels(brdu2$Time), 
                            "Hours" 
                            ) 
levels(brdu2$Time) 
 
# Bar Plot ----------------------------------------------------------- 
brdu.plot <- ggplot(data = brdu2, 
                    aes(x = EF, 
                        y = Mean.Percent., 
                        fill = EF 
                        ) 
                    ) +  
  geom_bar(stat = "identity") + 
  scale_fill_grey() +  
  facet_grid(. ~ Time) + 
  labs(y = "BrdU-positive Cells (%)", 
       x = "Electric Field Strength (mV/mm)" 
       ) + 
  theme_bw(base_size = 28) +  
  theme(legend.position = "none", 
        panel.border = element_rect(colour = "black", 
                                    size = 1.25 
                                    ), 
        panel.grid = element_blank(), 
        strip.background = element_rect(fill = "white", 
                                        colour = "white" 
                                        ), 
        axis.ticks.x = element_blank() 
        ) + 
  coord_cartesian(ylim = c(0, max(brdu2$Mean.Percent. + 
brdu2$Std.Err.Percent.) + 8)) + 
  geom_errorbar(aes(ymin = Mean.Percent. - Std.Err.Percent., 
                    ymax = Mean.Percent. + Std.Err.Percent. 
                    ), 
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                width = 0.25, 
                size = 0.75 
                ) 
brdu.plot 
 
Morphology – FFT experiments 
Only 3 columns are needed for this data faile: “EF” “Angle” and “Value”. 
library(ggplot2) 
library(grid) 
 
# Load data 
fft1 <- read.csv(file.choose(), 
                 header = TRUE 
                 ) 
 
# change the number in this variable to plot different EF intensities 
ef.level1 <- 400 
 
fft.plot <- ggplot(data = fft1[fft1$EF == ef.level1,], 
                   aes(x = Angle, 
                       y = Value, 
                       ) 
                   ) + 
  geom_line(size = 2) + 
  coord_cartesian(xlim = c(0, 360), 
                  ylim = c(0, max(fft1$Value) + 1) 
                  ) + 
  scale_x_continuous(breaks = c(90, 180, 270, 360), 
                     labels = c("Anode", "", "Cathode", "") 
                     ) + 
  scale_y_continuous(breaks = NULL) + 
  labs(x = "Orientation (Relative to the EF)", 
       y = "Relative Pixel Alignment      " 
       ) + 
  theme_bw(base_size = 24) + 
  theme(legend.position = "bottom", 
        panel.border = element_blank(), 
        panel.grid.major = element_blank(), 
        axis.line = element_line(colour = "black", 
                                 lineend = "square", 
                                 size = 2 
                                 ), 
        axis.ticks.x = element_line(size = 2,  
                                    lineend = "square"  
                                    ), 
        axis.ticks.length = unit(.4, "cm"), 
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        axis.ticks.margin = unit(.2, "cm") 
        ) 
fft.plot 
Nuclear morphology 
### Load Packages ---------------------------------------------------- 
library(circular) 
library(ggplot2) 
 
### Load Data -------------------------------------------------------- 
nuc1 <- read.csv(file.choose(), 
                 header = TRUE 
                 ) 
head(nuc1) 
 
t1 <- 12 
boxplot(nuc1$AR[nuc1$time == t1] ~ 
                                as.factor(nuc1$EF[nuc1$time == t1]), 
        main = "Circularity Scores" 
        ) 
fit1 <- aov(nuc1$AR[nuc1$time == t1 & nuc1$Experiment == 2] ~ 
as.factor(nuc1$EF[nuc1$time == t1 & nuc1$Experiment == 2])) 
summary(fit1) 
TukeyHSD(fit1) 
plot(TukeyHSD(fit1)) 
rm(t1, fit1) 
 
# Determine whether nuclei are aligned ------------------------------- 
ef1 <- 0      # specify EF level for the test 
t1 <- 12 
 
# create a circular data set 
a1 <- circular(nuc1$Angle[nuc1$EF == ef1 & nuc1$time == t1],  
               units = "degrees",  
               modulo = "pi" 
               ) 
rayleigh.test(sample(2 * a1, 
                     size = 30 
                     ) 
              )[[2]] 
length(a1) 
mle.vonmises(a1)         # numbers in parentheses of results are the 
                         # standard error of those results 
mean.circular(a1) 
deg(sd.circular(a1)) 
 
# compare kappa between groups 
n1 <- 100 
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equal.kappa.test(circular(c(sample(nuc1$Angle[nuc1$EF == 400 & 
                                      nuc1$time == 12], 
                                   n1 
                                   ), 
                            sample(nuc1$Angle[nuc1$EF == 400 & 
                                      nuc1$time == 72], 
                                   n1 
                                   ) 
                            ), 
                          units = "degrees", 
                          modulo = "pi" 
                          ), 
                 c(rep(12, n1), 
                   rep(72, n1) 
                   ) 
                 ) 
 
rm(a1, ef1, n1, t1) 
 
# Graph alignment distributions -------------------------------------- 
t1 <- 12 
nuc1.dir <- ggplot(data = nuc1[nuc1$time == t1,], 
                   aes(x = c(Angle, Angle + 180)) 
                   ) +  
  geom_histogram(binwidth = 15, 
                 size = .75, 
                 fill = "grey" 
                 ) + 
  facet_grid(. ~ EF) + 
  coord_cartesian(xlim = c(-20, 380), 
                  ylim = c(0, 280) 
                  ) + 
  theme_bw(base_size = 28) + 
  scale_x_continuous(breaks = seq(0, 360, 
                                  by = 90 
                                  ), 
                     labels = c("C", "", "A", "", "C") 
                     ) + 
  theme(panel.border = element_rect(colour = "black", 
                                    size = 2 
                                    ), 
        panel.grid = element_blank(), 
        strip.background = element_rect(colour = "white", 
                                        size = 1.5, 
                                        fill = "white" 
                                        ) 
        ) + 
  labs(x = "Orientation Relative to the Electric Field", 
       y = "Number of Nuclei" 
       ) 
nuc1.dir 
rm(t1) 
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# Compare Nucleus Aspect Ratio --------------------------------------- 
t1 <- 72 
exp1 <- c(6, 10) 
nuc2 <- nuc1[nuc1$time == t1 & nuc1$Experiment %in% exp1,] 
 
fit1 <- aov(nuc2$AR ~ as.factor(nuc2$EF)) 
summary(fit1) 
plot(TukeyHSD(fit1)) 
TukeyHSD(fit1) 
 
rm(t1, exp1, nuc2) 
 
# Graph Nucleus Aspect Ratio ----------------------------------------- 
t1 <- 72 
exp1 <- c(6, 10) 
nuc2 <- nuc1[nuc1$time == t1 & nuc1$Experiment %in% exp1,] 
 
ar1.plot <- ggplot(data = nuc2, 
                   aes(x = as.factor(EF), 
                       y = AR 
                       ) 
                   ) + 
  geom_boxplot() + 
  theme_bw(base_size = 28) + 
  theme(panel.grid = element_blank(), 
        panel.border = element_blank(), 
        axis.line = element_line(colour = "black", 
                                 lineend = "square" 
                                 ) 
        ) + 
  labs(x = "Electric Field Strength (mV/mm)", 
       y = "Aspect Ratio" 
       ) 
rm(t1, exp1, nuc2) 
R Scripts for Chapter 3 
For the cerebellar astrocyte analyses, the structure of the data files and the code 
for the analyses in R are identical for each of the analyses that were done for cortical 
astrocytes in chapter two. The only exception is a minor modification for the analysis of 
migration data. The migration analysis was identical, but the data were compiled slightly 
differently for the cortical astrocytes than they were for the cerebellar astrocytes. 
Specifically, the cortical astrocyte migration data for the current-reversal analysis were 
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stored in a separate .csv file, while all of the migration data for the cerebellar astrocytes 
were stored in the same .csv file. The changes in the script for data loading reflects the 
fact that only 1 .csv file had to be loaded, and a second data subset that did not contain 
the current reversal group was created. The following script is for loading the cerebellar 
astrocyte data only; the rest of the analysis (including the libraries, functions, statistical 
tests, and graphs) are identical. 
Migration analysis modification for cerebellar astrocytes 
Scripts are organized in the same fashion as those for the migration analysis. 
See description found on page 305 for more information. 
# Load Data ---------------------------------------------------------- 
mig1R <- read.csv(file.choose(), 
                  header = TRUE 
                  ) 
 
# mig2 is the data set that will be used to plot cell tracks 
mig2 <- mig1R[mig1R$EF %in% c(0, 4, 40, 400) & mig1R$time <= 12, ] 
mig2$ef.factor <- factor(mig2$EF, 
                         levels = c(0, 4, 40, 400) 
                         ) 
 
mig1R$time[mig1R$EF == 0] <- mig1R$time[mig1R$EF == 0] - 0.5 
 
mig1R.baseline <- read.csv(file.choose(), 
                           header = TRUE 
                           ) 
mig1R <- rbind(mig1R.baseline, 
               mig1R 
               ) 
mig1R <- mig1R[mig1R$time >= 0 & mig1R$time <= 12, ] 
mig1R$ef.factor <- factor(mig1R$EF, 
                          levels = c(0, 4, 40, 400, "400-Reverse"), 
                          labels = c("0", "4", "40", "400", "400 (R)") 
                          ) 
 
mig1 <- mig1R[mig1R$ef.factor %in% levels(mig1R$ef.factor)[c(1:4)], ] 
mig1$ef.factor <- factor(mig1$ef.factor, 
                         levels = levels(mig1$ef.factor)[c(1:4)] 
                         ) 
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rm(mig1R.baseline) 
R Scripts for Chapter 4 
Plotting current density analysis 
### Load Packages ---------------------------------------------------- 
library(ggplot2) 
 
# These values were taken from the JMP analysis that I completed 
# on 7/6/15 
 
g1 <- c("Intact", "Lesioned") 
m1 <- c(13.43, -34.85) 
s1 <- c(4.394, 4.500) 
 
d1 <- data.frame(site = g1, 
                 mean = m1, 
                 sem = s1 
                 ) 
 
plot1 <- ggplot(data = d1, 
                aes(x = site, 
                    y = mean 
                    ) 
                ) +  
  geom_bar(stat = "identity", 
           colour = "grey", 
           fill = "grey", 
           width = .8, 
           position = "dodge" 
           ) + 
  geom_errorbar(aes(ymin = mean - sem, 
                    ymax = mean + sem 
                    ), 
                width = 0.25, 
                size = 1 
                ) + 
  geom_hline(yintercept = 0, 
             colour = "black", 
             size = 1.25 
             ) + 
  coord_cartesian(ylim = c(-45, 30)) + 
  scale_y_continuous(breaks = c(seq(-40, 20, 10)), 
                     labels = c(seq(-40, 20, 10)) 
                     ) + 
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  theme_bw(base_size = 28) + 
  theme(panel.grid = element_blank(), 
        panel.border = element_rect(colour = "black", 
                                    size = 1.25 
                                    ) 
        ) + 
  labs(y = expression(paste("Current Density: ", mu, "A/cm") ^2), 
       x = element_blank() 
       ) + 
  annotate("segment", 
           x = 1, 
           xend = 2, 
           y = 23, 
           yend = 23, 
           colour = "black", 
           size = 1.25 
           ) + 
  annotate("text", 
           x = 1.5, 
           y = 25, 
           size = rel(8), 
           label = "*p < 0.0001", 
           colour = "black" 
           ) 
plot1 
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